
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Immune and Vascular Function in Cardiometabolic Disorders: Interplay With Sex Differences and Impact on Incretin Therapy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532CB88AF1F6C3052CB80053EC9B7D.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368768/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Acta Physiologica (Oxford, England)">
<meta name="citation_title" content="Immune and Vascular Function in Cardiometabolic Disorders: Interplay With Sex Differences and Impact on Incretin Therapy">
<meta name="citation_author" content="Anirudh Subramanian Muralikrishnan">
<meta name="citation_author_institution" content="Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria">
<meta name="citation_author" content="Valentina Biasin">
<meta name="citation_author_institution" content="Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria">
<meta name="citation_author_institution" content="Lung Research Cluster, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria">
<meta name="citation_author" content="Diana Zabini">
<meta name="citation_author_institution" content="Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria">
<meta name="citation_author" content="Elena Osto">
<meta name="citation_author_institution" content="Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria">
<meta name="citation_author_institution" content="Vetsuisse Faculty, University of Zurich, Zurich, Switzerland">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="241">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="e70091">
<meta name="citation_doi" content="10.1111/apha.70091">
<meta name="citation_pmid" content="40838278">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368768/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368768/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368768/pdf/APHA-241-e70091.pdf">
<meta name="description" content="Vascular dysfunction, driven by endothelial impairment, arterial stiffness, inflammation, and immune activation, contributes to cardiometabolic disorders such as hypertension and atherosclerosis. Sex differences and sex hormones influence the ...">
<meta name="og:title" content="Immune and Vascular Function in Cardiometabolic Disorders: Interplay With Sex Differences and Impact on Incretin Therapy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Vascular dysfunction, driven by endothelial impairment, arterial stiffness, inflammation, and immune activation, contributes to cardiometabolic disorders such as hypertension and atherosclerosis. Sex differences and sex hormones influence the ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368768/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12368768">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/apha.70091"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/APHA-241-e70091.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368768%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12368768/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12368768/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368768/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/apha.70091" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Acta Physiol (Oxf)</button></div>. 2025 Aug 21;241(9):e70091. doi: <a href="https://doi.org/10.1111/apha.70091" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/apha.70091</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Acta%20Physiol%20(Oxf)%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Acta%20Physiol%20(Oxf)%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Acta%20Physiol%20(Oxf)%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Acta%20Physiol%20(Oxf)%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Immune and Vascular Function in Cardiometabolic Disorders: Interplay With Sex Differences and Impact on Incretin Therapy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Muralikrishnan%20AS%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Anirudh Subramanian Muralikrishnan</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Anirudh Subramanian Muralikrishnan</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Muralikrishnan%20AS%22%5BAuthor%5D" class="usa-link"><span class="name western">Anirudh Subramanian Muralikrishnan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Biasin%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Valentina Biasin</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Valentina Biasin</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Lung Research Cluster, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Biasin%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Valentina Biasin</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zabini%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Diana Zabini</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Diana Zabini</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zabini%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Diana Zabini</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Osto%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Elena Osto</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Elena Osto</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>Vetsuisse Faculty, University of Zurich, Zurich, Switzerland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Osto%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elena Osto</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="apha70091-aff-0001">
<sup>
<sup>1</sup>
</sup>Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria</div>
<div id="apha70091-aff-0002">
<sup>
<sup>2</sup>
</sup>Lung Research Cluster, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria</div>
<div id="apha70091-aff-0003">
<sup>
<sup>3</sup>
</sup>Vetsuisse Faculty, University of Zurich, Zurich, Switzerland</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Elena Osto (<span>elena.osto@medunigraz.at</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 10; Received 2024 Dec 6; Accepted 2025 Aug 5; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Acta Physiologica</em> published by John Wiley &amp; Sons Ltd on behalf of Scandinavian Physiological Society.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12368768  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40838278/" class="usa-link">40838278</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="apha70091-sec-1001"><h3 class="pmc_sec_title">Background and Aims</h3>
<p>Vascular dysfunction, driven by endothelial impairment, arterial stiffness, inflammation, and immune activation, contributes to cardiometabolic disorders such as hypertension and atherosclerosis. Sex differences and sex hormones influence the progression of vascular and immune dysfunction. Incretin hormones, including glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP), regulate glucose homeostasis and also impact vascular and immuno‐metabolic health. This review examines their roles in these processes, with emphasis on sex‐specific effects.</p></section><section id="apha70091-sec-1002"><h3 class="pmc_sec_title">Methods</h3>
<p>A narrative review of preclinical and clinical studies assessing GLP‐1 and GIP actions on vascular function, immune regulation, and metabolism, and their modulation by sex and sex hormones.</p></section><section id="apha70091-sec-1003"><h3 class="pmc_sec_title">Results</h3>
<p>Incretins improve endothelial function, reduce vascular inflammation, and modulate immune‐metabolic crosstalk, processes often impaired in cardiometabolic disease. Sex differences affect incretin secretion, signalling, and therapeutic responses, though underlying mechanisms remain unclear.</p></section><section id="apha70091-sec-1004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Incretin hormones are promising targets for improving vascular and immune‐metabolic health in cardiometabolic disorders. Understanding sex‐specific mechanisms will be essential for optimizing incretin‐based therapies.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> endothelial cells, GIP, GLP‐1, immune cells, incretins, sex differences</p></section></section><section id="apha70091-sec-0001"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Cardiometabolic disease (CMD) encompasses the interplay between metabolic dysfunction (such as obesity, dyslipidemia and diabetes), atherosclerotic cardiovascular disease, and its complications [<a href="#apha70091-bib-0001" class="usa-link" aria-describedby="apha70091-bib-0001">1</a>]. The development of CMD is influenced by multifaceted risk factors, including age [<a href="#apha70091-bib-0002" class="usa-link" aria-describedby="apha70091-bib-0002">2</a>], genetic predisposition [<a href="#apha70091-bib-0003" class="usa-link" aria-describedby="apha70091-bib-0003">3</a>], environmental factors like poor diet and physical inactivity, and hormonal disruptions such as insulin resistance [<a href="#apha70091-bib-0004" class="usa-link" aria-describedby="apha70091-bib-0004">4</a>]. CMDs share key pathological molecular mechanisms, including chronic inflammation and endothelial dysfunction [<a href="#apha70091-bib-0005" class="usa-link" aria-describedby="apha70091-bib-0005">5</a>]. Indeed, endothelial dysfunction driven by metabolic changes is considered one of the first hallmarks of CMD leading to impaired blood flow, hypertension, and atherosclerosis [<a href="#apha70091-bib-0006" class="usa-link" aria-describedby="apha70091-bib-0006">6</a>]. A systemic chronic low‐grade inflammation, driven by cellular metabolic alterations in multiple immune cell subsets, is observed throughout the different stages of CMD [<a href="#apha70091-bib-0007" class="usa-link" aria-describedby="apha70091-bib-0007">7</a>, <a href="#apha70091-bib-0008" class="usa-link" aria-describedby="apha70091-bib-0008">8</a>]. Incretin hormones, primarily glucagon‐like peptide‐1 (GLP‐1) and gastric inhibitory polypeptide (GIP), are gut‐derived peptides that regulate post‐prandial blood glucose levels by promoting insulin release and by inhibiting glucagon secretion in response to food intake [<a href="#apha70091-bib-0009" class="usa-link" aria-describedby="apha70091-bib-0009">9</a>, <a href="#apha70091-bib-0010" class="usa-link" aria-describedby="apha70091-bib-0010">10</a>]. Incretin‐based therapies using single agonists towards GLP‐1 receptor (GLP‐1R) or GIP receptor (GIPR) and dual agonists towards GLP‐1R/GIPR have proven to be effective therapeutic options in type 2 diabetes (T2D), obesity, and related CVDs [<a href="#apha70091-bib-0011" class="usa-link" aria-describedby="apha70091-bib-0011">11</a>, <a href="#apha70091-bib-0012" class="usa-link" aria-describedby="apha70091-bib-0012">12</a>]. However, incretin and incretin‐based therapies exert pleiotropic effects on the heart [<a href="#apha70091-bib-0013" class="usa-link" aria-describedby="apha70091-bib-0013">13</a>], brain [<a href="#apha70091-bib-0014" class="usa-link" aria-describedby="apha70091-bib-0014">14</a>, <a href="#apha70091-bib-0015" class="usa-link" aria-describedby="apha70091-bib-0015">15</a>], muscles, and adipose tissue [<a href="#apha70091-bib-0016" class="usa-link" aria-describedby="apha70091-bib-0016">16</a>]. Strong evidence indicates that these therapies offer cardiovascular benefits by improving endothelial dysfunction and reducing systemic inflammation [<a href="#apha70091-bib-0017" class="usa-link" aria-describedby="apha70091-bib-0017">17</a>, <a href="#apha70091-bib-0018" class="usa-link" aria-describedby="apha70091-bib-0018">18</a>].</p>
<p>This review provides an overview of vascular and immune functions and emerging evidence on their interaction with incretin hormones and analogs. Physiological and CMD conditions will be reviewed, particularly in relation to obesity, T2D, and associated cardiovascular risk factors such as hypertension and atherosclerosis. The discussion of molecular mechanisms will include a focus on sex differences, emphasizing the importance of incorporating sex‐dependent factors in CMD research. Sex will be considered as a biological variable, influenced by endocrine, genetic, and anatomical factors, while gender, shaped by social, economic, and political influences, will not be the primary focus of this review [<a href="#apha70091-bib-0019" class="usa-link" aria-describedby="apha70091-bib-0019">19</a>, <a href="#apha70091-bib-0020" class="usa-link" aria-describedby="apha70091-bib-0020">20</a>].</p></section><section id="apha70091-sec-0002"><h2 class="pmc_sec_title">2. Molecular Mechanisms in Physiology and CMD
</h2>
<section id="apha70091-sec-0003"><h3 class="pmc_sec_title">2.1. Endothelial Function</h3>
<p>Endothelial cells (ECs) are critical regulators of vascular function, serving as a dynamic interface between the bloodstream and surrounding tissues. ECs can regulate vascular tone in response to physiological demands, by synthesizing vasodilators, such as nitric oxide (NO) and prostacyclin [<a href="#apha70091-bib-0021" class="usa-link" aria-describedby="apha70091-bib-0021">21</a>, <a href="#apha70091-bib-0022" class="usa-link" aria-describedby="apha70091-bib-0022">22</a>], as well as vasoconstrictors, including Endothelin‐1 and Angiotensin II [<a href="#apha70091-bib-0023" class="usa-link" aria-describedby="apha70091-bib-0023">23</a>, <a href="#apha70091-bib-0024" class="usa-link" aria-describedby="apha70091-bib-0024">24</a>]. One of the most important vasodilatory mechanisms is the NO‐driven mechanism. In ECs, NO is produced by NO synthase (eNOS) from L‐Arginine, which, together with other co‐factors such as NADPH [<a href="#apha70091-bib-0025" class="usa-link" aria-describedby="apha70091-bib-0025">25</a>], leads to the production of NO [<a href="#apha70091-bib-0026" class="usa-link" aria-describedby="apha70091-bib-0026">26</a>]. NO is essential for vasodilation, as it diffuses to the adjacent vascular smooth muscle cells (VSMCs), where it activates guanylate cyclase [<a href="#apha70091-bib-0027" class="usa-link" aria-describedby="apha70091-bib-0027">27</a>]. The consequent production of cyclic guanosine monophosphate decreases intracellular calcium on VSMCs, leading to vascular relaxation and hence vasodilation [<a href="#apha70091-bib-0027" class="usa-link" aria-describedby="apha70091-bib-0027">27</a>]. Importantly, NADPH is not only critical for NO production, but also essential to counteract oxidative stress [<a href="#apha70091-bib-0028" class="usa-link" aria-describedby="apha70091-bib-0028">28</a>]. Given the oxygen‐rich arterial environment, NADPH ‐ among other anti‐oxidant agents‐ is fundamental to limit excessive oxidative stress [<a href="#apha70091-bib-0029" class="usa-link" aria-describedby="apha70091-bib-0029">29</a>]. Oxidative stress can lead to disruption of cell–cell contact with consequent increase of EC permeability [<a href="#apha70091-bib-0030" class="usa-link" aria-describedby="apha70091-bib-0030">30</a>], expression of adhesion molecules [<a href="#apha70091-bib-0031" class="usa-link" aria-describedby="apha70091-bib-0031">31</a>], recruitment of immune cells, and initiation of pro‐inflammatory processes [<a href="#apha70091-bib-0032" class="usa-link" aria-describedby="apha70091-bib-0032">32</a>]. Importantly, NADPH production is tightly connected to the EC metabolism, which can profoundly influence endothelial function [<a href="#apha70091-bib-0033" class="usa-link" aria-describedby="apha70091-bib-0033">33</a>]. In fact, quiescent ECs mostly rely on glycolysis for ATP production [<a href="#apha70091-bib-0034" class="usa-link" aria-describedby="apha70091-bib-0034">34</a>], while proliferating ECs decrease glycolysis in favor of fatty acid oxidation [<a href="#apha70091-bib-0035" class="usa-link" aria-describedby="apha70091-bib-0035">35</a>]. NADPH production can be indirectly enhanced by glycolysis, as glucose‐6 phosphate feeds into the pentose phosphate pathway—an essential source of NADPH [<a href="#apha70091-bib-0036" class="usa-link" aria-describedby="apha70091-bib-0036">36</a>]. Altogether, the endothelium's ability to supply surrounding tissues with essential nutrients, signaling molecules, and cellular components, as well as to regulate vascular tone, is tightly dependent on its metabolic state. Vascular endothelial dysfunction is closely associated with the onset and progression of obesity and related metabolic and cardiovascular complications, such as hypertension and atherosclerosis [<a href="#apha70091-bib-0037" class="usa-link" aria-describedby="apha70091-bib-0037">37</a>]. T2D, characterized by dysregulated glucose control, strongly affects EC metabolism [<a href="#apha70091-bib-0038" class="usa-link" aria-describedby="apha70091-bib-0038">38</a>]. Indeed, excessive glucose paradoxically impairs glycolysis [<a href="#apha70091-bib-0039" class="usa-link" aria-describedby="apha70091-bib-0039">39</a>], resulting in reduced NADPH and diminished anti‐oxidant effect [<a href="#apha70091-bib-0039" class="usa-link" aria-describedby="apha70091-bib-0039">39</a>]. An imbalance between reactive oxygen species (ROS) and anti‐oxidant defenses directly damages ECs, and reduces NO availability [<a href="#apha70091-bib-0040" class="usa-link" aria-describedby="apha70091-bib-0040">40</a>]. Similarly, while at physiological levels fatty acids are normally taken up by ECs and stored in lipid droplets [<a href="#apha70091-bib-0041" class="usa-link" aria-describedby="apha70091-bib-0041">41</a>], in excessive concentrations, they cause lipo‐toxicity, increase the permeability of the endothelium, and attract immune cells, further aggravating endothelial damage and inflammation [<a href="#apha70091-bib-0042" class="usa-link" aria-describedby="apha70091-bib-0042">42</a>] (Figure <a href="#apha70091-fig-0001" class="usa-link">1</a>).</p>
<figure class="fig xbox font-sm" id="apha70091-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572d/12368768/80834304eeb9/APHA-241-e70091-g003.jpg" loading="lazy" id="jats-graphic-1" height="408" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/apha70091-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Graphic representation of the endothelial and immune cell dysfunction in atherosclerotic CMD. Increased circulating glucose and fatty acids might affect both immune and endothelial cell metabolism. The elevated circulating lipids/fatty acids/oxidized low density lipoprotein accumulate underneath the endothelial layer, creating a lipid core in the atherosclerotic plaque. Increased permeability of the endothelium via reactive oxygen species (ROS) and excess lipid accumulation leads to lipo‐toxicity, causing enhanced transmigration of immune cells through the endothelial layer. Macrophages engulf the abundant lipids, transforming into foam cells. The increased permeability and the decreased nitric oxide (crossed‐NO symbol) production from endothelial cells exacerbate endothelial dysfunction. Concomitantly, pro‐inflammatory T‐cell subsets secrete pro‐inflammatory cytokines, which further augment endothelial dysfunction in a chronic and vicious loop. The box in the upper left corner indicates the known sex differences among endothelial and immune function in physiological conditions. CMD, cardiometabolic disease; IL, Interleukin; MMPs, metalloproteinases; oxLDL, oxidized low‐density lipoprotein; ROS, reactive oxygen species; TGF‐β, Transforming growth factor beta Created with Biorender; Th1, T helper 1 cells; Th17, T helper 17 cells; Th2, T helper 2 cells; TNFα, Tumor necrosis factor alpha; Treg, T regulatory cells.</p></figcaption></figure></section><section id="apha70091-sec-0004"><h3 class="pmc_sec_title">2.2. Sex Differences in Endothelial Function</h3>
<p>Various sex‐related differences impact endothelial function. While research exploring the role of sex chromosomes is beginning to emerge [<a href="#apha70091-bib-0043" class="usa-link" aria-describedby="apha70091-bib-0043">43</a>, <a href="#apha70091-bib-0044" class="usa-link" aria-describedby="apha70091-bib-0044">44</a>], the most extensively studied and well‐characterized influences are those driven by sex hormones [<a href="#apha70091-bib-0045" class="usa-link" aria-describedby="apha70091-bib-0045">45</a>]. Indeed, sex hormone receptors are present in endothelium [<a href="#apha70091-bib-0045" class="usa-link" aria-describedby="apha70091-bib-0045">45</a>, <a href="#apha70091-bib-0046" class="usa-link" aria-describedby="apha70091-bib-0046">46</a>] and in vitro experiments on different types of ECs, such as human pulmonary, aortic, coronary, and umbilical ECs, show that 17β‐estradiol enhances NO production [<a href="#apha70091-bib-0047" class="usa-link" aria-describedby="apha70091-bib-0047">47</a>, <a href="#apha70091-bib-0048" class="usa-link" aria-describedby="apha70091-bib-0048">48</a>]. Interestingly, the in vitro effect of androgens on eNOS expression and activation in human umbilical endothelial cells (HUVECs) is observed at physiological levels of testosterone or dihydrotestosterone (DHT) (100 pmol/L‐100 nmol/L) and lost with supra‐physiological levels (&gt; 100 nmol/L), suggesting that only a well‐defined concentration of testosterone or DHT can actually exert beneficial effects [<a href="#apha70091-bib-0049" class="usa-link" aria-describedby="apha70091-bib-0049">49</a>]. The increased NO production induced by androgens could partly reflect the conversion of androgens to estrogen by the aromatase enzyme, as this enzyme is present in ECs [<a href="#apha70091-bib-0049" class="usa-link" aria-describedby="apha70091-bib-0049">49</a>]. This conversion could, however, be specific to the microvasculature, as the aromatase enzyme is not expressed in the larger arteries, such as the aorta or the pulmonary artery [<a href="#apha70091-bib-0050" class="usa-link" aria-describedby="apha70091-bib-0050">50</a>]. 17β‐estradiol generally exerts a protective role in EC activation and the initiation of inflammation [<a href="#apha70091-bib-0051" class="usa-link" aria-describedby="apha70091-bib-0051">51</a>, <a href="#apha70091-bib-0052" class="usa-link" aria-describedby="apha70091-bib-0052">52</a>, <a href="#apha70091-bib-0053" class="usa-link" aria-describedby="apha70091-bib-0053">53</a>] by reducing tumor necrosis factor alpha (TNFα)‐mediated adhesion of monocytes and by reducing the production of interleukin 8 (IL‐8) and monocyte chemoattractant protein‐1 (MCP‐1) from HUVECs [<a href="#apha70091-bib-0051" class="usa-link" aria-describedby="apha70091-bib-0051">51</a>]. Interestingly, the decreased production of these pro‐inflammatory cytokines is due to their reduced secretion rather than reduced transcription, suggesting a non‐genomic action of 17β‐estradiol. These in vitro results were further confirmed in a clinical trial in which post‐menopausal women subjected to hormone replacement therapy with 17β‐estradiol display reduced MCP‐1 and adhesion molecule levels in their serum [<a href="#apha70091-bib-0052" class="usa-link" aria-describedby="apha70091-bib-0052">52</a>, <a href="#apha70091-bib-0053" class="usa-link" aria-describedby="apha70091-bib-0053">53</a>]. Similarly, to the effects of testosterone and DHT on NO production, the effect of androgens on EC activation is also concentration‐dependent. Some studies report a reduction of TNFα‐induced vascular cell adhesion protein 1 (VCAM‐1) in HUVECs and human aortic endothelial cells (HAECs) with physiological levels of DHT and testosterone (≤ 100 nM) [<a href="#apha70091-bib-0054" class="usa-link" aria-describedby="apha70091-bib-0054">54</a>, <a href="#apha70091-bib-0055" class="usa-link" aria-describedby="apha70091-bib-0055">55</a>]. Importantly, this reduction was mediated by the androgen receptor‐dependent transcription of nuclear factor kappa B (NFκB) [<a href="#apha70091-bib-0055" class="usa-link" aria-describedby="apha70091-bib-0055">55</a>]. On the other hand, a few studies also report increased NFκB‐dependent expression of VCAM‐1 in HUVECs and HAECs with supra‐physiological (400 nM) concentrations of testosterone [<a href="#apha70091-bib-0056" class="usa-link" aria-describedby="apha70091-bib-0056">56</a>, <a href="#apha70091-bib-0057" class="usa-link" aria-describedby="apha70091-bib-0057">57</a>]. This divergence in androgen effect is highly concentration‐dependent, supporting the notion of a well‐controlled mechanism of action. Altogether, sex hormones modulate endothelial function in a concentration‐dependent manner: 17β‐estradiol promotes NO production and reduces inflammation, while testosterone and DHT can be protective at physiological levels but pro‐inflammatory at high concentrations.</p>
<p>Sex hormone‐independent influence of ECs is less studied and characterized in the field of endothelial function. A recent genome‐wide association study (GWAS) performed on ECs isolated from umbilical cords of girl‐boy twins revealed that several genes are differentially expressed in the two sexes, and the difference is independent of the sex hormones [<a href="#apha70091-bib-0058" class="usa-link" aria-describedby="apha70091-bib-0058">58</a>]. Interestingly, one of these genes encoding for an ATPase (ATP2B1) which dampens eNOS function, shows lower expression in female [<a href="#apha70091-bib-0058" class="usa-link" aria-describedby="apha70091-bib-0058">58</a>]. These results align with the experimental findings, showing greater basal protein kinase G (PKG)‐mediated NO production in female rats compared with males, resulting in a reduced constrictor response to phenylephrine [<a href="#apha70091-bib-0059" class="usa-link" aria-describedby="apha70091-bib-0059">59</a>]. Interestingly, this effect was sex hormone‐independent, as proven by ovariectomy, suggesting an involvement of sex hormone‐independent mechanisms. Additionally, higher NO production and concomitant lowering of ROS levels was also shown in a study comparing female and male HUVECs [<a href="#apha70091-bib-0060" class="usa-link" aria-describedby="apha70091-bib-0060">60</a>] (Table <a href="#apha70091-tbl-0001" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="apha70091-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Qualitative overview of the main physiological differences between healthy female (pre‐menopausal) and male in endothelial and immune cells. Created with Biorender.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<tbody valign="top"><tr><td valign="middle" align="left" rowspan="1" colspan="1">
<img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572d/12368768/393963547110/APHA-241-e70091-g002.jpg" loading="lazy" alt="graphic file with name APHA-241-e70091-g002.jpg">
</td></tr></tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/apha70091-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Another GWAS study identified a higher male‐biased variant of the gene encoding for endothelin receptor A and for nectin‐2, involved in endothelial vasoconstriction and trans‐endothelial migration of leukocytes, respectively [<a href="#apha70091-bib-0061" class="usa-link" aria-describedby="apha70091-bib-0061">61</a>], supporting increased vasodilation and decreased permeability in females compared to males (Table <a href="#apha70091-tbl-0001" class="usa-link">1</a>). DNA methylation studies revealed that men display an inactivation of cystathionine γ‐lyase due to its hypermethylation [<a href="#apha70091-bib-0062" class="usa-link" aria-describedby="apha70091-bib-0062">62</a>]. This enzyme is responsible for producing hydrogen sulphide, which acts as a vasodilator and anti‐oxidant in the endothelium [<a href="#apha70091-bib-0063" class="usa-link" aria-describedby="apha70091-bib-0063">63</a>]. Altogether, these results show a sex hormone‐independent importance of sex‐specific epigenetic mechanisms and sex‐driven genetic variance.</p>
<p>Altogether, these results suggest that sex hormone–independent biological differences may create an intrinsic vulnerability for CVD in men compared to women. In women, the loss of the additive protective effect of 17β‐estradiol during menopause could potentially explain the higher cardiometabolic risk in post‐menopausal women [<a href="#apha70091-bib-0064" class="usa-link" aria-describedby="apha70091-bib-0064">64</a>].</p></section><section id="apha70091-sec-0005"><h3 class="pmc_sec_title">2.3. Immune Cell and Cytokine Function</h3>
<p>Immune cells defend the body against pathogens, regulate tissue surveillance and repair, and maintain metabolism and inflammation [<a href="#apha70091-bib-0065" class="usa-link" aria-describedby="apha70091-bib-0065">65</a>]. A dysregulation of these physiological mechanisms contributes to the progression of all CMDs, leading to a characteristic chronic low‐grade inflammation. This occurs as a result of immune dysfunction, characterized by changes in the circulating levels of cytokines via increased inflammatory mediators like IL‐1β, IL‐6, Interferon gamma (IFN‐γ), TNF‐α, and reduced levels of cytokines like adiponectin and IL‐10, which have an anti‐inflammatory function [<a href="#apha70091-bib-0066" class="usa-link" aria-describedby="apha70091-bib-0066">66</a>]. Among several different immune cells, this section will focus on the three major homeostatic balances in immune cell phenotype that need to be maintained for healthy function.</p>
<p>The immune dysfunction and chronic low‐grade inflammation both result from dysregulation in the delicate balance between three pairs of pro‐inflammatory and anti‐inflammatory immune cells: M1/M2 macrophages, CD4‐positive (CD4+) type 1 helper (Th1)/Type 2 helper (Th2) and IL‐17 secreting (Th17)/regulatory T (Treg) cells [<a href="#apha70091-bib-0067" class="usa-link" aria-describedby="apha70091-bib-0067">67</a>].</p>
<section id="apha70091-sec-0006"><h4 class="pmc_sec_title">2.3.1. Macrophages</h4>
<p>Macrophages are versatile immune cells that maintain tissue homeostasis, orchestrate immune responses, and facilitate repair processes [<a href="#apha70091-bib-0068" class="usa-link" aria-describedby="apha70091-bib-0068">68</a>]. Derived from monocytes or yolk‐sac progenitors during embryogenesis, macrophages are widely distributed across tissues, adapting their functions to meet the specific physiological demands of their local environments [<a href="#apha70091-bib-0069" class="usa-link" aria-describedby="apha70091-bib-0069">69</a>]. For example, macrophages contribute to embryonic development by shaping tissues and vasculature through secretion of growth factors like vascular endothelial growth factor [<a href="#apha70091-bib-0070" class="usa-link" aria-describedby="apha70091-bib-0070">70</a>]. They also have a key function in tissue injury and repair through secretion of growth factors like transforming growth factor beta (TGFβ) and platelet‐derived growth factor, which support regeneration [<a href="#apha70091-bib-0071" class="usa-link" aria-describedby="apha70091-bib-0071">71</a>].</p>
<p>When dysregulated, they act as key drivers of inflammation and tissue remodeling in CMD, and their dysfunction in the balance between the M1/M2 phenotypes (Table <a href="#apha70091-tbl-0002" class="usa-link">2</a>) perpetuates inflammation, metabolic dysregulation, and cardiovascular strain, driving the progression of diseases such as atherosclerosis and hypertension [<a href="#apha70091-bib-0072" class="usa-link" aria-describedby="apha70091-bib-0072">72</a>]. Macrophages have been extensively studied in the context of CMDs, where, in obesity and T2D a polarization occurs towards the M1 pro‐inflammatory phenotype, mainly in the adipose tissue. This shift results in a reduction of M2 phenotype macrophages, which, in turn reduce anti‐inflammatory signals while driving up pro‐inflammatory signals [<a href="#apha70091-bib-0073" class="usa-link" aria-describedby="apha70091-bib-0073">73</a>]. In atherosclerosis, circulating monocytes are recruited to atherosclerotic lesions where they activate to become macrophages and engulf oxidized low‐density lipoprotein (oxLDL), transforming into foam cells that secrete cytokines (e.g., IL‐1β, TNF‐α) and matrix metalloproteinases (MMPs), promoting inflammation, plaque instability, and potential rupture [<a href="#apha70091-bib-0074" class="usa-link" aria-describedby="apha70091-bib-0074">74</a>]. In a rat model of hypertension, macrophages caused inflammation in ECs through macrophage‐derived exosomes [<a href="#apha70091-bib-0075" class="usa-link" aria-describedby="apha70091-bib-0075">75</a>]. Macrophages contribute to intimal thickening, extracellular matrix remodeling, and fibrous cap formation through IL‐1β‐mediated interaction with VSMCs in a STAT3‐dependent manner—all processes that are hallmarks of vascular remodeling during atherosclerosis progression [<a href="#apha70091-bib-0076" class="usa-link" aria-describedby="apha70091-bib-0076">76</a>].</p>
<section class="tw xbox font-sm" id="apha70091-tbl-0002"><h5 class="obj_head">TABLE 2.</h5>
<div class="caption p"><p>Specification of different immune cell subsets.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Cell type</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Abbreviation</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Surface markers</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Transcription factor</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Secretory profile</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Role in CMD</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Type1 macrophages</td>
<td align="center" valign="top" rowspan="1" colspan="1">M1</td>
<td align="center" valign="top" rowspan="1" colspan="1">MHC‐II CD86+ CD80+</td>
<td align="center" valign="top" rowspan="1" colspan="1">IRF3, IRF5</td>
<td align="center" valign="top" rowspan="1" colspan="1">TNFa, IL6, IL12</td>
<td align="center" rowspan="3" valign="top" colspan="1">Proinflammatory</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">T‐helper 1</td>
<td align="center" valign="top" rowspan="1" colspan="1">Th1</td>
<td align="center" valign="top" rowspan="1" colspan="1">CD4+ CXCR3− CCR4− CCR6+</td>
<td align="center" valign="top" rowspan="1" colspan="1">T‐bet</td>
<td align="center" valign="top" rowspan="1" colspan="1">IFN‐γ, TNF‐α</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">T‐helper 17</td>
<td align="center" valign="top" rowspan="1" colspan="1">Th17</td>
<td align="center" valign="top" rowspan="1" colspan="1">CD4+ CXCR3+ CCR4− CCR6−</td>
<td align="center" valign="top" rowspan="1" colspan="1">RORC2</td>
<td align="center" valign="top" rowspan="1" colspan="1">IL‐17, IL‐22</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Type 2 macrophages</td>
<td align="center" valign="top" rowspan="1" colspan="1">M2</td>
<td align="center" valign="top" rowspan="1" colspan="1">CD163+ CD206+ CD209+</td>
<td align="center" valign="top" rowspan="1" colspan="1">IRF4, KLF4</td>
<td align="center" valign="top" rowspan="1" colspan="1">Arginase‐1, IL10</td>
<td align="center" rowspan="3" valign="top" colspan="1">Anti‐inflammatory</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">T‐helper 2</td>
<td align="center" valign="top" rowspan="1" colspan="1">Th2</td>
<td align="center" valign="top" rowspan="1" colspan="1">CD4+ CXCR3− CCR4+ CCR6−</td>
<td align="center" valign="top" rowspan="1" colspan="1">GATA‐3</td>
<td align="center" valign="top" rowspan="1" colspan="1">IL‐4, IL‐5, IL‐13</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Regulatory T cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Treg</td>
<td align="center" valign="top" rowspan="1" colspan="1">CD4+ CD25+ CD127−</td>
<td align="center" valign="top" rowspan="1" colspan="1">FOXP3</td>
<td align="center" valign="top" rowspan="1" colspan="1">IL‐10, TGF‐β</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/apha70091-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="apha70091-sec-0007"><h4 class="pmc_sec_title">2.3.2. 
CD4 ± T‐Cells</h4>
<p>CD4 + T‐cells, also known as helper T‐cells, are a crucial subset of lymphocytes in the adaptive immune system that play a central role in coordinating and orchestrating the activity of innate and adaptive immune cells through cytokine secretion and cell–cell interactions [<a href="#apha70091-bib-0077" class="usa-link" aria-describedby="apha70091-bib-0077">77</a>]. CD4 + T‐cells secrete specific cytokines based on their differentiation into distinct subsets with specific functions (Table <a href="#apha70091-tbl-0002" class="usa-link">2</a>). The activation and differentiation of CD4 + T‐cells are influenced metabolically. In a naive state, T‐cells primarily rely on oxidative phosphorylation and fatty acid oxidation for ATP generation. Upon activation, they shift to glycolysis for rapid energy production, even in the presence of oxygen, following the classic Warburg effect, to support effector differentiation [<a href="#apha70091-bib-0078" class="usa-link" aria-describedby="apha70091-bib-0078">78</a>].</p>
<p>CD4 + T‐cells play a significant role in orchestrating inflammation, contributing to disease initiation, progression, and complications. The balance between pro‐inflammatory and regulatory subsets of CD4 + T‐cells is critical in determining the overall immune response in CMD [<a href="#apha70091-bib-0079" class="usa-link" aria-describedby="apha70091-bib-0079">79</a>]. Apart from the dysregulation of the pro/anti‐inflammatory balance in CMD, a shift towards a state of cellular dysfunction that occurs after prolonged activation is observed, termed T‐cell exhaustion [<a href="#apha70091-bib-0080" class="usa-link" aria-describedby="apha70091-bib-0080">80</a>, <a href="#apha70091-bib-0081" class="usa-link" aria-describedby="apha70091-bib-0081">81</a>]. The persistent low‐grade inflammation and metabolic stress can drive T‐cell exhaustion, causing progressive loss of effector functions, reduced cytokine production, and impaired proliferation [<a href="#apha70091-bib-0082" class="usa-link" aria-describedby="apha70091-bib-0082">82</a>, <a href="#apha70091-bib-0083" class="usa-link" aria-describedby="apha70091-bib-0083">83</a>]. This section discusses the CD4+ subsets in the context of obesity, T2D, and related comorbidities.</p>
<section id="apha70091-sec-0008"><h5 class="pmc_sec_title">2.3.2.1. Th1/Th2 Balance</h5>
<p>Th1 cells function through the production of IFN‐γ, exacerbating tissue damage and metabolic imbalances, fueling a cycle that worsens CMD. In obesity, elevated levels of certain fatty acids (e.g., butyrate) promote Th1 differentiation in humans and mice [<a href="#apha70091-bib-0084" class="usa-link" aria-describedby="apha70091-bib-0084">84</a>, <a href="#apha70091-bib-0085" class="usa-link" aria-describedby="apha70091-bib-0085">85</a>], while systemic metabolic stress further activates Th1 cells [<a href="#apha70091-bib-0086" class="usa-link" aria-describedby="apha70091-bib-0086">86</a>]. In mice, an imbalance in the Th1/Th2 ratio towards a pro‐Th1 phenotype leads to increased atherosclerotic progression in an IL‐6‐dependent manner, working in tandem with acute phase reactants like serum amyloid A [<a href="#apha70091-bib-0087" class="usa-link" aria-describedby="apha70091-bib-0087">87</a>]. Additionally, Th1 cells are involved in hypertension pathogenesis via IFN‐γ‐induced overexpression of angiotensin in rat renal proximal tubule cells in a JAK2/STAT3‐dependent manner [<a href="#apha70091-bib-0088" class="usa-link" aria-describedby="apha70091-bib-0088">88</a>, <a href="#apha70091-bib-0089" class="usa-link" aria-describedby="apha70091-bib-0089">89</a>]. The IFN‐γ secreted by Th1 cells also causes activation of cardiac fibroblasts by inducing TGF‐β in mice [<a href="#apha70091-bib-0090" class="usa-link" aria-describedby="apha70091-bib-0090">90</a>], suggesting an immune‐mediated mechanism for cardiac fibrosis and dysfunction resulting in heart failure. Th2 cell responses, which normally occur through the secretion of cytokines like IL‐4, IL‐5, and IL‐13, are very context‐dependent. In obesity, Th2 cells promote downstream differentiation of M2‐macrophages via the activation of STAT6 in adipose tissue, promoting a more anti‐inflammatory profile [<a href="#apha70091-bib-0091" class="usa-link" aria-describedby="apha70091-bib-0091">91</a>]; however, chronic Th2 activation can paradoxically contribute to metabolic dysregulation by inducing fibrosis and altering tissue structure [<a href="#apha70091-bib-0092" class="usa-link" aria-describedby="apha70091-bib-0092">92</a>]. On the other hand, IL‐4 and IL‐13 can stimulate cardiac fibroblasts and inadvertently promote maladaptive tissue remodeling and fibrosis, worsening outcomes in conditions like hypertension, obesity, and heart failure [<a href="#apha70091-bib-0093" class="usa-link" aria-describedby="apha70091-bib-0093">93</a>].</p></section><section id="apha70091-sec-0009"><h5 class="pmc_sec_title">2.3.2.2. Th17/Treg Balance</h5>
<p>Th17 cells contribute to CMD by producing the pro‐inflammatory cytokine IL‐17, which recruits and activates neutrophils and amplifies inflammation in affected tissues such as adipose, liver, and vascular walls [<a href="#apha70091-bib-0094" class="usa-link" aria-describedby="apha70091-bib-0094">94</a>]. In hypertension in rats, Th17 cells increase blood pressure and induce vascular dysfunction by strongly enhancing pathways that lead to an increase in salt reabsorption and elevated vascular tone [<a href="#apha70091-bib-0095" class="usa-link" aria-describedby="apha70091-bib-0095">95</a>]. At a molecular level, Th17‐mediated IL‐17 secretion via the MAPK‐NFκB signaling could promote oxidative stress and further inflammatory cytokine release contributing to hypertension [<a href="#apha70091-bib-0096" class="usa-link" aria-describedby="apha70091-bib-0096">96</a>]. Studies on rodent models of hypertension induced by Angiotensin II [<a href="#apha70091-bib-0095" class="usa-link" aria-describedby="apha70091-bib-0095">95</a>], mineralocorticoid‐dependent hypertension [<a href="#apha70091-bib-0097" class="usa-link" aria-describedby="apha70091-bib-0097">97</a>], hypertension in response to cyclosporine A [<a href="#apha70091-bib-0098" class="usa-link" aria-describedby="apha70091-bib-0098">98</a>], or in a model of pre‐eclampsia [<a href="#apha70091-bib-0099" class="usa-link" aria-describedby="apha70091-bib-0099">99</a>] with IL‐17 attenuation by genetic intervention or by receptor blockade have all shown that a lack of IL‐17 prevents hypertension. Th17 cells also exacerbate obesity‐related insulin resistance by increasing inflammation in adipose tissue [<a href="#apha70091-bib-0100" class="usa-link" aria-describedby="apha70091-bib-0100">100</a>]. In obesity, elevated IL‐6 causes the number of Th17 cells to increase. IL‐17 secreted by Th17 targets adipocytes and triggers downstream pro‐inflammatory signaling, while IL‐21 secreted by Th17 inhibits Treg differentiation and function [<a href="#apha70091-bib-0101" class="usa-link" aria-describedby="apha70091-bib-0101">101</a>]. These effects in obesity, in turn, accelerate progression to CVDs. Th17‐mediated pro‐inflammatory responses and reduction in Treg‐mediated anti‐inflammatory responses exacerbate atherosclerosis, acute coronary syndrome, and congestive heart failure [<a href="#apha70091-bib-0102" class="usa-link" aria-describedby="apha70091-bib-0102">102</a>]. In heart failure with preserved ejection fraction, elevated Th17 cell activity contributes to fibrosis and cardiac dysfunction, worsening disease progression and outcomes [<a href="#apha70091-bib-0103" class="usa-link" aria-describedby="apha70091-bib-0103">103</a>]. Treg cells are best known as critical regulators of inflammation and metabolism and function by secreting suppressive cytokines like IL‐10 and TGF‐β [<a href="#apha70091-bib-0104" class="usa-link" aria-describedby="apha70091-bib-0104">104</a>].</p></section></section></section><section id="apha70091-sec-0010"><h3 class="pmc_sec_title">2.4. Sex Differences in Immune Function</h3>
<p>Sex differences in immune responses are influenced by genetic, hormonal, and environmental factors. The X chromosome carries numerous immune‐related genes, including those encoding Toll‐like receptors (e.g., TLR7), cytokine receptors, and immune signaling molecules [<a href="#apha70091-bib-0105" class="usa-link" aria-describedby="apha70091-bib-0105">105</a>]. The Y chromosome encodes male‐specific factors that modulate immunity, such as male‐specific minor histocompatibility antigens [<a href="#apha70091-bib-0106" class="usa-link" aria-describedby="apha70091-bib-0106">106</a>]. Sex hormones modulate immune responses by influencing the activity of immune cells, driving stronger immunity against infections in women (via estrogens) and suppressing inflammation in men (via androgens) [<a href="#apha70091-bib-0107" class="usa-link" aria-describedby="apha70091-bib-0107">107</a>]. These factors together contribute to females typically having more robust macrophage activation (Table <a href="#apha70091-tbl-0001" class="usa-link">1</a>) and cytokine production, such as TNF‐α, IL‐1β, and IL‐6, compared to males. Women also have a higher CD4 + T‐cell count and greater cytokine production (e.g., IL‐4, IL‐10), favoring Th2 responses [<a href="#apha70091-bib-0108" class="usa-link" aria-describedby="apha70091-bib-0108">108</a>]. Men exhibit a higher proportion of CD8<sup>+</sup> T‐cells but with reduced cytotoxicity and persistence [<a href="#apha70091-bib-0108" class="usa-link" aria-describedby="apha70091-bib-0108">108</a>] (Table <a href="#apha70091-tbl-0001" class="usa-link">1</a>).</p>
<p>Sex differences therefore play a crucial role by driving differences in immune cell populations. In fact, macrophages and T‐cells and have diverse functions, contributing to sex‐specific CMD development by mediating inflammation, tissue remodeling, and metabolic regulation.</p>
<p>17β‐estradiol in pre‐menopausal women generally enhances anti‐inflammatory immune functions. It promotes regulatory Treg activity, which helps suppress excessive inflammation by releasing cytokines like IL‐10 and TGF‐β, supporting tissue tolerance and immune homeostasis [<a href="#apha70091-bib-0109" class="usa-link" aria-describedby="apha70091-bib-0109">109</a>]. Differences in levels of 17β‐estradiol can also affect the balance between Th1/Th2 cell types, where lower levels (luteal phase) encourage a skew towards the Th1 phenotype via IFN‐γ [<a href="#apha70091-bib-0110" class="usa-link" aria-describedby="apha70091-bib-0110">110</a>] and higher levels (follicular phase) promote Th2 differentiation through increased IL‐4 production [<a href="#apha70091-bib-0111" class="usa-link" aria-describedby="apha70091-bib-0111">111</a>]. 17β‐estradiol also pushes macrophages to adopt an M2 phenotype, which is associated with tissue repair and anti‐inflammatory effects [<a href="#apha70091-bib-0112" class="usa-link" aria-describedby="apha70091-bib-0112">112</a>]. Pre‐menopausal women have a lower prevalence of atherosclerosis and hypertension than age‐matched men [<a href="#apha70091-bib-0113" class="usa-link" aria-describedby="apha70091-bib-0113">113</a>] which could be partly attributed to this estrogen‐mediated immune modulation, providing a degree of protection against CMD‐related inflammation in women [<a href="#apha70091-bib-0114" class="usa-link" aria-describedby="apha70091-bib-0114">114</a>]. However, after menopause, with declining 17β‐estradiol levels, Tregs and M2 macrophages decrease, and inflammatory T‐cell populations like Th1 and Th17 increase, resembling the more pro‐inflammatory immune environment typically seen in men. This shift corresponds to a heightened CMD risk in post‐menopausal women [<a href="#apha70091-bib-0115" class="usa-link" aria-describedby="apha70091-bib-0115">115</a>].</p>
<p>In clinical studies, testosterone provides anti‐inflammatory effects via the suppression of pro‐inflammatory cytokines and the simultaneous enhancement of anti‐inflammatory cytokines [<a href="#apha70091-bib-0116" class="usa-link" aria-describedby="apha70091-bib-0116">116</a>]. In vitro studies using peripheral blood mononuclear cells from humans treated with anabolic androgen (metribolone) and in vivo studies using orchiectomized animal models have shown that androgens inhibit Th1 and potentially Th17 differentiation through up‐regulation of phosphatase Ptpn1 [<a href="#apha70091-bib-0117" class="usa-link" aria-describedby="apha70091-bib-0117">117</a>], while causing (DHT‐treated CD4 + T‐cells) an expansion of Treg by upregulating FOXP3 expression [<a href="#apha70091-bib-0118" class="usa-link" aria-describedby="apha70091-bib-0118">118</a>]. Several correlation studies have shown that endogenous testosterone levels in men declines with age, while cardiovascular mortality increases [<a href="#apha70091-bib-0119" class="usa-link" aria-describedby="apha70091-bib-0119">119</a>, <a href="#apha70091-bib-0120" class="usa-link" aria-describedby="apha70091-bib-0120">120</a>, <a href="#apha70091-bib-0121" class="usa-link" aria-describedby="apha70091-bib-0121">121</a>, <a href="#apha70091-bib-0122" class="usa-link" aria-describedby="apha70091-bib-0122">122</a>]. Though at physiologically optimal levels, testosterone is considered cardioprotective, one study has shown that, similarly to high testosterone levels, low levels of testosterone are also correlated with an increased risk of ischemic arterial events [<a href="#apha70091-bib-0123" class="usa-link" aria-describedby="apha70091-bib-0123">123</a>]. The effects of testosterone on CMD could be through modulation of immune cells, but this needs further understanding. Overall, these sex‐based immune differences affect CMD progression, with women showing a greater predisposition towards autoimmune diseases [<a href="#apha70091-bib-0124" class="usa-link" aria-describedby="apha70091-bib-0124">124</a>], and men showing testosterone dose‐dependent CMD phenotypes. Understanding these mechanisms may improve precision treatments, considering sex‐specific immune responses to address CMDs more effectively.</p></section></section><section id="apha70091-sec-0011"><h2 class="pmc_sec_title">3. The Incretins in Physiology and Disease</h2>
<section id="apha70091-sec-0012"><h3 class="pmc_sec_title">3.1. Incretin and Incretin‐Analog Biology</h3>
<p>Incretins are members of the glucagon superfamily and are gut‐derived hormones that play an important role in whole‐body physiology. There are two main incretin hormones in humans, namely GLP‐1 and GIP. GLP‐1 is derived from the proglucagon‐preprotein (encoded by the GCG gene) and processed into its active form through multiple cleavage steps [<a href="#apha70091-bib-0125" class="usa-link" aria-describedby="apha70091-bib-0125">125</a>]. This occurs mostly in specialized epithelial cells called enteroendocrine L‐cells, located within the mucosal lining of the ileum and colon in the gastrointestinal tract [<a href="#apha70091-bib-0126" class="usa-link" aria-describedby="apha70091-bib-0126">126</a>], and only in a minor percentage in the pancreatic α‐cells [<a href="#apha70091-bib-0127" class="usa-link" aria-describedby="apha70091-bib-0127">127</a>, <a href="#apha70091-bib-0128" class="usa-link" aria-describedby="apha70091-bib-0128">128</a>, <a href="#apha70091-bib-0129" class="usa-link" aria-describedby="apha70091-bib-0129">129</a>, <a href="#apha70091-bib-0130" class="usa-link" aria-describedby="apha70091-bib-0130">130</a>]. GLP‐1 is secreted in response to carbohydrate and fat intake to enhance insulin secretion from pancreatic β‐cells in a glucose‐dependent manner. Moreover, GLP‐1 inhibits glucagon release and slows gastric emptying, promoting satiety and reducing food intake [<a href="#apha70091-bib-0131" class="usa-link" aria-describedby="apha70091-bib-0131">131</a>, <a href="#apha70091-bib-0132" class="usa-link" aria-describedby="apha70091-bib-0132">132</a>, <a href="#apha70091-bib-0133" class="usa-link" aria-describedby="apha70091-bib-0133">133</a>]. Additionally, GLP‐1 enhances browning of white adipose tissue, increases intracellular cholesterol efflux in macrophages, and also limits steatosis in the liver [<a href="#apha70091-bib-0134" class="usa-link" aria-describedby="apha70091-bib-0134">134</a>, <a href="#apha70091-bib-0135" class="usa-link" aria-describedby="apha70091-bib-0135">135</a>, <a href="#apha70091-bib-0136" class="usa-link" aria-describedby="apha70091-bib-0136">136</a>]. GIP is produced in K‐cells of the small intestine; it is similarly stimulated by nutrient ingestion, particularly carbohydrates and fats, and functions by controlling nutrient balance and blood glucose levels [<a href="#apha70091-bib-0010" class="usa-link" aria-describedby="apha70091-bib-0010">10</a>]. GIP may stimulate glucagon release in certain conditions such as T2D [<a href="#apha70091-bib-0137" class="usa-link" aria-describedby="apha70091-bib-0137">137</a>] and plays a role in lipid metabolism by promoting triglyceride clearance from blood and increasing fat storage in adipocytes [<a href="#apha70091-bib-0138" class="usa-link" aria-describedby="apha70091-bib-0138">138</a>, <a href="#apha70091-bib-0139" class="usa-link" aria-describedby="apha70091-bib-0139">139</a>]. GLP‐1 and GIP carry out their signaling through G‐protein coupled receptors: GLP‐1R and GIPR, respectively. In the blood circulation, GLP‐1 and GIP both have very short half‐lives of just a few minutes, being degraded by dipeptidyl peptidase‐4 (DPP4)‐mediated proteolysis which is the mechanism that maintains incretin hormone homeostasis [<a href="#apha70091-bib-0140" class="usa-link" aria-describedby="apha70091-bib-0140">140</a>].</p>
<p>The therapeutic use of incretin mimetics, particularly GLP‐1R agonists and dual agonists to GLP‐1R/GIPR, has gained prominence in the last decade. The agonists enhance insulin secretion in a glucose‐dependent manner, suppressing glucagon release, and promoting weight loss by increasing satiety [<a href="#apha70091-bib-0009" class="usa-link" aria-describedby="apha70091-bib-0009">9</a>, <a href="#apha70091-bib-0141" class="usa-link" aria-describedby="apha70091-bib-0141">141</a>, <a href="#apha70091-bib-0142" class="usa-link" aria-describedby="apha70091-bib-0142">142</a>]. Incretin‐based therapy exerts effects such as reducing body weight (BW) by influencing appetite in the brain [<a href="#apha70091-bib-0143" class="usa-link" aria-describedby="apha70091-bib-0143">143</a>] as shown in a clinical trial with semaglutide vs. placebo [<a href="#apha70091-bib-0144" class="usa-link" aria-describedby="apha70091-bib-0144">144</a>] Additionally, incretin‐based therapy decreases adipose tissue mass and enhances EC vasodilation, as evidenced by a clinical trial with exenatide in male patients with hypertension and other cardiovascular complications associated with obesity and T2D [<a href="#apha70091-bib-0145" class="usa-link" aria-describedby="apha70091-bib-0145">145</a>]. The effect of co‐administration of GIPR and GLP‐1R agonists in rodents has shown enhanced effects on lowering blood glucose and promoting weight loss [<a href="#apha70091-bib-0146" class="usa-link" aria-describedby="apha70091-bib-0146">146</a>]. Tirzepatide, an imbalanced dual agonist of GLP‐1R/GIPR, has been approved for therapy in both T2D [<a href="#apha70091-bib-0147" class="usa-link" aria-describedby="apha70091-bib-0147">147</a>] and obesity [<a href="#apha70091-bib-0148" class="usa-link" aria-describedby="apha70091-bib-0148">148</a>]. Clinical trials with tirzepatide have shown a greater effect on glycemic control through improving β‐cell function while reducing glucose excursions, in terms of lowering insulin and glucagon secretion, compared to single GLP‐1R agonist therapy, supporting the beneficial role of the GIPR agonist [<a href="#apha70091-bib-0149" class="usa-link" aria-describedby="apha70091-bib-0149">149</a>]. On a molecular level in human pancreatic cells, tirzepatide has high affinity for GIPR‐based signaling while a lower affinity towards GLP‐1R [<a href="#apha70091-bib-0150" class="usa-link" aria-describedby="apha70091-bib-0150">150</a>]. This mechanism leads to internalization of the GIPR, working effectively as a functional antagonist of GIP instead of its intended agonistic purpose [<a href="#apha70091-bib-0151" class="usa-link" aria-describedby="apha70091-bib-0151">151</a>]. Along this notion, an ongoing phase 2 clinical trial employing GLP‐1R agonist/GIPR antagonists (MariTide, <a href="https://clinicaltrials.gov/ct2/show/NCT05669599" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05669599</a>) has also shown effective reduction in BW and better glycemic control compared to the placebo arm. Altogether, the exact mechanisms by which GIPR‐targeting drugs exert their effects remain unclear—particularly whether they act through receptor agonism or antagonism [<a href="#apha70091-bib-0152" class="usa-link" aria-describedby="apha70091-bib-0152">152</a>]—highlighting the need for further research.</p></section><section id="apha70091-sec-0013"><h3 class="pmc_sec_title">3.2. Effects of Incretins in Endothelial Cells</h3>
<p>GLP‐1R and GIPR are present on venous and arterial vascular ECs [<a href="#apha70091-bib-0153" class="usa-link" aria-describedby="apha70091-bib-0153">153</a>, <a href="#apha70091-bib-0154" class="usa-link" aria-describedby="apha70091-bib-0154">154</a>], enabling direct actions of hormones or agonists. Indeed, GLP‐1, but not GIP, increases NO production in HUVECs through cAMP signaling [<a href="#apha70091-bib-0153" class="usa-link" aria-describedby="apha70091-bib-0153">153</a>]. Similarly, the GLP‐1R agonist exendin activates the PI3K/Akt –eNOS pathway in human coronary artery ECs (HCAECs), resulting in increased proliferation as well [<a href="#apha70091-bib-0155" class="usa-link" aria-describedby="apha70091-bib-0155">155</a>]. An in vitro study using palmitate‐induced oxidative injury in islet microvascular ECs shows that liraglutide treatment ameliorates oxidative injury in a PKA/eNOS‐dependent manner [<a href="#apha70091-bib-0156" class="usa-link" aria-describedby="apha70091-bib-0156">156</a>]. In line with this study, in vivo, GLP‐1R activation by liraglutide preserved endothelium‐mediated vasorelaxation in Angiotensin II‐induced hypertensive rats [<a href="#apha70091-bib-0154" class="usa-link" aria-describedby="apha70091-bib-0154">154</a>]. In this study, the preserved NO bioavailability in liraglutide‐treated rats resulted from decreased oxidative stress and prevented uncoupling of eNOS due to a lower vessel wall infiltration of inflammatory monocytes and neutrophils [<a href="#apha70091-bib-0154" class="usa-link" aria-describedby="apha70091-bib-0154">154</a>]. Corroborating the anti‐inflammatory effect of GLP‐1 and its analogues, another study showed that GLP‐1 limited the advanced glycation end product (AGE)‐induced up‐regulation of VCAM‐1 expression in hyperglycemic HUVECs by suppressing the receptor of AGE (RAGE) and the subsequent generation of ROS [<a href="#apha70091-bib-0157" class="usa-link" aria-describedby="apha70091-bib-0157">157</a>]. However, not only the anti‐inflammatory effects induced by GLP‐1 are PI3K/Akt/eNOS‐mediated, but also its angiogenic potential. Indeed, recent studies demonstrate that GLP‐1 promotes angiogenesis not only in vitro in HUVECs [<a href="#apha70091-bib-0158" class="usa-link" aria-describedby="apha70091-bib-0158">158</a>] but also in vivo in a model of diabetic hind‐limb ischemia [<a href="#apha70091-bib-0159" class="usa-link" aria-describedby="apha70091-bib-0159">159</a>]. In both studies, the angiogenic effect was mediated by the Akt/eNOS pathway, suggesting a crucial role of this pathway in many GLP‐1‐induced effects. GLP‐1‐mediated pathways have also been implicated in reversing endothelial dysfunction in obese rats [<a href="#apha70091-bib-0160" class="usa-link" aria-describedby="apha70091-bib-0160">160</a>] and in enhancing coronary artery vasodilation in humans [<a href="#apha70091-bib-0161" class="usa-link" aria-describedby="apha70091-bib-0161">161</a>]. On the other hand, in some studies, GIP increases Endothelin‐1 [<a href="#apha70091-bib-0162" class="usa-link" aria-describedby="apha70091-bib-0162">162</a>, <a href="#apha70091-bib-0163" class="usa-link" aria-describedby="apha70091-bib-0163">163</a>, <a href="#apha70091-bib-0164" class="usa-link" aria-describedby="apha70091-bib-0164">164</a>] and also NO [<a href="#apha70091-bib-0160" class="usa-link" aria-describedby="apha70091-bib-0160">160</a>], production, while other evidence documents no influence of GIP on NO production [<a href="#apha70091-bib-0151" class="usa-link" aria-describedby="apha70091-bib-0151">151</a>]. These differences could be partially attributed to variations in EC sources, such as arterial versus venous origins [<a href="#apha70091-bib-0162" class="usa-link" aria-describedby="apha70091-bib-0162">162</a>], or distinct compartments, like liver arteries versus umbilical veins [<a href="#apha70091-bib-0153" class="usa-link" aria-describedby="apha70091-bib-0153">153</a>]. However, the exact mechanism driving these discrepancies remains unclear. Altogether, these results clearly suggest a vaso‐protective effect of GLP‐1 analogs while GIP‐targeted therapies are less studied and shown to be more varied and context‐dependent.</p></section><section id="apha70091-sec-0014"><h3 class="pmc_sec_title">3.3. Effect of Incretin in Immune Cells</h3>
<p>Since the advent of incretin‐based therapy and its anti‐inflammatory impact, there is increasing attention given to the interaction between incretin hormones and immune cells that is not fully understood. Both GLP‐1R and GIPR are expressed on several immune cell subsets, like CD4+/CD8+ T‐cells [<a href="#apha70091-bib-0165" class="usa-link" aria-describedby="apha70091-bib-0165">165</a>, <a href="#apha70091-bib-0166" class="usa-link" aria-describedby="apha70091-bib-0166">166</a>] and macrophages [<a href="#apha70091-bib-0166" class="usa-link" aria-describedby="apha70091-bib-0166">166</a>, <a href="#apha70091-bib-0167" class="usa-link" aria-describedby="apha70091-bib-0167">167</a>]. GLP‐1 increases cholesterol efflux in macrophages by increasing ATP‐binding cassette transporter A1 (ABCA1) or apolipoprotein AI (apo AI) expression [<a href="#apha70091-bib-0135" class="usa-link" aria-describedby="apha70091-bib-0135">135</a>]. A study conducted using a GLP‐1R knockout mouse model has shown that GLP‐1R signaling may regulate lymphocyte proliferation and maintenance of peripheral regulatory T‐cells [<a href="#apha70091-bib-0168" class="usa-link" aria-describedby="apha70091-bib-0168">168</a>]. Under metabolic stress, GIP and its receptor link energy availability to the control of hematopoiesis by modulating bone marrow TLR and Notch signaling [<a href="#apha70091-bib-0166" class="usa-link" aria-describedby="apha70091-bib-0166">166</a>]. GLP‐1R is shown to act as a negative co‐stimulatory molecule in a subset of CD4+ and CD8+ T‐cells, controlling T‐cell activation, IFN‐γ secretion, cell metabolism, and death [<a href="#apha70091-bib-0165" class="usa-link" aria-describedby="apha70091-bib-0165">165</a>]. Both GLP‐1 and GIP have been implicated in the regulation of Th17/Treg balance, which is essential for immune homeostasis, in many diseases such as inflammatory bowel disease, gastrointestinal cancers, and several autoimmune diseases [<a href="#apha70091-bib-0169" class="usa-link" aria-describedby="apha70091-bib-0169">169</a>, <a href="#apha70091-bib-0170" class="usa-link" aria-describedby="apha70091-bib-0170">170</a>]. The exact mechanisms of GLP‐1 and GIP receptor signaling remain unclear; however, the adoptive transfer of GIPR‐deficient bone marrow into high‐fat diet‐fed mice reduces Treg populations in visceral adipose tissue compared to wild‐type bone marrow [<a href="#apha70091-bib-0171" class="usa-link" aria-describedby="apha70091-bib-0171">171</a>]. Additionally, the GLP‐1 analog liraglutide selectively inhibits Th1 and Th17 proliferation in vitro, indicating an anti‐inflammatory effect [<a href="#apha70091-bib-0172" class="usa-link" aria-describedby="apha70091-bib-0172">172</a>]. Studies using the agonists have illuminated the direct immuno‐metabolic and immuno‐regulatory roles of GLP‐1 and GIP on multiple immune cell subsets [<a href="#apha70091-bib-0173" class="usa-link" aria-describedby="apha70091-bib-0173">173</a>]. Indeed, incretin agonists have a significant effect on the underlying chronic inflammation in CMDs [<a href="#apha70091-bib-0174" class="usa-link" aria-describedby="apha70091-bib-0174">174</a>] and on the general metabolism of immune cells [<a href="#apha70091-bib-0018" class="usa-link" aria-describedby="apha70091-bib-0018">18</a>]. GLP‐1 and GIP reprogram immune cell metabolism by shifting macrophages [<a href="#apha70091-bib-0175" class="usa-link" aria-describedby="apha70091-bib-0175">175</a>] and T cells from a pro‐inflammatory, glycolysis‐driven state towards oxidative phosphorylation and lipid metabolism. This metabolic rewiring supports anti‐inflammatory phenotypes, including M2‐like macrophages [<a href="#apha70091-bib-0175" class="usa-link" aria-describedby="apha70091-bib-0175">175</a>] and regulatory or anergic/exhausted T cells, contributing to immune tolerance and reduced tissue inflammation [<a href="#apha70091-bib-0165" class="usa-link" aria-describedby="apha70091-bib-0165">165</a>]. The effects of the agonists are mostly anti‐inflammatory and of a protective nature. Specifically, 12 weeks of treatment with GLP‐1R agonists in T2D patients (data about the sex of participants are not reported) reduced inflammation significantly by reducing the production of ROS, inflammatory mediators like TNF‐α/IL‐1β, and NFκB activation in blood mononuclear cells [<a href="#apha70091-bib-0176" class="usa-link" aria-describedby="apha70091-bib-0176">176</a>]. GLP‐1R agonism is also known to directly inhibit monocyte adhesion to ECs, leading to an attenuation of the atherosclerotic plaque [<a href="#apha70091-bib-0177" class="usa-link" aria-describedby="apha70091-bib-0177">177</a>]. In murine models of obesity, liraglutide could effectively change the CD4 + T‐cell subsets and the cytokines, leading to an increase in Th2 and Treg and a concomitant reduction in Th1 and Th17 cells [<a href="#apha70091-bib-0178" class="usa-link" aria-describedby="apha70091-bib-0178">178</a>]. The role of GIP, on the other hand, is context‐dependent. Paradoxically, both agonism and antagonism of GIPR can either exacerbate or alleviate inflammation [<a href="#apha70091-bib-0179" class="usa-link" aria-describedby="apha70091-bib-0179">179</a>]. The dual agonist tirzepatide alleviates oxidative stress and IL‐17‐based inflammation [<a href="#apha70091-bib-0180" class="usa-link" aria-describedby="apha70091-bib-0180">180</a>].</p></section><section id="apha70091-sec-0015"><h3 class="pmc_sec_title">3.4. Sex Differences on Incretin Biology and Therapy</h3>
<p>A significant amount of research has focused on identifying the exact mechanisms of incretin action. However, fewer mechanistic biological or animal studies have explored potential sex‐related differences in the efficacy of incretin‐based treatments. In clinical trials, although both sexes are typically included, females are often underrepresented, making it challenging to conduct a proper comparison between the sexes [<a href="#apha70091-bib-0181" class="usa-link" aria-describedby="apha70091-bib-0181">181</a>, <a href="#apha70091-bib-0182" class="usa-link" aria-describedby="apha70091-bib-0182">182</a>] and to draw reliable conclusions for both sexes. However, a recent study conducted in T2D patients demonstrated that hazard ratios (HRs) for cardiovascular events (non‐fatal acute myocardial infarction, unstable angina, heart failure, or stroke) were lower with GLP‐1RA compared with sulfonylureas, in women than in men [<a href="#apha70091-bib-0183" class="usa-link" aria-describedby="apha70091-bib-0183">183</a>], which could be attributed to the greater weight loss achieved in females compared to males [<a href="#apha70091-bib-0184" class="usa-link" aria-describedby="apha70091-bib-0184">184</a>]. The physiology of incretin shows differences between men and women regarding production and effects. Indeed, pre‐menopausal women exhibited a 2‐fold enhanced GLP‐1 and insulin production as measured in the circulation during standardized intraduodenal glucose (2 and 3 Kcal/min) injection compared to men [<a href="#apha70091-bib-0185" class="usa-link" aria-describedby="apha70091-bib-0185">185</a>]. The increased GLP‐1 production in females is further enhanced in the luteal phase of the menstrual cycle compared to the follicular phase [<a href="#apha70091-bib-0186" class="usa-link" aria-describedby="apha70091-bib-0186">186</a>], suggesting also an association of GLP‐1 production with progesterone. Estrogen also influences GLP‐1 secretion. Ovariectomized reporter mice (Venus fluorochrome in proglucagon‐producing cells and the Cherry fluorochrome in insulin‐producing cells) present decreased GLP‐1 production, which could be reversed with 17β‐estradiol supplementation [<a href="#apha70091-bib-0187" class="usa-link" aria-describedby="apha70091-bib-0187">187</a>]. Similarly, 17β‐estradiol enhances GLP‐1 release from human pancreatic α cells [<a href="#apha70091-bib-0187" class="usa-link" aria-describedby="apha70091-bib-0187">187</a>]. Importantly, this effect is mediated by both genomic (estrogen receptor α/β (ERα and ERβ)) and non‐genomic pathways (G protein‐coupled estrogen receptor 1, GPER‐1) in the pancreas but only by the genomic ERβ signaling in the intestine [<a href="#apha70091-bib-0187" class="usa-link" aria-describedby="apha70091-bib-0187">187</a>]. Estradiol not only directly influences GLP‐1 production and action, but can have an additive effect on GLP‐1 action. Indeed, a stable GLP‐1‐17β‐estradiol conjugate has demonstrated superior efficacy over GLP‐1 single hormone in treating metabolic syndrome in both male and female mice [<a href="#apha70091-bib-0188" class="usa-link" aria-describedby="apha70091-bib-0188">188</a>]. Interestingly, the GLP‐1‐17β‐estradiol conjugate was able to synergistically activate GLP‐1‐responsive anorexic regions in the central nervous system, leading to a higher reduction in hunger compared to GLP‐1 alone [<a href="#apha70091-bib-0189" class="usa-link" aria-describedby="apha70091-bib-0189">189</a>, <a href="#apha70091-bib-0190" class="usa-link" aria-describedby="apha70091-bib-0190">190</a>]. This effect was mediated by GLP‐1 functioning as a carrier to deliver 17β‐estradiol into GLP‐1 receptor–expressing cells, where it could activate estrogen‐responsive elements [<a href="#apha70091-bib-0191" class="usa-link" aria-describedby="apha70091-bib-0191">191</a>]. The clear synergistic effect of estrogen and GLP‐1 could explain some sex‐associated effects observed in incretin therapy. For instance, dulaglutide induces greater BW loss in women (post‐menopausal) compared to men [<a href="#apha70091-bib-0184" class="usa-link" aria-describedby="apha70091-bib-0184">184</a>, <a href="#apha70091-bib-0192" class="usa-link" aria-describedby="apha70091-bib-0192">192</a>]. Additionally, more severe gastrointestinal adverse effects were also observed in women compared to men [<a href="#apha70091-bib-0184" class="usa-link" aria-describedby="apha70091-bib-0184">184</a>], a result which was attributed to a higher plasma concentration of the drug due to lower BW of women compared to men. However, a subsequent study revealed that at equal plasma concentrations of liraglutide, women (pre‐ and post‐menopausal) still experienced more gastrointestinal adverse effects [<a href="#apha70091-bib-0193" class="usa-link" aria-describedby="apha70091-bib-0193">193</a>]. These results suggest a clear synergistic positive effect of estrogen and incretins, which are further complicated in transgender medicine. Indeed, a recent study has revealed decreasing insulin sensitivity in transgender women (male to female) following hormonal therapy [<a href="#apha70091-bib-0194" class="usa-link" aria-describedby="apha70091-bib-0194">194</a>], clearly indicating a negative effect of female hormone therapy on biological men. On the other hand, the same study reports increasing insulin sensitivity in transgender men (female to male) following male hormonal therapy, suggesting a positive effect of male hormonal therapy on biological females. This observation is in line with a mechanistic study that reported a positive effect of DHT in enhancing GLP‐1‐mediated insulin production from pancreatic β‐cells [<a href="#apha70091-bib-0195" class="usa-link" aria-describedby="apha70091-bib-0195">195</a>]. The relationship between androgens and incretins might, however, be bidirectional. Indeed, a pilot prospective randomized open‐label study observed a normalization of testosterone levels upon liraglutide treatment in hypogonadal obese men [<a href="#apha70091-bib-0196" class="usa-link" aria-describedby="apha70091-bib-0196">196</a>]. On the other hand, liraglutide in combination with metformin was shown to decrease testosterone levels in obese polycystic ovary syndrome patients in comparison to metformin alone [<a href="#apha70091-bib-0197" class="usa-link" aria-describedby="apha70091-bib-0197">197</a>].</p>
<p>Altogether, the current evidence clearly suggests a bidirectional influence between sex and incretin therapy; however more mechanistic studies on sex‐related differences in incretin therapy will undoubtedly be needed for a deeper understanding.</p></section></section><section id="apha70091-sec-0016"><h2 class="pmc_sec_title">4. Interplay and Outlook</h2>
<p>The reviewed literature shows the close connection existing in CMDs between vascular and immune dysfunction and metabolic impairments. Dysmetabolic ECs undergo heightened glycolysis at first and then stalled glycolysis later, leading to oxidative stress, increased EC permeability/activation, and decreased NO production [<a href="#apha70091-bib-0198" class="usa-link" aria-describedby="apha70091-bib-0198">198</a>]. CMDs are associated with low‐grade inflammation driven by activated and pro‐inflammatory T‐cells, which, in a vicious loop, further exacerbates endothelial dysfunction [<a href="#apha70091-bib-0199" class="usa-link" aria-describedby="apha70091-bib-0199">199</a>]. Activated T‐cells increase glycolysis and mitochondrial oxidation, which, in the long term leads, to mitochondrial dysfunction and cell exhaustion [<a href="#apha70091-bib-0200" class="usa-link" aria-describedby="apha70091-bib-0200">200</a>]. Th17 cells exhibit their pro‐inflammatory phenotype by exhibiting active glycolysis and the pentose phosphate pathway [<a href="#apha70091-bib-0201" class="usa-link" aria-describedby="apha70091-bib-0201">201</a>], while the Tregs depend more on fatty acid oxidation and OXPHOS [<a href="#apha70091-bib-0202" class="usa-link" aria-describedby="apha70091-bib-0202">202</a>]. Interestingly, loss of Y chromosomes is tightly associated with exhaustion and senescence of immune cells, and it has been reported to increase cardiovascular risk [<a href="#apha70091-bib-0203" class="usa-link" aria-describedby="apha70091-bib-0203">203</a>], together suggesting that the sex‐variable as a key modulator of CMD. Not only the Y chromosomes but also testosterone levels, when dysregulated, seem to influence both endothelial and immune cell dysfunction [<a href="#apha70091-bib-0204" class="usa-link" aria-describedby="apha70091-bib-0204">204</a>]. This evidence suggests that alterations in sex hormones and chromosomes likely predispose individuals to endothelial and immune dysfunction. In CMD, both previously mentioned cell types are influenced by intrinsic metabolic dysfunction. Therefore, it is crucial to examine the complex interplay between ECs and immune cells in a sex‐dependent manner to deepen our understanding and help tailor more effective incretin‐based therapies.</p>
<p>While some studies report an anti‐inflammatory effect (Figure <a href="#apha70091-fig-0002" class="usa-link">2</a>), the exact mechanisms and whether incretins can rewire the dysfunctional metabolism of immune cells remain unclear. Similarly, although incretins improve endothelial function (Figure <a href="#apha70091-fig-0002" class="usa-link">2</a>), it is not yet known if this is due to a metabolic shift in EC towards a quiescent phenotype. Given the significant metabolic effects of incretin analogs, it is likely that their benefits are partly mediated by direct actions on both endothelial and immune cells, as well as their interaction. It should not be forgotten that these effects are also likely indirect, as a result of weight loss and general improvement in metabolic health. In current clinical trials of incretin‐based therapies, high‐sensitivity C‐reactive protein and flow‐mediated vasodilation are the most commonly used readouts to assess immune and endothelial function, respectively (Table <a href="#apha70091-tbl-0003" class="usa-link">3</a>). At the cellular level, most studies focus on macrophages in the endothelial‐immune crosstalk in CMD, with little research focusing on other cell types, such as T‐cells, in the context of incretin therapies. As ECs and immune cells can cyclically activate each other [<a href="#apha70091-bib-0205" class="usa-link" aria-describedby="apha70091-bib-0205">205</a>], incretin effects on one component may indirectly influence the other.</p>
<figure class="fig xbox font-sm" id="apha70091-fig-0002"><h3 class="obj_head">FIGURE 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572d/12368768/483e68bdb5db/APHA-241-e70091-g001.jpg" loading="lazy" id="jats-graphic-3" height="488" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/apha70091-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Graphical representation of specific molecular mechanisms activated in CMD at both immune and endothelial cell level. The left panel show the pathological situation, without therapy, which is characterized by increased circulatory glucose levels, EC dysfunction, eNOS uncoupling resulting in abrogation of NO production and increased inflammatory markers affecting the interaction between ECs and effector T‐cell. The right panel represents the current knowledge about incretin therapy in terms of its effect on reduction of circulatory glucose levels, reduction in inflammatory cytokine production and restoration of EC function and NO production. The future questions which need to be addressed in terms of incretin therapy include the effect of incretin therapy on EC and T‐cell metabolism and the interaction between the two cells. A major open aspect of these questions is the effect of sex differences on both the already documented effects and on possible effects that could be uncovered in the future. AGEs, advanced glycation end products; CCL2, chemokine (C‐C motif) ligand 2; CMD, cardiometabolic disease; EC, endothelial cell; NO, Nitric oxide; PPP, pentose phosphate pathway; ROS, reactive oxygen species. The normal arrows show mechanisms that are intact while the dotted arrows indicate compromised/abrogated mechanisms, The upward pointing arrow show an increase in production and the downward pointing arrows show a decrease in production. The green tick marks show effects supported by evidence in literature, while the red question marks indicate the open questions. The X‐mark on EC dysfunction indicates a return from dysfunctional state to a quiescent state.</p></figcaption></figure><section class="tw xbox font-sm" id="apha70091-tbl-0003"><h3 class="obj_head">TABLE 3.</h3>
<div class="caption p"><p>Summary of recent clinical trials investigating different incretin‐based therapies with specific vascular and/or immune objectives.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">PMID</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Authors</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Year</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Intervention</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Population</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Primary outcome</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Vascular readout</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Immune readout</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">34542221</td>
<td align="center" valign="top" rowspan="1" colspan="1">Wilson J.M. et al.</td>
<td align="center" valign="top" rowspan="1" colspan="1">2021</td>
<td align="center" valign="top" rowspan="1" colspan="1">Tirzepatide vs. Placebo</td>
<td align="center" valign="top" rowspan="1" colspan="1">T2D for 6 months or longer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Improved glycemic control and loss of BW</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓ ICAM</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓ hsCRP</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">30759365</td>
<td align="center" valign="top" rowspan="1" colspan="1">Patti A.M. et al.</td>
<td align="center" valign="top" rowspan="1" colspan="1">2019</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exenatide vs. Placebo</td>
<td align="center" valign="top" rowspan="1" colspan="1">T2D</td>
<td align="center" valign="top" rowspan="1" colspan="1">Improved cardio‐metabolic parameters</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑ FMD</td>
<td align="center" valign="top" rowspan="1" colspan="1">N.A.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">31326727</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anholm C. et al.</td>
<td align="center" valign="top" rowspan="1" colspan="1">2019</td>
<td align="center" valign="top" rowspan="1" colspan="1">Liraglutide vs. placebo</td>
<td align="center" valign="top" rowspan="1" colspan="1">CAD + T2D (metformin +)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Decreased low density lipoprotein</td>
<td align="center" valign="top" rowspan="1" colspan="1">N.A.</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓ hsCRP</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">37883939</td>
<td align="center" valign="top" rowspan="1" colspan="1">Stenlid R. et al.</td>
<td align="center" valign="top" rowspan="1" colspan="1">2023</td>
<td align="center" valign="top" rowspan="1" colspan="1">Exenatide vs. Placebo</td>
<td align="center" valign="top" rowspan="1" colspan="1">Obesity Adolescents</td>
<td align="center" valign="top" rowspan="1" colspan="1">Reduced obesity related inflammation</td>
<td align="center" valign="top" rowspan="1" colspan="1">N.A.</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓ IL‐18Ra</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">33830637</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bray J.J.H. et al.</td>
<td align="center" valign="top" rowspan="1" colspan="1">2021</td>
<td align="center" valign="top" rowspan="1" colspan="1">Meta‐analysis of multiple GLP‐1RAs</td>
<td align="center" valign="top" rowspan="1" colspan="1">Pre‐diabetes and T2D</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐inflammatory and anti‐oxidant effects</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓ MDA</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓ TNFα and hsCRP</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">35370959</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yuhan Wang et al.</td>
<td align="center" valign="top" rowspan="1" colspan="1">2022</td>
<td align="center" valign="top" rowspan="1" colspan="1">Meta‐analysis of anti‐diabetic drugs</td>
<td align="center" valign="top" rowspan="1" colspan="1">T2D w/wo high CVD risk</td>
<td align="center" valign="top" rowspan="1" colspan="1">GLP‐1Ras‐ improved endothelial function</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑ FMD</td>
<td align="center" valign="top" rowspan="1" colspan="1">N.A.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">30622967</td>
<td align="center" valign="top" rowspan="1" colspan="1">Batzias K. et al.</td>
<td align="center" valign="top" rowspan="1" colspan="1">2018</td>
<td align="center" valign="top" rowspan="1" colspan="1">Meta‐analysis of anti‐diabetic drugs</td>
<td align="center" valign="top" rowspan="1" colspan="1">T2D</td>
<td align="center" valign="top" rowspan="1" colspan="1">GLP‐1Ras‐ improved vascular function</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓ PWV</td>
<td align="center" valign="top" rowspan="1" colspan="1">N.A.</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/apha70091-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="apha70091-note-0003"><p>Abbreviations: BW, body weight; CAD, coronary artery disease; CVD, cardiovascular disease; FMD, flow mediated dilation; hs CRP, high‐sensitive c‐reactive protein; MDA, malondialdehyde; N.A., not assessed; PWV, pulse wave velocity; T2D, type 2 diabetes.</p></div></div></section><p>Endothelial and immune cells are influenced by sex‐dependent factors, highlighting the need to study incretin efficacy in relation to hormonal status. Hypogonadic men or post‐menopausal women may experience lower efficacy of incretin therapy due to more pronounced endothelial/immune dysfunction associated with low circulating hormone concentrations. Incretin therapies may result in greater BW loss in women, even with the same body mass index as men [<a href="#apha70091-bib-0184" class="usa-link" aria-describedby="apha70091-bib-0184">184</a>]. This difference has been attributed to interactions between incretins and sex‐specific hormones such as leptin and sex steroids [<a href="#apha70091-bib-0192" class="usa-link" aria-describedby="apha70091-bib-0192">192</a>] Interestingly, incretin hormones also exert anorexigenic effects on the brain, which has been shown to be enhanced by estrogen in synergy with GLP‐1 [<a href="#apha70091-bib-0189" class="usa-link" aria-describedby="apha70091-bib-0189">189</a>, <a href="#apha70091-bib-0190" class="usa-link" aria-describedby="apha70091-bib-0190">190</a>], suggesting that pre‐menopausal women may benefit more from incretin therapy. While the differences in BW loss between sexes may reflect population characteristics, the therapy efficacy could vary by sex and reproductive hormonal stage. Future studies should incorporate these variables to better understand mechanisms, tailor therapies, and predict responses, especially for patients with hormonal imbalances like polycystic ovary syndrome.</p>
<p>Experimental and clinical studies on sex‐driven differences face key limitations, particularly the underrepresentation of females. Clinical trials should have sufficient female participants for meaningful analysis, while preclinical, in vivo studies must incorporate female mice to identify sex‐based treatment differences. Traditional animal models employed various intervention strategies such as ovariectomy, orchiectomy, hormone replacement, or receptor knockout to explore sex hormones‐induced effects but largely ignored the sex chromosomal components. To allow the differentiation between chromosomal and sex hormonal effects, the Four Core Genotype model was additionally developed [<a href="#apha70091-bib-0206" class="usa-link" aria-describedby="apha70091-bib-0206">206</a>]. Also, in vitro experiments should use both female and male cells to examine molecular sex‐dependent differences. Addressing these factors, often overlooked, should be required by funding agencies, publishers, and policymakers to advance personalized medicine.</p>
<p>In conclusion, while incretin therapies hold promise for treating CMD by improving cardiovascular health and immune responses, further research is needed to understand their endothelial/immune effects and the role of sex differences. Future studies should focus on the molecular and hormonal interactions underlying these effects, as well as long‐term outcomes and personalized treatments based on sex, genetics, and disease state. Addressing these gaps will help optimize incretin‐based therapy for both male and female patients, improving cardiovascular outcomes across diverse populations.</p></section><section id="apha70091-sec-0018"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>A.S.M. and V.B. contributed equally to the conceptualization, literature search, data analysis, and drafting of the manuscript and are both recognized as co‐first authors. D.Z. assisted with the critical revision of the manuscript for important intellectual content and contributed to refining the final version. E.O. provided overall guidance throughout the writing process and finalized the manuscript for submission. All authors have read and approved the final version of the manuscript.</p></section><section id="apha70091-sec-0017"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="notes1"><p>

Muralikrishnan A. S., Biasin V., Zabini D., and Osto E., “Immune and Vascular Function in Cardiometabolic Disorders: Interplay With Sex Differences and Impact on Incretin Therapy,” Acta Physiologica
241, no. 9 (2025): e70091, 10.1111/apha.70091.

</p>
<section id="apha70091-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="apha70091-note-0001"><p>
<strong>Funding:</strong> The continued financial support by the Swiss National Science Foundation PRIMA: PR00P3_179861/1 and all the funding recieved from The Swiss Life Foundation, The Heubergstiftung, The Philhuman Stiftung, Novartis Foundation, and The Swiss Heart Foundation, Switzerland, to E.O.; the support of the Otto Loewi Research Center, Medical University of Graz, Austria and Austria Science Foundation (FWF) [Grant <a href="https://doi.org/10.55776/DOC129" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.55776/DOC129</a>] (doc. funds RESPImmun) to V.B., and the support of the City of Graz to V.B. and A.S.M. are gratefully acknowledged.</p></div>
<div class="fn p" id="apha70091-note-0002"><p>Anirudh Subramanian Muralikrishnan and Valentina Biasin equally contributed to this work.</p></div>
</div></section></section><section id="apha70091-sec-0020"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Data sharing not applicable to this article as no datasets were generated or analysed during the current study.</p></section><section id="apha70091-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="apha70091-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="apha70091-bib-0001">
<span class="label">1.</span><cite>
Lüscher T. F., “CardioMetabolic Medicine: The Advent of Systems Cardiology and the New Cardiovascular Generalist?,” European Heart Journal (2025): ehaf368, 10.1093/eurheartj/ehaf368.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehaf368" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40504016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=CardioMetabolic%20Medicine:%20The%20Advent%20of%20Systems%20Cardiology%20and%20the%20New%20Cardiovascular%20Generalist?&amp;author=T.%20F.%20L%C3%BCscher&amp;publication_year=2025&amp;pages=ehaf368&amp;pmid=40504016&amp;doi=10.1093/eurheartj/ehaf368&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0002">
<span class="label">2.</span><cite>
Jiang M., Tian S., Liu S., et al., “Accelerated Biological Aging Elevates the Risk of Cardiometabolic Multimorbidity and Mortality,” Nature Cardiovascular Research
3 (2024): 332–342.</cite> [<a href="https://doi.org/10.1038/s44161-024-00438-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39196113/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Cardiovascular%20Research&amp;title=Accelerated%20Biological%20Aging%20Elevates%20the%20Risk%20of%20Cardiometabolic%20Multimorbidity%20and%20Mortality&amp;author=M.%20Jiang&amp;author=S.%20Tian&amp;author=S.%20Liu&amp;volume=3&amp;publication_year=2024&amp;pages=332-342&amp;pmid=39196113&amp;doi=10.1038/s44161-024-00438-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0003">
<span class="label">3.</span><cite>
Whitfield J. B., “Genetic Insights Into Cardiometabolic Risk Factors,” Clinical Biochemist Reviews
35 (2014): 15–36.
</cite> [<a href="/articles/PMC3961996/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24659834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Biochemist%20Reviews&amp;title=Genetic%20Insights%20Into%20Cardiometabolic%20Risk%20Factors&amp;author=J.%20B.%20Whitfield&amp;volume=35&amp;publication_year=2014&amp;pages=15-36&amp;pmid=24659834&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0004">
<span class="label">4.</span><cite>
Valenzuela P. L., Carrera‐Bastos P., Castillo‐García A., Lieberman D. E., Santos‐Lozano A., and Lucia A., “Obesity and the Risk of Cardiometabolic Diseases,” Nature Reviews. Cardiology
20 (2023): 475–494.
</cite> [<a href="https://doi.org/10.1038/s41569-023-00847-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36927772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Cardiology&amp;title=Obesity%20and%20the%20Risk%20of%20Cardiometabolic%20Diseases&amp;author=P.%20L.%20Valenzuela&amp;author=P.%20Carrera%E2%80%90Bastos&amp;author=A.%20Castillo%E2%80%90Garc%C3%ADa&amp;author=D.%20E.%20Lieberman&amp;author=A.%20Santos%E2%80%90Lozano&amp;volume=20&amp;publication_year=2023&amp;pages=475-494&amp;pmid=36927772&amp;doi=10.1038/s41569-023-00847-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0005">
<span class="label">5.</span><cite>
Boutagy N. E., Singh A. K., and Sessa W. C., “Targeting the Vasculature in Cardiometabolic Disease,” Journal of Clinical Investigation
132 (2022): e148556.
</cite> [<a href="https://doi.org/10.1172/JCI148556" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8920329/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35289308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Targeting%20the%20Vasculature%20in%20Cardiometabolic%20Disease&amp;author=N.%20E.%20Boutagy&amp;author=A.%20K.%20Singh&amp;author=W.%20C.%20Sessa&amp;volume=132&amp;publication_year=2022&amp;pages=e148556&amp;pmid=35289308&amp;doi=10.1172/JCI148556&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0006">
<span class="label">6.</span><cite>
Alexander Y., Osto E., Schmidt‐Trucksäss A., et al., “Endothelial Function in Cardiovascular Medicine: A Consensus Paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis,” Cardiovascular Research
117 (2021): 29–42.
</cite> [<a href="https://doi.org/10.1093/cvr/cvaa085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7797212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32282914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Endothelial%20Function%20in%20Cardiovascular%20Medicine:%20A%20Consensus%20Paper%20of%20the%20European%20Society%20of%20Cardiology%20Working%20Groups%20on%20Atherosclerosis%20and%20Vascular%20Biology,%20Aorta%20and%20Peripheral%20Vascular%20Diseases,%20Coronary%20Pathophysiology%20and%20Microcirculation,%20and%20Thrombosis&amp;author=Y.%20Alexander&amp;author=E.%20Osto&amp;author=A.%20Schmidt%E2%80%90Trucks%C3%A4ss&amp;volume=117&amp;publication_year=2021&amp;pages=29-42&amp;pmid=32282914&amp;doi=10.1093/cvr/cvaa085&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0007">
<span class="label">7.</span><cite>
Swirski F. K. and Nahrendorf M., “Cardioimmunology: The Immune System in Cardiac Homeostasis and Disease,” Nature Reviews. Immunology
18 (2018): 733–744.</cite> [<a href="https://doi.org/10.1038/s41577-018-0065-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30228378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Immunology&amp;title=Cardioimmunology:%20The%20Immune%20System%20in%20Cardiac%20Homeostasis%20and%20Disease&amp;author=F.%20K.%20Swirski&amp;author=M.%20Nahrendorf&amp;volume=18&amp;publication_year=2018&amp;pages=733-744&amp;pmid=30228378&amp;doi=10.1038/s41577-018-0065-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0008">
<span class="label">8.</span><cite>
Kominsky D. J., Campbell E. L., and Colgan S. P., “Metabolic Shifts in Immunity and Inflammation,” Journal of Immunology
184 (2010): 4062–4068.</cite> [<a href="https://doi.org/10.4049/jimmunol.0903002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4077461/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20368286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Metabolic%20Shifts%20in%20Immunity%20and%20Inflammation&amp;author=D.%20J.%20Kominsky&amp;author=E.%20L.%20Campbell&amp;author=S.%20P.%20Colgan&amp;volume=184&amp;publication_year=2010&amp;pages=4062-4068&amp;pmid=20368286&amp;doi=10.4049/jimmunol.0903002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0009">
<span class="label">9.</span><cite>
Kreymann B., Williams G., Ghatei M. A., and Bloom S. R., “Glucagon‐Like Peptide‐1 7‐36: A Physiological Incretin in Man,” Lancet
2 (1987): 1300–1304.
</cite> [<a href="https://doi.org/10.1016/s0140-6736(87)91194-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2890903/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Glucagon%E2%80%90Like%20Peptide%E2%80%901%207%E2%80%9036:%20A%20Physiological%20Incretin%20in%20Man&amp;author=B.%20Kreymann&amp;author=G.%20Williams&amp;author=M.%20A.%20Ghatei&amp;author=S.%20R.%20Bloom&amp;volume=2&amp;publication_year=1987&amp;pages=1300-1304&amp;pmid=2890903&amp;doi=10.1016/s0140-6736(87)91194-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0010">
<span class="label">10.</span><cite>
Tseng C. C., Kieffer T. J., Jarboe L. A., Usdin T. B., and Wolfe M. M., “Postprandial Stimulation of Insulin Release by Glucose‐Dependent Insulinotropic Polypeptide (GIP). Effect of a Specific Glucose‐Dependent Insulinotropic Polypeptide Receptor Antagonist in the Rat,” Journal of Clinical Investigation
98 (1996): 2440–2445.
</cite> [<a href="https://doi.org/10.1172/JCI119060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC507699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8958204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Postprandial%20Stimulation%20of%20Insulin%20Release%20by%20Glucose%E2%80%90Dependent%20Insulinotropic%20Polypeptide%20(GIP).%20Effect%20of%20a%20Specific%20Glucose%E2%80%90Dependent%20Insulinotropic%20Polypeptide%20Receptor%20Antagonist%20in%20the%20Rat&amp;author=C.%20C.%20Tseng&amp;author=T.%20J.%20Kieffer&amp;author=L.%20A.%20Jarboe&amp;author=T.%20B.%20Usdin&amp;author=M.%20M.%20Wolfe&amp;volume=98&amp;publication_year=1996&amp;pages=2440-2445&amp;pmid=8958204&amp;doi=10.1172/JCI119060&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0011">
<span class="label">11.</span><cite>
Gill A., Hoogwerf B. J., Burger J., et al., “Effect of Exenatide on Heart Rate and Blood Pressure in Subjects With Type 2 Diabetes Mellitus: A Double‐Blind, Placebo‐Controlled, Randomized Pilot Study,” Cardiovascular Diabetology
9 (2010): 6.
</cite> [<a href="https://doi.org/10.1186/1475-2840-9-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2823663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20109208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Effect%20of%20Exenatide%20on%20Heart%20Rate%20and%20Blood%20Pressure%20in%20Subjects%20With%20Type%202%20Diabetes%20Mellitus:%20A%20Double%E2%80%90Blind,%20Placebo%E2%80%90Controlled,%20Randomized%20Pilot%20Study&amp;author=A.%20Gill&amp;author=B.%20J.%20Hoogwerf&amp;author=J.%20Burger&amp;volume=9&amp;publication_year=2010&amp;pages=6&amp;pmid=20109208&amp;doi=10.1186/1475-2840-9-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0012">
<span class="label">12.</span><cite>
Read P. A., Khan F. Z., and Dutka D. P., “Cardioprotection Against Ischaemia Induced by Dobutamine Stress Using Glucagon‐Like Peptide‐1 in Patients With Coronary Artery Disease,” Heart
98 (2012): 408–413.
</cite> [<a href="https://doi.org/10.1136/hrt.2010.219345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21561896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart&amp;title=Cardioprotection%20Against%20Ischaemia%20Induced%20by%20Dobutamine%20Stress%20Using%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%20in%20Patients%20With%20Coronary%20Artery%20Disease&amp;author=P.%20A.%20Read&amp;author=F.%20Z.%20Khan&amp;author=D.%20P.%20Dutka&amp;volume=98&amp;publication_year=2012&amp;pages=408-413&amp;pmid=21561896&amp;doi=10.1136/hrt.2010.219345&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0013">
<span class="label">13.</span><cite>
Nikolaidis L. A., Elahi D., Hentosz T., et al., “Recombinant Glucagon‐Like Peptide‐1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing‐Induced Dilated Cardiomyopathy,” Circulation
110 (2004): 955–961.
</cite> [<a href="https://doi.org/10.1161/01.CIR.0000139339.85840.DD" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15313949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Recombinant%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%20Increases%20Myocardial%20Glucose%20Uptake%20and%20Improves%20Left%20Ventricular%20Performance%20in%20Conscious%20Dogs%20With%20Pacing%E2%80%90Induced%20Dilated%20Cardiomyopathy&amp;author=L.%20A.%20Nikolaidis&amp;author=D.%20Elahi&amp;author=T.%20Hentosz&amp;volume=110&amp;publication_year=2004&amp;pages=955-961&amp;pmid=15313949&amp;doi=10.1161/01.CIR.0000139339.85840.DD&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0014">
<span class="label">14.</span><cite>
Turton M. D., O'Shea D., Gunn I., et al., “A Role for Glucagon‐Like Peptide‐1 in the Central Regulation of Feeding,” Nature
379 (1996): 69–72.
</cite> [<a href="https://doi.org/10.1038/379069a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8538742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A%20Role%20for%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%20in%20the%20Central%20Regulation%20of%20Feeding&amp;author=M.%20D.%20Turton&amp;author=D.%20O'Shea&amp;author=I.%20Gunn&amp;volume=379&amp;publication_year=1996&amp;pages=69-72&amp;pmid=8538742&amp;doi=10.1038/379069a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0015">
<span class="label">15.</span><cite>
Nyberg J., Anderson M. F., Meister B., et al., “Glucose‐Dependent Insulinotropic Polypeptide Is Expressed in Adult Hippocampus and Induces Progenitor Cell Proliferation,” Journal of Neuroscience
25 (2005): 1816–1825.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.4920-04.2005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6725940/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15716418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=Glucose%E2%80%90Dependent%20Insulinotropic%20Polypeptide%20Is%20Expressed%20in%20Adult%20Hippocampus%20and%20Induces%20Progenitor%20Cell%20Proliferation&amp;author=J.%20Nyberg&amp;author=M.%20F.%20Anderson&amp;author=B.%20Meister&amp;volume=25&amp;publication_year=2005&amp;pages=1816-1825&amp;pmid=15716418&amp;doi=10.1523/JNEUROSCI.4920-04.2005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0016">
<span class="label">16.</span><cite>
Villanueva‐Peñacarrillo M. L., Márquez L., González N., Díaz‐Miguel M., and Valverde I., “Effect of GLP‐1 on Lipid Metabolism in Human Adipocytes,” Hormone and Metabolic Research
33 (2001): 73–77.
</cite> [<a href="https://doi.org/10.1055/s-2001-12428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11294496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hormone%20and%20Metabolic%20Research&amp;title=Effect%20of%20GLP%E2%80%901%20on%20Lipid%20Metabolism%20in%20Human%20Adipocytes&amp;author=M.%20L.%20Villanueva%E2%80%90Pe%C3%B1acarrillo&amp;author=L.%20M%C3%A1rquez&amp;author=N.%20Gonz%C3%A1lez&amp;author=M.%20D%C3%ADaz%E2%80%90Miguel&amp;author=I.%20Valverde&amp;volume=33&amp;publication_year=2001&amp;pages=73-77&amp;pmid=11294496&amp;doi=10.1055/s-2001-12428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0017">
<span class="label">17.</span><cite>
Ussher J. R. and Drucker D. J., “Cardiovascular Actions of Incretin‐Based Therapies,” Circulation Research
114 (2014): 1788–1803.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.114.301958" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24855202/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Cardiovascular%20Actions%20of%20Incretin%E2%80%90Based%20Therapies&amp;author=J.%20R.%20Ussher&amp;author=D.%20J.%20Drucker&amp;volume=114&amp;publication_year=2014&amp;pages=1788-1803&amp;pmid=24855202&amp;doi=10.1161/CIRCRESAHA.114.301958&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0018">
<span class="label">18.</span><cite>
Fishman S., Zvibel I., and Varol C., “Incretin Hormones in the Control of Immunometabolism,” Immunometabolism
1 (2019): e190004.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Immunometabolism&amp;title=Incretin%20Hormones%20in%20the%20Control%20of%20Immunometabolism&amp;author=S.%20Fishman&amp;author=I.%20Zvibel&amp;author=C.%20Varol&amp;volume=1&amp;publication_year=2019&amp;pages=e190004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0019">
<span class="label">19.</span><cite>
Okunrintemi V., Valero‐Elizondo J., Patrick B., et al., “Gender Differences in Patient‐Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease,” Journal of the American Heart Association
7 (2018): e010498.
</cite> [<a href="https://doi.org/10.1161/JAHA.118.010498" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6405598/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30561253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Heart%20Association&amp;title=Gender%20Differences%20in%20Patient%E2%80%90Reported%20Outcomes%20Among%20Adults%20With%20Atherosclerotic%20Cardiovascular%20Disease&amp;author=V.%20Okunrintemi&amp;author=J.%20Valero%E2%80%90Elizondo&amp;author=B.%20Patrick&amp;volume=7&amp;publication_year=2018&amp;pages=e010498&amp;pmid=30561253&amp;doi=10.1161/JAHA.118.010498&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0020">
<span class="label">20.</span><cite>
Regitz‐Zagrosek V. and Gebhard C., “Gender Medicine: Effects of Sex and Gender on Cardiovascular Disease Manifestation and Outcomes,” Nature Reviews. Cardiology
20 (2023): 236–247.
</cite> [<a href="https://doi.org/10.1038/s41569-022-00797-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9628527/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36316574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Cardiology&amp;title=Gender%20Medicine:%20Effects%20of%20Sex%20and%20Gender%20on%20Cardiovascular%20Disease%20Manifestation%20and%20Outcomes&amp;author=V.%20Regitz%E2%80%90Zagrosek&amp;author=C.%20Gebhard&amp;volume=20&amp;publication_year=2023&amp;pages=236-247&amp;pmid=36316574&amp;doi=10.1038/s41569-022-00797-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0021">
<span class="label">21.</span><cite>
Furchgott R. F. and Zawadzki J. V., “The Obligatory Role of Endothelial Cells in the Relaxation of Arterial Smooth Muscle by Acetylcholine,” Nature
288 (1980): 373–376.
</cite> [<a href="https://doi.org/10.1038/288373a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6253831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The%20Obligatory%20Role%20of%20Endothelial%20Cells%20in%20the%20Relaxation%20of%20Arterial%20Smooth%20Muscle%20by%20Acetylcholine&amp;author=R.%20F.%20Furchgott&amp;author=J.%20V.%20Zawadzki&amp;volume=288&amp;publication_year=1980&amp;pages=373-376&amp;pmid=6253831&amp;doi=10.1038/288373a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0022">
<span class="label">22.</span><cite>
Moncada S., Higgs E. A., and Vane J. R., “Human Arterial and Venous Tissues Generate Prostacyclin (Prostaglandin x), a Potent Inhibitor of Platelet Aggregation,” Lancet
1 (1977): 18–20.
</cite> [<a href="https://doi.org/10.1016/s0140-6736(77)91655-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/63657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Human%20Arterial%20and%20Venous%20Tissues%20Generate%20Prostacyclin%20(Prostaglandin%20x),%20a%20Potent%20Inhibitor%20of%20Platelet%20Aggregation&amp;author=S.%20Moncada&amp;author=E.%20A.%20Higgs&amp;author=J.%20R.%20Vane&amp;volume=1&amp;publication_year=1977&amp;pages=18-20&amp;pmid=63657&amp;doi=10.1016/s0140-6736(77)91655-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0023">
<span class="label">23.</span><cite>
Kinlay S., Behrendt D., Wainstein M., et al., “Role of Endothelin‐1 in the Active Constriction of Human Atherosclerotic Coronary Arteries,” Circulation
104 (2001): 1114–1118.
</cite> [<a href="https://doi.org/10.1161/hc3501.095707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11535565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Role%20of%20Endothelin%E2%80%901%20in%20the%20Active%20Constriction%20of%20Human%20Atherosclerotic%20Coronary%20Arteries&amp;author=S.%20Kinlay&amp;author=D.%20Behrendt&amp;author=M.%20Wainstein&amp;volume=104&amp;publication_year=2001&amp;pages=1114-1118&amp;pmid=11535565&amp;doi=10.1161/hc3501.095707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0024">
<span class="label">24.</span><cite>
Saye J. A., Singer H. A., and Peach M. J., “Role of Endothelium in Conversion of Angiotensin I to Angiotensin II in Rabbit Aorta,” Hypertension
6 (1984): 216–221.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/6202632/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Role%20of%20Endothelium%20in%20Conversion%20of%20Angiotensin%20I%20to%20Angiotensin%20II%20in%20Rabbit%20Aorta&amp;author=J.%20A.%20Saye&amp;author=H.%20A.%20Singer&amp;author=M.%20J.%20Peach&amp;volume=6&amp;publication_year=1984&amp;pages=216-221&amp;pmid=6202632&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0025">
<span class="label">25.</span><cite>
Palmer R. M., Ashton D. S., and Moncada S., “Vascular Endothelial Cells Synthesize Nitric Oxide From L‐Arginine,” Nature
333 (1988): 664–666.
</cite> [<a href="https://doi.org/10.1038/333664a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3131684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Vascular%20Endothelial%20Cells%20Synthesize%20Nitric%20Oxide%20From%20L%E2%80%90Arginine&amp;author=R.%20M.%20Palmer&amp;author=D.%20S.%20Ashton&amp;author=S.%20Moncada&amp;volume=333&amp;publication_year=1988&amp;pages=664-666&amp;pmid=3131684&amp;doi=10.1038/333664a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0026">
<span class="label">26.</span><cite>
Moncada S. and Higgs A., “The L‐Arginine‐Nitric Oxide Pathway,” New England Journal of Medicine
329 (1993): 2002–2012.
</cite> [<a href="https://doi.org/10.1056/NEJM199312303292706" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7504210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=The%20L%E2%80%90Arginine%E2%80%90Nitric%20Oxide%20Pathway&amp;author=S.%20Moncada&amp;author=A.%20Higgs&amp;volume=329&amp;publication_year=1993&amp;pages=2002-2012&amp;pmid=7504210&amp;doi=10.1056/NEJM199312303292706&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0027">
<span class="label">27.</span><cite>
Rapoport R. M., Draznin M. B., and Murad F., “Endothelium‐Dependent Relaxation in Rat Aorta May Be Mediated Through Cyclic GMP‐Dependent Protein Phosphorylation,” Nature
306 (1983): 174–176.
</cite> [<a href="https://doi.org/10.1038/306174a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6316142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Endothelium%E2%80%90Dependent%20Relaxation%20in%20Rat%20Aorta%20May%20Be%20Mediated%20Through%20Cyclic%20GMP%E2%80%90Dependent%20Protein%20Phosphorylation&amp;author=R.%20M.%20Rapoport&amp;author=M.%20B.%20Draznin&amp;author=F.%20Murad&amp;volume=306&amp;publication_year=1983&amp;pages=174-176&amp;pmid=6316142&amp;doi=10.1038/306174a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0028">
<span class="label">28.</span><cite>
Corpas F. J., González‐Gordo S., and Palma J. M., “Nitric Oxide and Hydrogen Sulfide Modulate the NADPH‐Generating Enzymatic System in Higher Plants,” Journal of Experimental Botany
72 (2021): 830–847.
</cite> [<a href="https://doi.org/10.1093/jxb/eraa440" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32945878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Botany&amp;title=Nitric%20Oxide%20and%20Hydrogen%20Sulfide%20Modulate%20the%20NADPH%E2%80%90Generating%20Enzymatic%20System%20in%20Higher%20Plants&amp;author=F.%20J.%20Corpas&amp;author=S.%20Gonz%C3%A1lez%E2%80%90Gordo&amp;author=J.%20M.%20Palma&amp;volume=72&amp;publication_year=2021&amp;pages=830-847&amp;pmid=32945878&amp;doi=10.1093/jxb/eraa440&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0029">
<span class="label">29.</span><cite>
Kalucka J., Bierhansl L., Conchinha N. V., et al., “Quiescent Endothelial Cells Upregulate Fatty Acid β‐Oxidation for Vasculoprotection via Redox Homeostasis,” Cell Metabolism
28 (2018): 881–894.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2018.07.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30146488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metabolism&amp;title=Quiescent%20Endothelial%20Cells%20Upregulate%20Fatty%20Acid%20%CE%B2%E2%80%90Oxidation%20for%20Vasculoprotection%20via%20Redox%20Homeostasis&amp;author=J.%20Kalucka&amp;author=L.%20Bierhansl&amp;author=N.%20V.%20Conchinha&amp;volume=28&amp;publication_year=2018&amp;pages=881-894&amp;pmid=30146488&amp;doi=10.1016/j.cmet.2018.07.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0030">
<span class="label">30.</span><cite>
Hecquet C. M. and Malik A. B., “Role of H(2)O(2)‐Activated TRPM2 Calcium Channel in Oxidant‐Induced Endothelial Injury,” Thrombosis and Haemostasis
101 (2009): 619–625.
</cite> [<a href="/articles/PMC3699330/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19350103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thrombosis%20and%20Haemostasis&amp;title=Role%20of%20H(2)O(2)%E2%80%90Activated%20TRPM2%20Calcium%20Channel%20in%20Oxidant%E2%80%90Induced%20Endothelial%20Injury&amp;author=C.%20M.%20Hecquet&amp;author=A.%20B.%20Malik&amp;volume=101&amp;publication_year=2009&amp;pages=619-625&amp;pmid=19350103&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0031">
<span class="label">31.</span><cite>
Yang L., Froio R. M., Sciuto T. E., Dvorak A. M., Alon R., and Luscinskas F. W., “ICAM‐1 Regulates Neutrophil Adhesion and Transcellular Migration of TNF‐Alpha‐Activated Vascular Endothelium Under Flow,” Blood
106 (2005): 584–592.
</cite> [<a href="https://doi.org/10.1182/blood-2004-12-4942" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1635241/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15811956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=ICAM%E2%80%901%20Regulates%20Neutrophil%20Adhesion%20and%20Transcellular%20Migration%20of%20TNF%E2%80%90Alpha%E2%80%90Activated%20Vascular%20Endothelium%20Under%20Flow&amp;author=L.%20Yang&amp;author=R.%20M.%20Froio&amp;author=T.%20E.%20Sciuto&amp;author=A.%20M.%20Dvorak&amp;author=R.%20Alon&amp;volume=106&amp;publication_year=2005&amp;pages=584-592&amp;pmid=15811956&amp;doi=10.1182/blood-2004-12-4942&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0032">
<span class="label">32.</span><cite>
Zuchtriegel G., Uhl B., Hessenauer M. E. T., et al., “Spatiotemporal Expression Dynamics of Selectins Govern the Sequential Extravasation of Neutrophils and Monocytes in the Acute Inflammatory Response,” Arteriosclerosis, Thrombosis, and Vascular Biology
35 (2015): 899–910.
</cite> [<a href="https://doi.org/10.1161/ATVBAHA.114.305143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25722429/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arteriosclerosis,%20Thrombosis,%20and%20Vascular%20Biology&amp;title=Spatiotemporal%20Expression%20Dynamics%20of%20Selectins%20Govern%20the%20Sequential%20Extravasation%20of%20Neutrophils%20and%20Monocytes%20in%20the%20Acute%20Inflammatory%20Response&amp;author=G.%20Zuchtriegel&amp;author=B.%20Uhl&amp;author=M.%20E.%20T.%20Hessenauer&amp;volume=35&amp;publication_year=2015&amp;pages=899-910&amp;pmid=25722429&amp;doi=10.1161/ATVBAHA.114.305143&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0033">
<span class="label">33.</span><cite>
Eelen G., de Zeeuw P., Treps L., Harjes U., Wong B. W., and Carmeliet P., “Endothelial Cell Metabolism,” Physiological Reviews
98 (2018): 3–58.
</cite> [<a href="https://doi.org/10.1152/physrev.00001.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5866357/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29167330/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiological%20Reviews&amp;title=Endothelial%20Cell%20Metabolism&amp;author=G.%20Eelen&amp;author=P.%20de%20Zeeuw&amp;author=L.%20Treps&amp;author=U.%20Harjes&amp;author=B.%20W.%20Wong&amp;volume=98&amp;publication_year=2018&amp;pages=3-58&amp;pmid=29167330&amp;doi=10.1152/physrev.00001.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0034">
<span class="label">34.</span><cite>
De Bock K., Georgiadou M., Schoors S., et al., “Role of PFKFB3‐Driven Glycolysis in Vessel Sprouting,” Cell
154 (2013): 651–663.
</cite> [<a href="https://doi.org/10.1016/j.cell.2013.06.037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23911327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Role%20of%20PFKFB3%E2%80%90Driven%20Glycolysis%20in%20Vessel%20Sprouting&amp;author=K.%20De%20Bock&amp;author=M.%20Georgiadou&amp;author=S.%20Schoors&amp;volume=154&amp;publication_year=2013&amp;pages=651-663&amp;pmid=23911327&amp;doi=10.1016/j.cell.2013.06.037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0035">
<span class="label">35.</span><cite>
Schoors S., Bruning U., Missiaen R., et al., “Fatty Acid Carbon Is Essential for dNTP Synthesis in Endothelial Cells,” Nature
520 (2015): 192–197.
</cite> [<a href="https://doi.org/10.1038/nature14362" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4413024/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25830893/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Fatty%20Acid%20Carbon%20Is%20Essential%20for%20dNTP%20Synthesis%20in%20Endothelial%20Cells&amp;author=S.%20Schoors&amp;author=U.%20Bruning&amp;author=R.%20Missiaen&amp;volume=520&amp;publication_year=2015&amp;pages=192-197&amp;pmid=25830893&amp;doi=10.1038/nature14362&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0036">
<span class="label">36.</span><cite>
Stanton R. C., “Glucose‐6‐Phosphate Dehydrogenase, NADPH, and Cell Survival,” IUBMB Life
64 (2012): 362–369.
</cite> [<a href="https://doi.org/10.1002/iub.1017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3325335/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22431005/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IUBMB%20Life&amp;title=Glucose%E2%80%906%E2%80%90Phosphate%20Dehydrogenase,%20NADPH,%20and%20Cell%20Survival&amp;author=R.%20C.%20Stanton&amp;volume=64&amp;publication_year=2012&amp;pages=362-369&amp;pmid=22431005&amp;doi=10.1002/iub.1017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0037">
<span class="label">37.</span><cite>
Boulanger C. M., “Endothelium,” Arteriosclerosis, Thrombosis, and Vascular Biology
36 (2016): e26–e31.
</cite> [<a href="https://doi.org/10.1161/ATVBAHA.116.306940" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27010027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arteriosclerosis,%20Thrombosis,%20and%20Vascular%20Biology&amp;title=Endothelium&amp;author=C.%20M.%20Boulanger&amp;volume=36&amp;publication_year=2016&amp;pages=e26-e31&amp;pmid=27010027&amp;doi=10.1161/ATVBAHA.116.306940&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0038">
<span class="label">38.</span><cite>
Eelen G., de Zeeuw P., Simons M., and Carmeliet P., “Endothelial Cell Metabolism in Normal and Diseased Vasculature,” Circulation Research
116 (2015): 1231–1244.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.116.302855" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4380230/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25814684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Endothelial%20Cell%20Metabolism%20in%20Normal%20and%20Diseased%20Vasculature&amp;author=G.%20Eelen&amp;author=P.%20de%20Zeeuw&amp;author=M.%20Simons&amp;author=P.%20Carmeliet&amp;volume=116&amp;publication_year=2015&amp;pages=1231-1244&amp;pmid=25814684&amp;doi=10.1161/CIRCRESAHA.116.302855&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0039">
<span class="label">39.</span><cite>
Zhang Z., Apse K., Pang J., and Stanton R. C., “High Glucose Inhibits Glucose‐6‐Phosphate Dehydrogenase via cAMP in Aortic Endothelial Cells,” Journal of Biological Chemistry
275 (2000): 40042–40047.
</cite> [<a href="https://doi.org/10.1074/jbc.M007505200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11007790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biological%20Chemistry&amp;title=High%20Glucose%20Inhibits%20Glucose%E2%80%906%E2%80%90Phosphate%20Dehydrogenase%20via%20cAMP%20in%20Aortic%20Endothelial%20Cells&amp;author=Z.%20Zhang&amp;author=K.%20Apse&amp;author=J.%20Pang&amp;author=R.%20C.%20Stanton&amp;volume=275&amp;publication_year=2000&amp;pages=40042-40047&amp;pmid=11007790&amp;doi=10.1074/jbc.M007505200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0040">
<span class="label">40.</span><cite>
Cai H. and Harrison D. G., “Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress,” Circulation Research
87 (2000): 840–844.
</cite> [<a href="https://doi.org/10.1161/01.res.87.10.840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11073878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Endothelial%20Dysfunction%20in%20Cardiovascular%20Diseases:%20The%20Role%20of%20Oxidant%20Stress&amp;author=H.%20Cai&amp;author=D.%20G.%20Harrison&amp;volume=87&amp;publication_year=2000&amp;pages=840-844&amp;pmid=11073878&amp;doi=10.1161/01.res.87.10.840&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0041">
<span class="label">41.</span><cite>
Kuo A., Lee M. Y., and Sessa W. C., “Lipid Droplet Biogenesis and Function in the Endothelium,” Circulation Research
120 (2017): 1289–1297.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.116.310498" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5392152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28119423/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Lipid%20Droplet%20Biogenesis%20and%20Function%20in%20the%20Endothelium&amp;author=A.%20Kuo&amp;author=M.%20Y.%20Lee&amp;author=W.%20C.%20Sessa&amp;volume=120&amp;publication_year=2017&amp;pages=1289-1297&amp;pmid=28119423&amp;doi=10.1161/CIRCRESAHA.116.310498&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0042">
<span class="label">42.</span><cite>
Mallick R. and Duttaroy A. K., “Modulation of Endothelium Function by Fatty Acids,” Molecular and Cellular Biochemistry
477 (2022): 15–38.
</cite> [<a href="https://doi.org/10.1007/s11010-021-04260-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8755678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34529222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Biochemistry&amp;title=Modulation%20of%20Endothelium%20Function%20by%20Fatty%20Acids&amp;author=R.%20Mallick&amp;author=A.%20K.%20Duttaroy&amp;volume=477&amp;publication_year=2022&amp;pages=15-38&amp;pmid=34529222&amp;doi=10.1007/s11010-021-04260-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0043">
<span class="label">43.</span><cite>
Shin J., Hong J., Edwards‐Glenn J., et al., “Unraveling the Role of Sex in Endothelial Cell Dysfunction: Evidence From Lineage Tracing Mice and Cultured Cells,” Arteriosclerosis, Thrombosis, and Vascular Biology
44 (2024): 238–253.
</cite> [<a href="https://doi.org/10.1161/ATVBAHA.123.319833" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10842863/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38031841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arteriosclerosis,%20Thrombosis,%20and%20Vascular%20Biology&amp;title=Unraveling%20the%20Role%20of%20Sex%20in%20Endothelial%20Cell%20Dysfunction:%20Evidence%20From%20Lineage%20Tracing%20Mice%20and%20Cultured%20Cells&amp;author=J.%20Shin&amp;author=J.%20Hong&amp;author=J.%20Edwards%E2%80%90Glenn&amp;volume=44&amp;publication_year=2024&amp;pages=238-253&amp;pmid=38031841&amp;doi=10.1161/ATVBAHA.123.319833&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0044">
<span class="label">44.</span><cite>
Sakamuri A., Visniauskas B., Kilanowski‐Doroh I., et al., “Testosterone Deficiency Promotes Arterial Stiffening Independent of Sex Chromosome Complement,” Biology of Sex Differences
15 (2024): 46.
</cite> [<a href="https://doi.org/10.1186/s13293-024-00624-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11155160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38845040/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biology%20of%20Sex%20Differences&amp;title=Testosterone%20Deficiency%20Promotes%20Arterial%20Stiffening%20Independent%20of%20Sex%20Chromosome%20Complement&amp;author=A.%20Sakamuri&amp;author=B.%20Visniauskas&amp;author=I.%20Kilanowski%E2%80%90Doroh&amp;volume=15&amp;publication_year=2024&amp;pages=46&amp;pmid=38845040&amp;doi=10.1186/s13293-024-00624-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0045">
<span class="label">45.</span><cite>
Stanhewicz A. E., Wenner M. M., and Stachenfeld N. S., “Sex Differences in Endothelial Function Important to Vascular Health and Overall Cardiovascular Disease Risk Across the Lifespan,” American Journal of Physiology. Heart and Circulatory Physiology
315 (2018): H1569–H1588.
</cite> [<a href="https://doi.org/10.1152/ajpheart.00396.2018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6734083/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30216121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology.%20Heart%20and%20Circulatory%20Physiology&amp;title=Sex%20Differences%20in%20Endothelial%20Function%20Important%20to%20Vascular%20Health%20and%20Overall%20Cardiovascular%20Disease%20Risk%20Across%20the%20Lifespan&amp;author=A.%20E.%20Stanhewicz&amp;author=M.%20M.%20Wenner&amp;author=N.%20S.%20Stachenfeld&amp;volume=315&amp;publication_year=2018&amp;pages=H1569-H1588&amp;pmid=30216121&amp;doi=10.1152/ajpheart.00396.2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0046">
<span class="label">46.</span><cite>
Khalil R. A., “Sex Hormones as Potential Modulators of Vascular Function in Hypertension,” Hypertension
1979, no. 46 (2005): 249–254.</cite> [<a href="https://doi.org/10.1161/01.HYP.0000172945.06681.a4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1249514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15983238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Sex%20Hormones%20as%20Potential%20Modulators%20of%20Vascular%20Function%20in%20Hypertension&amp;author=R.%20A.%20Khalil&amp;volume=1979&amp;issue=46&amp;publication_year=2005&amp;pages=249-254&amp;pmid=15983238&amp;doi=10.1161/01.HYP.0000172945.06681.a4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0047">
<span class="label">47.</span><cite>
Zhang X., Wang L. Y., Jiang T. Y., et al., “Effects of Testosterone and 17‐Beta‐Estradiol on TNF‐Alpha‐Induced E‐Selectin and VCAM‐1 Expression in Endothelial Cells. Analysis of the Underlying Receptor Pathways,” Life Sciences
71 (2002): 15–29.
</cite> [<a href="https://doi.org/10.1016/s0024-3205(02)01567-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12020745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life%20Sciences&amp;title=Effects%20of%20Testosterone%20and%2017%E2%80%90Beta%E2%80%90Estradiol%20on%20TNF%E2%80%90Alpha%E2%80%90Induced%20E%E2%80%90Selectin%20and%20VCAM%E2%80%901%20Expression%20in%20Endothelial%20Cells.%20Analysis%20of%20the%20Underlying%20Receptor%20Pathways&amp;author=X.%20Zhang&amp;author=L.%20Y.%20Wang&amp;author=T.%20Y.%20Jiang&amp;volume=71&amp;publication_year=2002&amp;pages=15-29&amp;pmid=12020745&amp;doi=10.1016/s0024-3205(02)01567-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0048">
<span class="label">48.</span><cite>
Nevzati E., Shafighi M., Bakhtian K. D., Treiber H., Fandino J., and Fathi A. R., “Estrogen Induces Nitric Oxide Production via Nitric Oxide Synthase Activation in Endothelial Cells,” Acta Neurochirurgica. Supplement
120 (2015): 141–145.
</cite> [<a href="https://doi.org/10.1007/978-3-319-04981-6_24" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25366614/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neurochirurgica.%20Supplement&amp;title=Estrogen%20Induces%20Nitric%20Oxide%20Production%20via%20Nitric%20Oxide%20Synthase%20Activation%20in%20Endothelial%20Cells&amp;author=E.%20Nevzati&amp;author=M.%20Shafighi&amp;author=K.%20D.%20Bakhtian&amp;author=H.%20Treiber&amp;author=J.%20Fandino&amp;volume=120&amp;publication_year=2015&amp;pages=141-145&amp;pmid=25366614&amp;doi=10.1007/978-3-319-04981-6_24&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0049">
<span class="label">49.</span><cite>
Goglia L., Tosi V., Sanchez A. M., et al., “Endothelial Regulation of eNOS, PAI‐1 and t‐PA by Testosterone and Dihydrotestosterone In Vitro and In Vivo,” Molecular Human Reproduction
16 (2010): 761–769.
</cite> [<a href="https://doi.org/10.1093/molehr/gaq049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20547636/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Human%20Reproduction&amp;title=Endothelial%20Regulation%20of%20eNOS,%20PAI%E2%80%901%20and%20t%E2%80%90PA%20by%20Testosterone%20and%20Dihydrotestosterone%20In%C2%A0Vitro%20and%20In%C2%A0Vivo&amp;author=L.%20Goglia&amp;author=V.%20Tosi&amp;author=A.%20M.%20Sanchez&amp;volume=16&amp;publication_year=2010&amp;pages=761-769&amp;pmid=20547636&amp;doi=10.1093/molehr/gaq049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0050">
<span class="label">50.</span><cite>
Harada N., Sasano H., Murakami H., Ohkuma T., Nagura H., and Takagi Y., “Localized Expression of Aromatase in Human Vascular Tissues,” Circulation Research
84 (1999): 1285–1291.
</cite> [<a href="https://doi.org/10.1161/01.res.84.11.1285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10364566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Localized%20Expression%20of%20Aromatase%20in%20Human%20Vascular%20Tissues&amp;author=N.%20Harada&amp;author=H.%20Sasano&amp;author=H.%20Murakami&amp;author=T.%20Ohkuma&amp;author=H.%20Nagura&amp;volume=84&amp;publication_year=1999&amp;pages=1285-1291&amp;pmid=10364566&amp;doi=10.1161/01.res.84.11.1285&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0051">
<span class="label">51.</span><cite>
Rodríguez E., López R., Paez A., Massó F., and Montaño L. F., “17Beta‐Estradiol Inhibits the Adhesion of Leukocytes in TNF‐Alpha Stimulated Human Endothelial Cells by Blocking IL‐8 and MCP‐1 Secretion, but Not Its Transcription,” Life Sciences
71 (2002): 2181–2193.
</cite> [<a href="https://doi.org/10.1016/s0024-3205(02)01999-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12204776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life%20Sciences&amp;title=17Beta%E2%80%90Estradiol%20Inhibits%20the%20Adhesion%20of%20Leukocytes%20in%20TNF%E2%80%90Alpha%20Stimulated%20Human%20Endothelial%20Cells%20by%20Blocking%20IL%E2%80%908%20and%20MCP%E2%80%901%20Secretion,%20but%20Not%20Its%20Transcription&amp;author=E.%20Rodr%C3%ADguez&amp;author=R.%20L%C3%B3pez&amp;author=A.%20Paez&amp;author=F.%20Mass%C3%B3&amp;author=L.%20F.%20Monta%C3%B1o&amp;volume=71&amp;publication_year=2002&amp;pages=2181-2193&amp;pmid=12204776&amp;doi=10.1016/s0024-3205(02)01999-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0052">
<span class="label">52.</span><cite>
Störk S., von Schacky C., and Angerer P., “The Effect of 17beta‐Estradiol on Endothelial and Inflammatory Markers in Postmenopausal Women: A Randomized, Controlled Trial,” Atherosclerosis
165 (2002): 301–307.
</cite> [<a href="https://doi.org/10.1016/s0021-9150(02)00242-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12417281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=The%20Effect%20of%2017beta%E2%80%90Estradiol%20on%20Endothelial%20and%20Inflammatory%20Markers%20in%20Postmenopausal%20Women:%20A%20Randomized,%20Controlled%20Trial&amp;author=S.%20St%C3%B6rk&amp;author=C.%20von%20Schacky&amp;author=P.%20Angerer&amp;volume=165&amp;publication_year=2002&amp;pages=301-307&amp;pmid=12417281&amp;doi=10.1016/s0021-9150(02)00242-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0053">
<span class="label">53.</span><cite>
Störk S., Baumann K., von Schacky C., and Angerer P., “The Effect of 17 Beta‐Estradiol on MCP‐1 Serum Levels in Postmenopausal Women,” Cardiovascular Research
53 (2002): 642–649.
</cite> [<a href="https://doi.org/10.1016/s0008-6363(01)00461-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11861035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=The%20Effect%20of%2017%20Beta%E2%80%90Estradiol%20on%20MCP%E2%80%901%20Serum%20Levels%20in%20Postmenopausal%20Women&amp;author=S.%20St%C3%B6rk&amp;author=K.%20Baumann&amp;author=C.%20von%20Schacky&amp;author=P.%20Angerer&amp;volume=53&amp;publication_year=2002&amp;pages=642-649&amp;pmid=11861035&amp;doi=10.1016/s0008-6363(01)00461-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0054">
<span class="label">54.</span><cite>
Norata G. D., Tibolla G., Seccomandi P. M., Poletti A., and Catapano A. L., “Dihydrotestosterone Decreases Tumor Necrosis Factor‐Alpha and Lipopolysaccharide‐Induced Inflammatory Response in Human Endothelial Cells,” Journal of Clinical Endocrinology and Metabolism
91 (2006): 546–554.
</cite> [<a href="https://doi.org/10.1210/jc.2005-1664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16317058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Endocrinology%20and%20Metabolism&amp;title=Dihydrotestosterone%20Decreases%20Tumor%20Necrosis%20Factor%E2%80%90Alpha%20and%20Lipopolysaccharide%E2%80%90Induced%20Inflammatory%20Response%20in%20Human%20Endothelial%20Cells&amp;author=G.%20D.%20Norata&amp;author=G.%20Tibolla&amp;author=P.%20M.%20Seccomandi&amp;author=A.%20Poletti&amp;author=A.%20L.%20Catapano&amp;volume=91&amp;publication_year=2006&amp;pages=546-554&amp;pmid=16317058&amp;doi=10.1210/jc.2005-1664&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0055">
<span class="label">55.</span><cite>
Hatakeyama H., Nishizawa M., Nakagawa A., Nakano S., Kigoshi T., and Uchida K., “Testosterone Inhibits Tumor Necrosis Factor‐Alpha‐Induced Vascular Cell Adhesion Molecule‐1 Expression in Human Aortic Endothelial Cells,” FEBS Letters
530 (2002): 129–132.
</cite> [<a href="https://doi.org/10.1016/s0014-5793(02)03440-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12387879/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Letters&amp;title=Testosterone%20Inhibits%20Tumor%20Necrosis%20Factor%E2%80%90Alpha%E2%80%90Induced%20Vascular%20Cell%20Adhesion%20Molecule%E2%80%901%20Expression%20in%20Human%20Aortic%20Endothelial%20Cells&amp;author=H.%20Hatakeyama&amp;author=M.%20Nishizawa&amp;author=A.%20Nakagawa&amp;author=S.%20Nakano&amp;author=T.%20Kigoshi&amp;volume=530&amp;publication_year=2002&amp;pages=129-132&amp;pmid=12387879&amp;doi=10.1016/s0014-5793(02)03440-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0056">
<span class="label">56.</span><cite>
Death A. K., McGrath K. C., Sader M. A., et al., “Dihydrotestosterone Promotes Vascular Cell Adhesion Molecule‐1 Expression in Male Human Endothelial Cells via a Nuclear Factor‐kappaB‐Dependent Pathway,” Endocrinology
145 (2004): 1889–1897.
</cite> [<a href="https://doi.org/10.1210/en.2003-0789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14684616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Dihydrotestosterone%20Promotes%20Vascular%20Cell%20Adhesion%20Molecule%E2%80%901%20Expression%20in%20Male%20Human%20Endothelial%20Cells%20via%20a%20Nuclear%20Factor%E2%80%90kappaB%E2%80%90Dependent%20Pathway&amp;author=A.%20K.%20Death&amp;author=K.%20C.%20McGrath&amp;author=M.%20A.%20Sader&amp;volume=145&amp;publication_year=2004&amp;pages=1889-1897&amp;pmid=14684616&amp;doi=10.1210/en.2003-0789&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0057">
<span class="label">57.</span><cite>
McCrohon J. A., Jessup W., Handelsman D. J., and Celermajer D. S., “Androgen Exposure Increases Human Monocyte Adhesion to Vascular Endothelium and Endothelial Cell Expression of Vascular Cell Adhesion Molecule‐1,” Circulation
99 (1999): 2317–2322.
</cite> [<a href="https://doi.org/10.1161/01.cir.99.17.2317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10226099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Androgen%20Exposure%20Increases%20Human%20Monocyte%20Adhesion%20to%20Vascular%20Endothelium%20and%20Endothelial%20Cell%20Expression%20of%20Vascular%20Cell%20Adhesion%20Molecule%E2%80%901&amp;author=J.%20A.%20McCrohon&amp;author=W.%20Jessup&amp;author=D.%20J.%20Handelsman&amp;author=D.%20S.%20Celermajer&amp;volume=99&amp;publication_year=1999&amp;pages=2317-2322&amp;pmid=10226099&amp;doi=10.1161/01.cir.99.17.2317&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0058">
<span class="label">58.</span><cite>
Hartman R. J. G., Kapteijn D. M. C., Haitjema S., et al., “Intrinsic Transcriptomic Sex Differences in Human Endothelial Cells at Birth and in Adults Are Associated With Coronary Artery Disease Targets,” Scientific Reports
10 (2020): 12367.
</cite> [<a href="https://doi.org/10.1038/s41598-020-69451-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7378217/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32704153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Intrinsic%20Transcriptomic%20Sex%20Differences%20in%20Human%20Endothelial%20Cells%20at%20Birth%20and%20in%20Adults%20Are%20Associated%20With%20Coronary%20Artery%20Disease%20Targets&amp;author=R.%20J.%20G.%20Hartman&amp;author=D.%20M.%20C.%20Kapteijn&amp;author=S.%20Haitjema&amp;volume=10&amp;publication_year=2020&amp;pages=12367&amp;pmid=32704153&amp;doi=10.1038/s41598-020-69451-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0059">
<span class="label">59.</span><cite>
Teede H., van der Zypp A., and Majewski H., “Gender Differences in Protein Kinase G‐Mediated Vasorelaxation of Rat Aorta,” Clinical Science
1979, no. 100 (2001): 473–479.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/11294687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Science&amp;title=Gender%20Differences%20in%20Protein%20Kinase%20G%E2%80%90Mediated%20Vasorelaxation%20of%20Rat%20Aorta&amp;author=H.%20Teede&amp;author=A.%20van%20der%20Zypp&amp;author=H.%20Majewski&amp;volume=1979&amp;issue=100&amp;publication_year=2001&amp;pages=473-479&amp;pmid=11294687&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0060">
<span class="label">60.</span><cite>
Addis R., Campesi I., Fois M., et al., “Human Umbilical Endothelial Cells (HUVECs) Have a Sex: Characterisation of the Phenotype of Male and Female Cells,” Biology of Sex Differences
5 (2014): 18.
</cite> [<a href="https://doi.org/10.1186/s13293-014-0018-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4273493/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25535548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biology%20of%20Sex%20Differences&amp;title=Human%20Umbilical%20Endothelial%20Cells%20(HUVECs)%20Have%20a%20Sex:%20Characterisation%20of%20the%20Phenotype%20of%20Male%20and%20Female%20Cells&amp;author=R.%20Addis&amp;author=I.%20Campesi&amp;author=M.%20Fois&amp;volume=5&amp;publication_year=2014&amp;pages=18&amp;pmid=25535548&amp;doi=10.1186/s13293-014-0018-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0061">
<span class="label">61.</span><cite>
Aragam K. G., Jiang T., Goel A., et al., “Discovery and Systematic Characterization of Risk Variants and Genes for Coronary Artery Disease in Over a Million Participants,” Nature Genetics
54 (2022): 1803–1815.
</cite> [<a href="https://doi.org/10.1038/s41588-022-01233-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9729111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36474045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Genetics&amp;title=Discovery%20and%20Systematic%20Characterization%20of%20Risk%20Variants%20and%20Genes%20for%20Coronary%20Artery%20Disease%20in%20Over%20a%20Million%20Participants&amp;author=K.%20G.%20Aragam&amp;author=T.%20Jiang&amp;author=A.%20Goel&amp;volume=54&amp;publication_year=2022&amp;pages=1803-1815&amp;pmid=36474045&amp;doi=10.1038/s41588-022-01233-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0062">
<span class="label">62.</span><cite>
Giannakopoulou E., Konstantinou F., Ragia G., et al., “Epigenetics‐By‐Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ‐Lyase Gene Promoter Methylation,” OMICS: A Journal of Integrative Biology
21 (2017): 741–748.
</cite> [<a href="https://doi.org/10.1089/omi.2017.0149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29173085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=OMICS:%20A%20Journal%20of%20Integrative%20Biology&amp;title=Epigenetics%E2%80%90By%E2%80%90Sex%20Interaction%20for%20Coronary%20Artery%20Disease%20Risk%20Conferred%20by%20the%20Cystathionine%20%CE%B3%E2%80%90Lyase%20Gene%20Promoter%20Methylation&amp;author=E.%20Giannakopoulou&amp;author=F.%20Konstantinou&amp;author=G.%20Ragia&amp;volume=21&amp;publication_year=2017&amp;pages=741-748&amp;pmid=29173085&amp;doi=10.1089/omi.2017.0149&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0063">
<span class="label">63.</span><cite>
Altaany Z., Moccia F., Munaron L., Mancardi D., and Wang R., “Hydrogen Sulfide and Endothelial Dysfunction: Relationship With Nitric Oxide,” Current Medicinal Chemistry
21 (2014): 3646–3661.
</cite> [<a href="https://doi.org/10.2174/0929867321666140706142930" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25005182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Medicinal%20Chemistry&amp;title=Hydrogen%20Sulfide%20and%20Endothelial%20Dysfunction:%20Relationship%20With%20Nitric%20Oxide&amp;author=Z.%20Altaany&amp;author=F.%20Moccia&amp;author=L.%20Munaron&amp;author=D.%20Mancardi&amp;author=R.%20Wang&amp;volume=21&amp;publication_year=2014&amp;pages=3646-3661&amp;pmid=25005182&amp;doi=10.2174/0929867321666140706142930&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0064">
<span class="label">64.</span><cite>
El Khoudary S. R., Aggarwal B., Beckie T. M., et al., “Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association,” Circulation
142 (2020): e506–e532.
</cite> [<a href="https://doi.org/10.1161/CIR.0000000000000912" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33251828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Menopause%20Transition%20and%20Cardiovascular%20Disease%20Risk:%20Implications%20for%20Timing%20of%20Early%20Prevention:%20A%20Scientific%20Statement%20From%20the%20American%20Heart%20Association&amp;author=S.%20R.%20El%20Khoudary&amp;author=B.%20Aggarwal&amp;author=T.%20M.%20Beckie&amp;volume=142&amp;publication_year=2020&amp;pages=e506-e532&amp;pmid=33251828&amp;doi=10.1161/CIR.0000000000000912&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0065">
<span class="label">65.</span><cite>
Clarke A. J. and Simon A. K., “Autophagy in the Renewal, Differentiation and Homeostasis of Immune Cells,” Nature Reviews. Immunology
19 (2019): 170–183.</cite> [<a href="https://doi.org/10.1038/s41577-018-0095-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30531943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Immunology&amp;title=Autophagy%20in%20the%20Renewal,%20Differentiation%20and%20Homeostasis%20of%20Immune%20Cells&amp;author=A.%20J.%20Clarke&amp;author=A.%20K.%20Simon&amp;volume=19&amp;publication_year=2019&amp;pages=170-183&amp;pmid=30531943&amp;doi=10.1038/s41577-018-0095-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0066">
<span class="label">66.</span><cite>
Khanna D., Khanna S., Khanna P., Kahar P., and Patel B. M., “Obesity: A Chronic Low‐Grade Inflammation and Its Markers,” Cureus
14 (2022): e22711, 10.7759/cureus.22711.
</cite> [<a href="https://doi.org/10.7759/cureus.22711" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8967417/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35386146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cureus&amp;title=Obesity:%20A%20Chronic%20Low%E2%80%90Grade%20Inflammation%20and%20Its%20Markers&amp;author=D.%20Khanna&amp;author=S.%20Khanna&amp;author=P.%20Khanna&amp;author=P.%20Kahar&amp;author=B.%20M.%20Patel&amp;volume=14&amp;publication_year=2022&amp;pages=e22711&amp;pmid=35386146&amp;doi=10.7759/cureus.22711&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0067">
<span class="label">67.</span><cite>
Park C.‐S. and Shastri N., “The Role of T Cells in Obesity‐Associated Inflammation and Metabolic Disease,” Immune Network
22 (2022): e13.
</cite> [<a href="https://doi.org/10.4110/in.2022.22.e13" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8901709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35291655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immune%20Network&amp;title=The%20Role%20of%20T%20Cells%20in%20Obesity%E2%80%90Associated%20Inflammation%20and%20Metabolic%20Disease&amp;author=C.%E2%80%90S.%20Park&amp;author=N.%20Shastri&amp;volume=22&amp;publication_year=2022&amp;pages=e13&amp;pmid=35291655&amp;doi=10.4110/in.2022.22.e13&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0068">
<span class="label">68.</span><cite>
Chen S., Saeed A. F. U. H., Liu Q., et al., “Macrophages in Immunoregulation and Therapeutics,” Signal Transduction and Targeted Therapy
8 (2023): 207.
</cite> [<a href="https://doi.org/10.1038/s41392-023-01452-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10200802/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37211559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduction%20and%20Targeted%20Therapy&amp;title=Macrophages%20in%20Immunoregulation%20and%20Therapeutics&amp;author=S.%20Chen&amp;author=A.%20F.%20U.%20H.%20Saeed&amp;author=Q.%20Liu&amp;volume=8&amp;publication_year=2023&amp;pages=207&amp;pmid=37211559&amp;doi=10.1038/s41392-023-01452-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0069">
<span class="label">69.</span><cite>
Williams J. W., Giannarelli C., Rahman A., Randolph G. J., and Kovacic J. C., “Macrophage Biology, Classification, and Phenotype in Cardiovascular Disease: JACC Macrophage in CVD Series (Part 1),” Journal of the American College of Cardiology
72 (2018): 2166–2180.
</cite> [<a href="https://doi.org/10.1016/j.jacc.2018.08.2148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6209330/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30360826/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20College%20of%20Cardiology&amp;title=Macrophage%20Biology,%20Classification,%20and%20Phenotype%20in%20Cardiovascular%20Disease:%20JACC%20Macrophage%20in%20CVD%20Series%20(Part%201)&amp;author=J.%20W.%20Williams&amp;author=C.%20Giannarelli&amp;author=A.%20Rahman&amp;author=G.%20J.%20Randolph&amp;author=J.%20C.%20Kovacic&amp;volume=72&amp;publication_year=2018&amp;pages=2166-2180&amp;pmid=30360826&amp;doi=10.1016/j.jacc.2018.08.2148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0070">
<span class="label">70.</span><cite>
Stremmel C., Schuchert R., Wagner F., et al., “Yolk Sac Macrophage Progenitors Traffic to the Embryo During Defined Stages of Development,” Nature Communications
9 (2018): 75.</cite> [<a href="https://doi.org/10.1038/s41467-017-02492-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5758709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29311541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Yolk%20Sac%20Macrophage%20Progenitors%20Traffic%20to%20the%20Embryo%20During%20Defined%20Stages%20of%20Development&amp;author=C.%20Stremmel&amp;author=R.%20Schuchert&amp;author=F.%20Wagner&amp;volume=9&amp;publication_year=2018&amp;pages=75&amp;pmid=29311541&amp;doi=10.1038/s41467-017-02492-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0071">
<span class="label">71.</span><cite>
Wynn T. A. and Barron L., “Macrophages: Master Regulators of Inflammation and Fibrosis,” Seminars in Liver Disease
30 (2010): 245–257.
</cite> [<a href="https://doi.org/10.1055/s-0030-1255354" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2924662/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20665377/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Seminars%20in%20Liver%20Disease&amp;title=Macrophages:%20Master%20Regulators%20of%20Inflammation%20and%20Fibrosis&amp;author=T.%20A.%20Wynn&amp;author=L.%20Barron&amp;volume=30&amp;publication_year=2010&amp;pages=245-257&amp;pmid=20665377&amp;doi=10.1055/s-0030-1255354&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0072">
<span class="label">72.</span><cite>
Chen R., Zhang H., Tang B., et al., “Macrophages in Cardiovascular Diseases: Molecular Mechanisms and Therapeutic Targets,” Signal Transduction and Targeted Therapy
9 (2024): 130.
</cite> [<a href="https://doi.org/10.1038/s41392-024-01840-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11139930/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38816371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduction%20and%20Targeted%20Therapy&amp;title=Macrophages%20in%20Cardiovascular%20Diseases:%20Molecular%20Mechanisms%20and%20Therapeutic%20Targets&amp;author=R.%20Chen&amp;author=H.%20Zhang&amp;author=B.%20Tang&amp;volume=9&amp;publication_year=2024&amp;pages=130&amp;pmid=38816371&amp;doi=10.1038/s41392-024-01840-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0073">
<span class="label">73.</span><cite>
Kraakman M. J., Murphy A. J., Jandeleit‐Dahm K., and Kammoun H. L., “Macrophage Polarization in Obesity and Type 2 Diabetes: Weighing Down Our Understanding of Macrophage Function?,” Frontiers in Immunology
5 (2014): 470.
</cite> [<a href="https://doi.org/10.3389/fimmu.2014.00470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4176397/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25309549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Immunology&amp;title=Macrophage%20Polarization%20in%20Obesity%20and%20Type%202%20Diabetes:%20Weighing%20Down%20Our%20Understanding%20of%20Macrophage%20Function?&amp;author=M.%20J.%20Kraakman&amp;author=A.%20J.%20Murphy&amp;author=K.%20Jandeleit%E2%80%90Dahm&amp;author=H.%20L.%20Kammoun&amp;volume=5&amp;publication_year=2014&amp;pages=470&amp;pmid=25309549&amp;doi=10.3389/fimmu.2014.00470&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0074">
<span class="label">74.</span><cite>
Bekkering S., Quintin J., Joosten L. A. B., van der Meer J. W. M., Netea M. G., and Riksen N. P., “Oxidized Low‐Density Lipoprotein Induces Long‐Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of Monocytes,” Arteriosclerosis, Thrombosis, and Vascular Biology
34 (2014): 1731–1738.
</cite> [<a href="https://doi.org/10.1161/ATVBAHA.114.303887" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24903093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arteriosclerosis,%20Thrombosis,%20and%20Vascular%20Biology&amp;title=Oxidized%20Low%E2%80%90Density%20Lipoprotein%20Induces%20Long%E2%80%90Term%20Proinflammatory%20Cytokine%20Production%20and%20Foam%20Cell%20Formation%20via%20Epigenetic%20Reprogramming%20of%20Monocytes&amp;author=S.%20Bekkering&amp;author=J.%20Quintin&amp;author=L.%20A.%20B.%20Joosten&amp;author=J.%20W.%20M.%20van%20der%20Meer&amp;author=M.%20G.%20Netea&amp;volume=34&amp;publication_year=2014&amp;pages=1731-1738&amp;pmid=24903093&amp;doi=10.1161/ATVBAHA.114.303887&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0075">
<span class="label">75.</span><cite>
Osada‐Oka M., Shiota M., Izumi Y., et al., “Macrophage‐Derived Exosomes Induce Inflammatory Factors in Endothelial Cells Under Hypertensive Conditions,” Hypertension Research
40 (2017): 353–360.
</cite> [<a href="https://doi.org/10.1038/hr.2016.163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27881852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension%20Research&amp;title=Macrophage%E2%80%90Derived%20Exosomes%20Induce%20Inflammatory%20Factors%20in%20Endothelial%20Cells%20Under%20Hypertensive%20Conditions&amp;author=M.%20Osada%E2%80%90Oka&amp;author=M.%20Shiota&amp;author=Y.%20Izumi&amp;volume=40&amp;publication_year=2017&amp;pages=353-360&amp;pmid=27881852&amp;doi=10.1038/hr.2016.163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0076">
<span class="label">76.</span><cite>
Ostriker A., Horita H. N., Poczobutt J., Weiser‐Evans M. C. M., and Nemenoff R. A., “Vascular Smooth Muscle Cell‐Derived Transforming Growth Factor‐β Promotes Maturation of Activated, Neointima Lesion‐Like Macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology
34 (2014): 877–886.
</cite> [<a href="https://doi.org/10.1161/ATVBAHA.114.303214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3966963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24526697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arteriosclerosis,%20Thrombosis,%20and%20Vascular%20Biology&amp;title=Vascular%20Smooth%20Muscle%20Cell%E2%80%90Derived%20Transforming%20Growth%20Factor%E2%80%90%CE%B2%20Promotes%20Maturation%20of%20Activated,%20Neointima%20Lesion%E2%80%90Like%20Macrophages&amp;author=A.%20Ostriker&amp;author=H.%20N.%20Horita&amp;author=J.%20Poczobutt&amp;author=M.%20C.%20M.%20Weiser%E2%80%90Evans&amp;author=R.%20A.%20Nemenoff&amp;volume=34&amp;publication_year=2014&amp;pages=877-886&amp;pmid=24526697&amp;doi=10.1161/ATVBAHA.114.303214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0077">
<span class="label">77.</span><cite>
Luckheeram R. V., Zhou R., Verma A. D., and Xia B., “CD4<sup>+</sup>T Cells: Differentiation and Functions,” Clinical and Developmental Immunology
2012 (2012): 925135.
</cite> [<a href="https://doi.org/10.1155/2012/925135" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3312336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22474485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Developmental%20Immunology&amp;title=CD4+T%20Cells:%20Differentiation%20and%20Functions&amp;author=R.%20V.%20Luckheeram&amp;author=R.%20Zhou&amp;author=A.%20D.%20Verma&amp;author=B.%20Xia&amp;volume=2012&amp;publication_year=2012&amp;pages=925135&amp;pmid=22474485&amp;doi=10.1155/2012/925135&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0078">
<span class="label">78.</span><cite>
Almeida L., Dhillon‐LaBrooy A., Carriche G., Berod L., and Sparwasser T., “CD4+ T‐Cell Differentiation and Function: Unifying Glycolysis, Fatty Acid Oxidation, Polyamines NAD Mitochondria,” Journal of Allergy and Clinical Immunology
148 (2021): 16–32.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2021.03.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33966898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=CD4+%20T%E2%80%90Cell%20Differentiation%20and%20Function:%20Unifying%20Glycolysis,%20Fatty%20Acid%20Oxidation,%20Polyamines%20NAD%20Mitochondria&amp;author=L.%20Almeida&amp;author=A.%20Dhillon%E2%80%90LaBrooy&amp;author=G.%20Carriche&amp;author=L.%20Berod&amp;author=T.%20Sparwasser&amp;volume=148&amp;publication_year=2021&amp;pages=16-32&amp;pmid=33966898&amp;doi=10.1016/j.jaci.2021.03.033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0079">
<span class="label">79.</span><cite>
DeBerge M., Chaudhary R., Schroth S., and Thorp E. B., “Immunometabolism at the Heart of Cardiovascular Disease,” JACC: Basic to Translational Science
8 (2023): 884–904.
</cite> [<a href="https://doi.org/10.1016/j.jacbts.2022.12.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10401297/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37547069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC:%20Basic%20to%20Translational%20Science&amp;title=Immunometabolism%20at%20the%20Heart%20of%20Cardiovascular%20Disease&amp;author=M.%20DeBerge&amp;author=R.%20Chaudhary&amp;author=S.%20Schroth&amp;author=E.%20B.%20Thorp&amp;volume=8&amp;publication_year=2023&amp;pages=884-904&amp;pmid=37547069&amp;doi=10.1016/j.jacbts.2022.12.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0080">
<span class="label">80.</span><cite>
Kado T., Nawaz A., Takikawa A., Usui I., and Tobe K., “Linkage of CD8+ T Cell Exhaustion With High‐Fat Diet‐Induced Tumourigenesis,” Scientific Reports
9 (2019): 12284.
</cite> [<a href="https://doi.org/10.1038/s41598-019-48678-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6706391/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31439906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Linkage%20of%20CD8+%20T%20Cell%20Exhaustion%20With%20High%E2%80%90Fat%20Diet%E2%80%90Induced%20Tumourigenesis&amp;author=T.%20Kado&amp;author=A.%20Nawaz&amp;author=A.%20Takikawa&amp;author=I.%20Usui&amp;author=K.%20Tobe&amp;volume=9&amp;publication_year=2019&amp;pages=12284&amp;pmid=31439906&amp;doi=10.1038/s41598-019-48678-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0081">
<span class="label">81.</span><cite>
Wherry E. J., “T Cell Exhaustion,” Nature Immunology
12 (2011): 492–499.
</cite> [<a href="https://doi.org/10.1038/ni.2035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21739672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Immunology&amp;title=T%20Cell%20Exhaustion&amp;author=E.%20J.%20Wherry&amp;volume=12&amp;publication_year=2011&amp;pages=492-499&amp;pmid=21739672&amp;doi=10.1038/ni.2035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0082">
<span class="label">82.</span><cite>
Shirakawa K., Yan X., Shinmura K., et al., “Obesity Accelerates T Cell Senescence in Murine Visceral Adipose Tissue,” Journal of Clinical Investigation
126 (2016): 4626–4639.
</cite> [<a href="https://doi.org/10.1172/JCI88606" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5127667/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27820698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Obesity%20Accelerates%20T%20Cell%20Senescence%20in%20Murine%20Visceral%20Adipose%20Tissue&amp;author=K.%20Shirakawa&amp;author=X.%20Yan&amp;author=K.%20Shinmura&amp;volume=126&amp;publication_year=2016&amp;pages=4626-4639&amp;pmid=27820698&amp;doi=10.1172/JCI88606&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0083">
<span class="label">83.</span><cite>
Porsche C. E., Delproposto J. B., Geletka L., O'Rourke R., and Lumeng C. N., “Obesity Results in Adipose Tissue T Cell Exhaustion,” JCI Insight
6 (2021): e139793.
</cite> [<a href="https://doi.org/10.1172/jci.insight.139793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8119198/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33724954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JCI%20Insight&amp;title=Obesity%20Results%20in%20Adipose%20Tissue%20T%20Cell%20Exhaustion&amp;author=C.%20E.%20Porsche&amp;author=J.%20B.%20Delproposto&amp;author=L.%20Geletka&amp;author=R.%20O'Rourke&amp;author=C.%20N.%20Lumeng&amp;volume=6&amp;publication_year=2021&amp;pages=e139793&amp;pmid=33724954&amp;doi=10.1172/jci.insight.139793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0084">
<span class="label">84.</span><cite>
Mizota T., Fujita‐Kambara C., Matsuya N., et al., “Effect of Dietary Fatty Acid Composition on Th1/Th2 Polarization in Lymphocytes,” JPEN Journal of Parenteral and Enteral Nutrition
33 (2009): 390–396.
</cite> [<a href="https://doi.org/10.1177/0148607108325252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19221048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JPEN%20Journal%20of%20Parenteral%20and%20Enteral%20Nutrition&amp;title=Effect%20of%20Dietary%20Fatty%20Acid%20Composition%20on%20Th1/Th2%20Polarization%20in%20Lymphocytes&amp;author=T.%20Mizota&amp;author=C.%20Fujita%E2%80%90Kambara&amp;author=N.%20Matsuya&amp;volume=33&amp;publication_year=2009&amp;pages=390-396&amp;pmid=19221048&amp;doi=10.1177/0148607108325252&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0085">
<span class="label">85.</span><cite>
Chen L., Sun M., Wu W., et al., “Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells' Differentiation and Function in Induction of Colitis,” Inflammatory Bowel Diseases
25 (2019): 1450–1461.
</cite> [<a href="https://doi.org/10.1093/ibd/izz046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6701512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30918945/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflammatory%20Bowel%20Diseases&amp;title=Microbiota%20Metabolite%20Butyrate%20Differentially%20Regulates%20Th1%20and%20Th17%20Cells'%20Differentiation%20and%20Function%20in%20Induction%20of%20Colitis&amp;author=L.%20Chen&amp;author=M.%20Sun&amp;author=W.%20Wu&amp;volume=25&amp;publication_year=2019&amp;pages=1450-1461&amp;pmid=30918945&amp;doi=10.1093/ibd/izz046&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0086">
<span class="label">86.</span><cite>
Bantug G. R., Galluzzi L., Kroemer G., and Hess C., “The Spectrum of T Cell Metabolism in Health and Disease,” Nature Reviews. Immunology
18 (2018): 19–34.</cite> [<a href="https://doi.org/10.1038/nri.2017.99" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28944771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Immunology&amp;title=The%20Spectrum%20of%20T%20Cell%20Metabolism%20in%20Health%20and%20Disease&amp;author=G.%20R.%20Bantug&amp;author=L.%20Galluzzi&amp;author=G.%20Kroemer&amp;author=C.%20Hess&amp;volume=18&amp;publication_year=2018&amp;pages=19-34&amp;pmid=28944771&amp;doi=10.1038/nri.2017.99&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0087">
<span class="label">87.</span><cite>
Schulte S., Sukhova G. K., and Libby P., “Genetically Programmed Biases in Th1 and Th2 Immune Responses Modulate Atherogenesis,” American Journal of Pathology
172 (2008): 1500–1508.
</cite> [<a href="https://doi.org/10.2353/ajpath.2008.070776" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2408411/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18467709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Pathology&amp;title=Genetically%20Programmed%20Biases%20in%20Th1%20and%20Th2%20Immune%20Responses%20Modulate%20Atherogenesis&amp;author=S.%20Schulte&amp;author=G.%20K.%20Sukhova&amp;author=P.%20Libby&amp;volume=172&amp;publication_year=2008&amp;pages=1500-1508&amp;pmid=18467709&amp;doi=10.2353/ajpath.2008.070776&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0088">
<span class="label">88.</span><cite>
Satou R., Miyata K., Gonzalez‐Villalobos R. A., Ingelfinger J. R., Navar L. G., and Kobori H., “Interferon‐γ Biphasically Regulates Angiotensinogen Expression via a JAK‐STAT Pathway and Suppressor of Cytokine Signaling 1 (SOCS1) in Renal Proximal Tubular Cells,” FASEB Journal
26 (2012): 1821–1830.
</cite> [<a href="https://doi.org/10.1096/fj.11-195198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3336777/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22302831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20Journal&amp;title=Interferon%E2%80%90%CE%B3%20Biphasically%20Regulates%20Angiotensinogen%20Expression%20via%20a%20JAK%E2%80%90STAT%20Pathway%20and%20Suppressor%20of%20Cytokine%20Signaling%201%20(SOCS1)%20in%20Renal%20Proximal%20Tubular%20Cells&amp;author=R.%20Satou&amp;author=K.%20Miyata&amp;author=R.%20A.%20Gonzalez%E2%80%90Villalobos&amp;author=J.%20R.%20Ingelfinger&amp;author=L.%20G.%20Navar&amp;volume=26&amp;publication_year=2012&amp;pages=1821-1830&amp;pmid=22302831&amp;doi=10.1096/fj.11-195198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0089">
<span class="label">89.</span><cite>
Zhang Z., Zhao L., Zhou X., Meng X., and Zhou X., “Role of Inflammation, Immunity, and Oxidative Stress in Hypertension: New Insights and Potential Therapeutic Targets,” Frontiers in Immunology
13 (2022): 1098725.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.1098725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9871625/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36703963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Immunology&amp;title=Role%20of%20Inflammation,%20Immunity,%20and%20Oxidative%20Stress%20in%20Hypertension:%20New%20Insights%20and%20Potential%20Therapeutic%20Targets&amp;author=Z.%20Zhang&amp;author=L.%20Zhao&amp;author=X.%20Zhou&amp;author=X.%20Meng&amp;author=X.%20Zhou&amp;volume=13&amp;publication_year=2022&amp;pages=1098725&amp;pmid=36703963&amp;doi=10.3389/fimmu.2022.1098725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0090">
<span class="label">90.</span><cite>
Nevers T., Salvador A. M., Velazquez F., et al., “Th1 Effector T Cells Selectively Orchestrate Cardiac Fibrosis in Nonischemic Heart Failure,” Journal of Experimental Medicine
214 (2017): 3311–3329.
</cite> [<a href="https://doi.org/10.1084/jem.20161791" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5679176/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28970239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Th1%20Effector%20T%20Cells%20Selectively%20Orchestrate%20Cardiac%20Fibrosis%20in%20Nonischemic%20Heart%20Failure&amp;author=T.%20Nevers&amp;author=A.%20M.%20Salvador&amp;author=F.%20Velazquez&amp;volume=214&amp;publication_year=2017&amp;pages=3311-3329&amp;pmid=28970239&amp;doi=10.1084/jem.20161791&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0091">
<span class="label">91.</span><cite>
Anderson C. F. and Mosser D. M., “A Novel Phenotype for an Activated Macrophage: The Type 2 Activated Macrophage,” Journal of Leukocyte Biology
72 (2002): 101–106.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/12101268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Leukocyte%20Biology&amp;title=A%20Novel%20Phenotype%20for%20an%20Activated%20Macrophage:%20The%20Type%202%20Activated%20Macrophage&amp;author=C.%20F.%20Anderson&amp;author=D.%20M.%20Mosser&amp;volume=72&amp;publication_year=2002&amp;pages=101-106&amp;pmid=12101268&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0092">
<span class="label">92.</span><cite>
Schmidt V., Hogan A. E., Fallon P. G., and Schwartz C., “Obesity‐Mediated Immune Modulation: One Step Forward, (Th)2 Steps Back,” Frontiers in Immunology
13 (2022): 932893.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.932893" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9279727/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35844529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Immunology&amp;title=Obesity%E2%80%90Mediated%20Immune%20Modulation:%20One%20Step%20Forward,%20(Th)2%20Steps%20Back&amp;author=V.%20Schmidt&amp;author=A.%20E.%20Hogan&amp;author=P.%20G.%20Fallon&amp;author=C.%20Schwartz&amp;volume=13&amp;publication_year=2022&amp;pages=932893&amp;pmid=35844529&amp;doi=10.3389/fimmu.2022.932893&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0093">
<span class="label">93.</span><cite>
Peng H., Sarwar Z., Yang X. P., et al., “Profibrotic Role for Interleukin‐4 in Cardiac Remodeling and Dysfunction,” Hypertension
66 (2015): 582–589.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.115.05627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4685692/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26195478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Profibrotic%20Role%20for%20Interleukin%E2%80%904%20in%20Cardiac%20Remodeling%20and%20Dysfunction&amp;author=H.%20Peng&amp;author=Z.%20Sarwar&amp;author=X.%20P.%20Yang&amp;volume=66&amp;publication_year=2015&amp;pages=582-589&amp;pmid=26195478&amp;doi=10.1161/HYPERTENSIONAHA.115.05627&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0094">
<span class="label">94.</span><cite>
Miossec P. and Kolls J. K., “Targeting IL‐17 and TH17 Cells in Chronic Inflammation,” Nature Reviews. Drug Discovery
11 (2012): 763–776.
</cite> [<a href="https://doi.org/10.1038/nrd3794" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23023676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Drug%20Discovery&amp;title=Targeting%20IL%E2%80%9017%20and%20TH17%20Cells%20in%20Chronic%20Inflammation&amp;author=P.%20Miossec&amp;author=J.%20K.%20Kolls&amp;volume=11&amp;publication_year=2012&amp;pages=763-776&amp;pmid=23023676&amp;doi=10.1038/nrd3794&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0095">
<span class="label">95.</span><cite>
Madhur M. S., Lob H. E., McCann L. A., et al., “Interleukin 17 Promotes Angiotensin II‐Induced Hypertension and Vascular Dysfunction,” Hypertension
55 (2010): 500–507.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.109.145094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2819301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20038749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Interleukin%2017%20Promotes%20Angiotensin%20II%E2%80%90Induced%20Hypertension%20and%20Vascular%20Dysfunction&amp;author=M.%20S.%20Madhur&amp;author=H.%20E.%20Lob&amp;author=L.%20A.%20McCann&amp;volume=55&amp;publication_year=2010&amp;pages=500-507&amp;pmid=20038749&amp;doi=10.1161/HYPERTENSIONAHA.109.145094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0096">
<span class="label">96.</span><cite>
Basile D. P., Abais‐Battad J. M., and Mattson D. L., “Contribution of Th17 Cells to Tissue Injury in Hypertension,” Current Opinion in Nephrology and Hypertension
30 (2021): 151–158.
</cite> [<a href="https://doi.org/10.1097/MNH.0000000000000680" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8221512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33394732/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Nephrology%20and%20Hypertension&amp;title=Contribution%20of%20Th17%20Cells%20to%20Tissue%20Injury%20in%20Hypertension&amp;author=D.%20P.%20Basile&amp;author=J.%20M.%20Abais%E2%80%90Battad&amp;author=D.%20L.%20Mattson&amp;volume=30&amp;publication_year=2021&amp;pages=151-158&amp;pmid=33394732&amp;doi=10.1097/MNH.0000000000000680&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0097">
<span class="label">97.</span><cite>
Amador C. A., Barrientos V., Peña J., et al., “Spironolactone Decreases DOCA‐Salt‐Induced Organ Damage by Blocking the Activation of T Helper 17 and the Downregulation of Regulatory T Lymphocytes,” Hypertension
63 (2014): 797–803.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.113.02883" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24420551/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Spironolactone%20Decreases%20DOCA%E2%80%90Salt%E2%80%90Induced%20Organ%20Damage%20by%20Blocking%20the%20Activation%20of%20T%20Helper%2017%20and%20the%20Downregulation%20of%20Regulatory%20T%20Lymphocytes&amp;author=C.%20A.%20Amador&amp;author=V.%20Barrientos&amp;author=J.%20Pe%C3%B1a&amp;volume=63&amp;publication_year=2014&amp;pages=797-803&amp;pmid=24420551&amp;doi=10.1161/HYPERTENSIONAHA.113.02883&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0098">
<span class="label">98.</span><cite>
Chiasson V. L., Pakanati A. R., Hernandez M., Young K. J., Bounds K. R., and Mitchell B. M., “Regulatory T‐Cell Augmentation or Interleukin‐17 Inhibition Prevents Calcineurin Inhibitor‐Induced Hypertension in Mice,” Hypertension
70, no. 1 (2017): 183–191.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.117.09374" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5501301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28584011/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Regulatory%20T%E2%80%90Cell%20Augmentation%20or%20Interleukin%E2%80%9017%20Inhibition%20Prevents%20Calcineurin%20Inhibitor%E2%80%90Induced%20Hypertension%20in%20Mice&amp;author=V.%20L.%20Chiasson&amp;author=A.%20R.%20Pakanati&amp;author=M.%20Hernandez&amp;author=K.%20J.%20Young&amp;author=K.%20R.%20Bounds&amp;volume=70&amp;issue=1&amp;publication_year=2017&amp;pages=183-191&amp;pmid=28584011&amp;doi=10.1161/HYPERTENSIONAHA.117.09374&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0099">
<span class="label">99.</span><cite>
Cornelius D. C., Hogg J. P., Scott J., et al., “Administration of Interleukin‐17 Soluble Receptor C Suppresses TH17 Cells, Oxidative Stress, and Hypertension in Response to Placental Ischemia During Pregnancy,” Hypertension
62 (2013): 1068–1073.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.113.01514" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3899693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24060899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Administration%20of%20Interleukin%E2%80%9017%20Soluble%20Receptor%20C%20Suppresses%20TH17%20Cells,%20Oxidative%20Stress,%20and%20Hypertension%20in%20Response%20to%20Placental%20Ischemia%20During%20Pregnancy&amp;author=D.%20C.%20Cornelius&amp;author=J.%20P.%20Hogg&amp;author=J.%20Scott&amp;volume=62&amp;publication_year=2013&amp;pages=1068-1073&amp;pmid=24060899&amp;doi=10.1161/HYPERTENSIONAHA.113.01514&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0100">
<span class="label">100.</span><cite>
Gilleron J., Bouget G., Ivanov S., et al., “Rab4b Deficiency in T Cells Promotes Adipose Treg/Th17 Imbalance, Adipose Tissue Dysfunction, and Insulin Resistance,” Cell Reports
25 (2018): 3329–3341.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2018.11.083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30566860/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Reports&amp;title=Rab4b%20Deficiency%20in%20T%20Cells%20Promotes%20Adipose%20Treg/Th17%20Imbalance,%20Adipose%20Tissue%20Dysfunction,%20and%20Insulin%20Resistance&amp;author=J.%20Gilleron&amp;author=G.%20Bouget&amp;author=S.%20Ivanov&amp;volume=25&amp;publication_year=2018&amp;pages=3329-3341&amp;pmid=30566860&amp;doi=10.1016/j.celrep.2018.11.083&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0101">
<span class="label">101.</span><cite>
Zhang S., Gang X., Yang S., et al., “The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases,” Frontiers in Immunology
12 (2021): 678355.
</cite> [<a href="https://doi.org/10.3389/fimmu.2021.678355" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8311559/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34322117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Immunology&amp;title=The%20Alterations%20in%20and%20the%20Role%20of%20the%20Th17/Treg%20Balance%20in%20Metabolic%20Diseases&amp;author=S.%20Zhang&amp;author=X.%20Gang&amp;author=S.%20Yang&amp;volume=12&amp;publication_year=2021&amp;pages=678355&amp;pmid=34322117&amp;doi=10.3389/fimmu.2021.678355&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0102">
<span class="label">102.</span><cite>
Wang X., Zhou H., Liu Q., et al., “Targeting Regulatory T Cells for Cardiovascular Diseases,” Frontiers in Immunology
14 (2023): 1126761.
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1126761" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9995594/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36911741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Immunology&amp;title=Targeting%20Regulatory%20T%20Cells%20for%20Cardiovascular%20Diseases&amp;author=X.%20Wang&amp;author=H.%20Zhou&amp;author=Q.%20Liu&amp;volume=14&amp;publication_year=2023&amp;pages=1126761&amp;pmid=36911741&amp;doi=10.3389/fimmu.2023.1126761&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0103">
<span class="label">103.</span><cite>
Sava R. I., Pepine C. J., and March K. L., “Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy,” Journal of Clinical Medicine
9 (2020): 241.
</cite> [<a href="https://doi.org/10.3390/jcm9010241" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7019215/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31963368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Medicine&amp;title=Immune%20Dysregulation%20in%20HFpEF:%20A%20Target%20for%20Mesenchymal%20Stem/Stromal%20Cell%20Therapy&amp;author=R.%20I.%20Sava&amp;author=C.%20J.%20Pepine&amp;author=K.%20L.%20March&amp;volume=9&amp;publication_year=2020&amp;pages=241&amp;pmid=31963368&amp;doi=10.3390/jcm9010241&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0104">
<span class="label">104.</span><cite>
Taams L. S., Vukmanovic‐Stejic M., Smith J., et al., “Antigen‐Specific T Cell Suppression by Human CD4+CD25+ Regulatory T Cells,” European Journal of Immunology
32 (2002): 1621–1630.
</cite> [<a href="https://doi.org/10.1002/1521-4141(200206)32:6&lt;1621::AID-IMMU1621&gt;3.0.CO;2-Q" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12115645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Immunology&amp;title=Antigen%E2%80%90Specific%20T%20Cell%20Suppression%20by%20Human%20CD4+CD25+%20Regulatory%20T%20Cells&amp;author=L.%20S.%20Taams&amp;author=M.%20Vukmanovic%E2%80%90Stejic&amp;author=J.%20Smith&amp;volume=32&amp;publication_year=2002&amp;pages=1621-1630&amp;pmid=12115645&amp;doi=10.1002/1521-4141(200206)32:6&lt;1621::AID-IMMU1621&gt;3.0.CO;2-Q&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0105">
<span class="label">105.</span><cite>
Libert C., Dejager L., and Pinheiro I., “The X Chromosome in Immune Functions: When a Chromosome Makes the Difference,” Nature Reviews. Immunology
10 (2010): 594–604.</cite> [<a href="https://doi.org/10.1038/nri2815" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20651746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Immunology&amp;title=The%20X%20Chromosome%20in%20Immune%20Functions:%20When%20a%20Chromosome%20Makes%20the%20Difference&amp;author=C.%20Libert&amp;author=L.%20Dejager&amp;author=I.%20Pinheiro&amp;volume=10&amp;publication_year=2010&amp;pages=594-604&amp;pmid=20651746&amp;doi=10.1038/nri2815&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0106">
<span class="label">106.</span><cite>
Case L. K., Wall E. H., Dragon J. A., et al., “The Y Chromosome as a Regulatory Element Shaping Immune Cell Transcriptomes and Susceptibility to Autoimmune Disease,” Genome Research
23 (2013): 1474–1485.
</cite> [<a href="https://doi.org/10.1101/gr.156703.113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3759723/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23800453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Research&amp;title=The%20Y%20Chromosome%20as%20a%20Regulatory%20Element%20Shaping%20Immune%20Cell%20Transcriptomes%20and%20Susceptibility%20to%20Autoimmune%20Disease&amp;author=L.%20K.%20Case&amp;author=E.%20H.%20Wall&amp;author=J.%20A.%20Dragon&amp;volume=23&amp;publication_year=2013&amp;pages=1474-1485&amp;pmid=23800453&amp;doi=10.1101/gr.156703.113&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0107">
<span class="label">107.</span><cite>
Taneja V., “Sex Hormones Determine Immune Response,” Frontiers in Immunology
9 (2018): 1931.
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.01931" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6119719/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30210492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Immunology&amp;title=Sex%20Hormones%20Determine%20Immune%20Response&amp;author=V.%20Taneja&amp;volume=9&amp;publication_year=2018&amp;pages=1931&amp;pmid=30210492&amp;doi=10.3389/fimmu.2018.01931&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0108">
<span class="label">108.</span><cite>
Klein S. L. and Flanagan K. L., “Sex Differences in Immune Responses,” Nature Reviews. Immunology
16 (2016): 626–638.</cite> [<a href="https://doi.org/10.1038/nri.2016.90" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27546235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Immunology&amp;title=Sex%20Differences%20in%20Immune%20Responses&amp;author=S.%20L.%20Klein&amp;author=K.%20L.%20Flanagan&amp;volume=16&amp;publication_year=2016&amp;pages=626-638&amp;pmid=27546235&amp;doi=10.1038/nri.2016.90&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0109">
<span class="label">109.</span><cite>
Fish E. N., “The X‐Files in Immunity: Sex‐Based Differences Predispose Immune Responses,” Nature Reviews. Immunology
8 (2008): 737–744.</cite> [<a href="https://doi.org/10.1038/nri2394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7097214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18728636/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Immunology&amp;title=The%20X%E2%80%90Files%20in%20Immunity:%20Sex%E2%80%90Based%20Differences%20Predispose%20Immune%20Responses&amp;author=E.%20N.%20Fish&amp;volume=8&amp;publication_year=2008&amp;pages=737-744&amp;pmid=18728636&amp;doi=10.1038/nri2394&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0110">
<span class="label">110.</span><cite>
Fox H. S., Bond B. L., and Parslow T. G., “Estrogen Regulates the IFN‐Gamma Promoter,” Journal of Immunology
146 (1991): 4362–4367.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1904081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Estrogen%20Regulates%20the%20IFN%E2%80%90Gamma%20Promoter&amp;author=H.%20S.%20Fox&amp;author=B.%20L.%20Bond&amp;author=T.%20G.%20Parslow&amp;volume=146&amp;publication_year=1991&amp;pages=4362-4367&amp;pmid=1904081&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0111">
<span class="label">111.</span><cite>
Faas M., Bouman A., Moesa H., Heineman M. J., de Leij L., and Schuiling G., “The Immune Response During the Luteal Phase of the Ovarian Cycle: A Th2‐Type Response?,” Fertility and Sterility
74 (2000): 1008–1013.
</cite> [<a href="https://doi.org/10.1016/s0015-0282(00)01553-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11056250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fertility%20and%20Sterility&amp;title=The%20Immune%20Response%20During%20the%20Luteal%20Phase%20of%20the%20Ovarian%20Cycle:%20A%20Th2%E2%80%90Type%20Response?&amp;author=M.%20Faas&amp;author=A.%20Bouman&amp;author=H.%20Moesa&amp;author=M.%20J.%20Heineman&amp;author=L.%20de%20Leij&amp;volume=74&amp;publication_year=2000&amp;pages=1008-1013&amp;pmid=11056250&amp;doi=10.1016/s0015-0282(00)01553-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0112">
<span class="label">112.</span><cite>
Campbell L., Emmerson E., Williams H., et al., “Estrogen Receptor‐Alpha Promotes Alternative Macrophage Activation During Cutaneous Repair,” Journal of Investigative Dermatology
134 (2014): 2447–2457.
</cite> [<a href="https://doi.org/10.1038/jid.2014.175" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24769859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Investigative%20Dermatology&amp;title=Estrogen%20Receptor%E2%80%90Alpha%20Promotes%20Alternative%20Macrophage%20Activation%20During%20Cutaneous%20Repair&amp;author=L.%20Campbell&amp;author=E.%20Emmerson&amp;author=H.%20Williams&amp;volume=134&amp;publication_year=2014&amp;pages=2447-2457&amp;pmid=24769859&amp;doi=10.1038/jid.2014.175&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0113">
<span class="label">113.</span><cite>
Meyer M. R., Haas E., and Barton M., “Gender Differences of Cardiovascular Disease: New Perspectives for Estrogen Receptor Signaling,” Hypertension
1979, no. 47 (2006): 1019–1026.</cite> [<a href="https://doi.org/10.1161/01.HYP.0000223064.62762.0b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16651458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Gender%20Differences%20of%20Cardiovascular%20Disease:%20New%20Perspectives%20for%20Estrogen%20Receptor%20Signaling&amp;author=M.%20R.%20Meyer&amp;author=E.%20Haas&amp;author=M.%20Barton&amp;volume=1979&amp;issue=47&amp;publication_year=2006&amp;pages=1019-1026&amp;pmid=16651458&amp;doi=10.1161/01.HYP.0000223064.62762.0b&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0114">
<span class="label">114.</span><cite>
Nilsson B.‐O., Olde B., and Leeb‐Lundberg L. M. F., “G Protein‐Coupled Oestrogen Receptor 1 (GPER1)/GPR30: A New Player in Cardiovascular and Metabolic Oestrogenic Signalling,” British Journal of Pharmacology
163 (2011): 1131–1139.
</cite> [<a href="https://doi.org/10.1111/j.1476-5381.2011.01235.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3144530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21250980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=G%20Protein%E2%80%90Coupled%20Oestrogen%20Receptor%201%20(GPER1)/GPR30:%20A%20New%20Player%20in%20Cardiovascular%20and%20Metabolic%20Oestrogenic%20Signalling&amp;author=B.%E2%80%90O.%20Nilsson&amp;author=B.%20Olde&amp;author=L.%20M.%20F.%20Leeb%E2%80%90Lundberg&amp;volume=163&amp;publication_year=2011&amp;pages=1131-1139&amp;pmid=21250980&amp;doi=10.1111/j.1476-5381.2011.01235.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0115">
<span class="label">115.</span><cite>
Ghosh M., Rodriguez‐Garcia M., and Wira C. R., “The Immune System in Menopause: Pros and Cons of Hormone Therapy,” Journal of Steroid Biochemistry and Molecular Biology
142 (2014): 171–175.
</cite> [<a href="https://doi.org/10.1016/j.jsbmb.2013.09.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3954964/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24041719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Steroid%20Biochemistry%20and%20Molecular%20Biology&amp;title=The%20Immune%20System%20in%20Menopause:%20Pros%20and%20Cons%20of%20Hormone%20Therapy&amp;author=M.%20Ghosh&amp;author=M.%20Rodriguez%E2%80%90Garcia&amp;author=C.%20R.%20Wira&amp;volume=142&amp;publication_year=2014&amp;pages=171-175&amp;pmid=24041719&amp;doi=10.1016/j.jsbmb.2013.09.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0116">
<span class="label">116.</span><cite>
Malkin C. J., Pugh P. J., Jones R. D., Kapoor D., Channer K. S., and Jones T. H., “The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men,” Journal of Clinical Endocrinology and Metabolism
89 (2004): 3313–3318.
</cite> [<a href="https://doi.org/10.1210/jc.2003-031069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15240608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Endocrinology%20and%20Metabolism&amp;title=The%20Effect%20of%20Testosterone%20Replacement%20on%20Endogenous%20Inflammatory%20Cytokines%20and%20Lipid%20Profiles%20in%20Hypogonadal%20Men&amp;author=C.%20J.%20Malkin&amp;author=P.%20J.%20Pugh&amp;author=R.%20D.%20Jones&amp;author=D.%20Kapoor&amp;author=K.%20S.%20Channer&amp;volume=89&amp;publication_year=2004&amp;pages=3313-3318&amp;pmid=15240608&amp;doi=10.1210/jc.2003-031069&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0117">
<span class="label">117.</span><cite>
Kissick H. T., Sanda M. G., Dunn L. K., et al., “Androgens Alter T‐Cell Immunity by Inhibiting T‐Helper 1 Differentiation,” Proceedings of the National Academy of Sciences of the United States of America
111 (2014): 9887–9892.
</cite> [<a href="https://doi.org/10.1073/pnas.1402468111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4103356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24958858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America&amp;title=Androgens%20Alter%20T%E2%80%90Cell%20Immunity%20by%20Inhibiting%20T%E2%80%90Helper%201%20Differentiation&amp;author=H.%20T.%20Kissick&amp;author=M.%20G.%20Sanda&amp;author=L.%20K.%20Dunn&amp;volume=111&amp;publication_year=2014&amp;pages=9887-9892&amp;pmid=24958858&amp;doi=10.1073/pnas.1402468111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0118">
<span class="label">118.</span><cite>
Walecki M., Eisel F., Klug J., et al., “Androgen Receptor Modulates Foxp3 Expression in CD4+CD25+Foxp3+ Regulatory T‐Cells,” Molecular Biology of the Cell
26 (2015): 2845–2857.
</cite> [<a href="https://doi.org/10.1091/mbc.E14-08-1323" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4571343/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26063731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Biology%20of%20the%20Cell&amp;title=Androgen%20Receptor%20Modulates%20Foxp3%20Expression%20in%20CD4+CD25+Foxp3+%20Regulatory%20T%E2%80%90Cells&amp;author=M.%20Walecki&amp;author=F.%20Eisel&amp;author=J.%20Klug&amp;volume=26&amp;publication_year=2015&amp;pages=2845-2857&amp;pmid=26063731&amp;doi=10.1091/mbc.E14-08-1323&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0119">
<span class="label">119.</span><cite>
Collet T.‐H., Ewing S. K., Ensrud K. E., et al., “Endogenous Testosterone Levels and the Risk of Incident Cardiovascular Events in Elderly Men: The MrOS Prospective Study,” Journal of the Endocrine Society
4 (2020): bvaa038.
</cite> [<a href="https://doi.org/10.1210/jendso/bvaa038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7173399/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32337470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20Endocrine%20Society&amp;title=Endogenous%20Testosterone%20Levels%20and%20the%20Risk%20of%20Incident%20Cardiovascular%20Events%20in%20Elderly%20Men:%20The%20MrOS%20Prospective%20Study&amp;author=T.%E2%80%90H.%20Collet&amp;author=S.%20K.%20Ewing&amp;author=K.%20E.%20Ensrud&amp;volume=4&amp;publication_year=2020&amp;pages=bvaa038&amp;pmid=32337470&amp;doi=10.1210/jendso/bvaa038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0120">
<span class="label">120.</span><cite>
Laughlin G. A., Barrett‐Connor E., and Bergstrom J., “Low Serum Testosterone and Mortality in Older Men,” Journal of Clinical Endocrinology and Metabolism
93 (2008): 68–75.
</cite> [<a href="https://doi.org/10.1210/jc.2007-1792" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2190742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17911176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Endocrinology%20and%20Metabolism&amp;title=Low%20Serum%20Testosterone%20and%20Mortality%20in%20Older%20Men&amp;author=G.%20A.%20Laughlin&amp;author=E.%20Barrett%E2%80%90Connor&amp;author=J.%20Bergstrom&amp;volume=93&amp;publication_year=2008&amp;pages=68-75&amp;pmid=17911176&amp;doi=10.1210/jc.2007-1792&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0121">
<span class="label">121.</span><cite>
Khaw K.‐T., Dowsett M., Folkerd E., et al., “Endogenous Testosterone and Mortality due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC‐Norfolk) Prospective Population Study,” Circulation
116 (2007): 2694–2701.
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.107.719005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18040028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Endogenous%20Testosterone%20and%20Mortality%20due%20to%20All%20Causes,%20Cardiovascular%20Disease,%20and%20Cancer%20in%20Men:%20European%20Prospective%20Investigation%20Into%20Cancer%20in%20Norfolk%20(EPIC%E2%80%90Norfolk)%20Prospective%20Population%20Study&amp;author=K.%E2%80%90T.%20Khaw&amp;author=M.%20Dowsett&amp;author=E.%20Folkerd&amp;volume=116&amp;publication_year=2007&amp;pages=2694-2701&amp;pmid=18040028&amp;doi=10.1161/CIRCULATIONAHA.107.719005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0122">
<span class="label">122.</span><cite>
Shores M. M., Biggs M. L., Arnold A. M., et al., “Testosterone, Dihydrotestosterone, and Incident Cardiovascular Disease and Mortality in the Cardiovascular Health Study,” Journal of Clinical Endocrinology and Metabolism
99 (2014): 2061–2068.
</cite> [<a href="https://doi.org/10.1210/jc.2013-3576" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4037728/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24628549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Endocrinology%20and%20Metabolism&amp;title=Testosterone,%20Dihydrotestosterone,%20and%20Incident%20Cardiovascular%20Disease%20and%20Mortality%20in%20the%20Cardiovascular%20Health%20Study&amp;author=M.%20M.%20Shores&amp;author=M.%20L.%20Biggs&amp;author=A.%20M.%20Arnold&amp;volume=99&amp;publication_year=2014&amp;pages=2061-2068&amp;pmid=24628549&amp;doi=10.1210/jc.2013-3576&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0123">
<span class="label">123.</span><cite>
Soisson V., Brailly‐Tabard S., Helmer C., et al., “A J‐Shaped Association Between Plasma Testosterone and Risk of Ischemic Arterial Event in Elderly Men: The French 3C Cohort Study,” Maturitas
75 (2013): 282–288.
</cite> [<a href="https://doi.org/10.1016/j.maturitas.2013.04.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23706278/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Maturitas&amp;title=A%20J%E2%80%90Shaped%20Association%20Between%20Plasma%20Testosterone%20and%20Risk%20of%20Ischemic%20Arterial%20Event%20in%20Elderly%20Men:%20The%20French%203C%20Cohort%20Study&amp;author=V.%20Soisson&amp;author=S.%20Brailly%E2%80%90Tabard&amp;author=C.%20Helmer&amp;volume=75&amp;publication_year=2013&amp;pages=282-288&amp;pmid=23706278&amp;doi=10.1016/j.maturitas.2013.04.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0124">
<span class="label">124.</span><cite>
Le Bras A., “New Insights Into Female Sex‐Biased Autoimmunity,” Laboratory Animals
53 (2024): 65.</cite> [<a href="https://doi.org/10.1038/s41684-024-01338-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38396244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Laboratory%20Animals&amp;title=New%20Insights%20Into%20Female%20Sex%E2%80%90Biased%20Autoimmunity&amp;author=A.%20Le%20Bras&amp;volume=53&amp;publication_year=2024&amp;pages=65&amp;pmid=38396244&amp;doi=10.1038/s41684-024-01338-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0125">
<span class="label">125.</span><cite>
Sternini C., Anselmi L., and Rozengurt E., “Enteroendocrine Cells: A Site of ‘Taste’ in Gastrointestinal Chemosensing,” Current Opinion in Endocrinology, Diabetes, and Obesity
15 (2008): 73–78.
</cite> [<a href="https://doi.org/10.1097/MED.0b013e3282f43a73" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2943060/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18185066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Endocrinology,%20Diabetes,%20and%20Obesity&amp;title=Enteroendocrine%20Cells:%20A%20Site%20of%20%E2%80%98Taste%E2%80%99%20in%20Gastrointestinal%20Chemosensing&amp;author=C.%20Sternini&amp;author=L.%20Anselmi&amp;author=E.%20Rozengurt&amp;volume=15&amp;publication_year=2008&amp;pages=73-78&amp;pmid=18185066&amp;doi=10.1097/MED.0b013e3282f43a73&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0126">
<span class="label">126.</span><cite>
Lim G. E. and Brubaker P. L., “Glucagon‐Like Peptide 1 Secretion by the L‐Cell,” Diabetes
55 (2006): S70–S77.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Glucagon%E2%80%90Like%20Peptide%201%20Secretion%20by%20the%20L%E2%80%90Cell&amp;author=G.%20E.%20Lim&amp;author=P.%20L.%20Brubaker&amp;volume=55&amp;publication_year=2006&amp;pages=S70-S77&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0127">
<span class="label">127.</span><cite>
Song Y., Koehler J. A., Baggio L. L., Powers A. C., Sandoval D. A., and Drucker D. J., “Gut‐Proglucagon‐Derived Peptides Are Essential for Regulating Glucose Homeostasis in Mice,” Cell Metabolism
30 (2019): 976–986.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2019.08.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8140521/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31495689/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metabolism&amp;title=Gut%E2%80%90Proglucagon%E2%80%90Derived%20Peptides%20Are%20Essential%20for%20Regulating%20Glucose%20Homeostasis%20in%20Mice&amp;author=Y.%20Song&amp;author=J.%20A.%20Koehler&amp;author=L.%20L.%20Baggio&amp;author=A.%20C.%20Powers&amp;author=D.%20A.%20Sandoval&amp;volume=30&amp;publication_year=2019&amp;pages=976-986&amp;pmid=31495689&amp;doi=10.1016/j.cmet.2019.08.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0128">
<span class="label">128.</span><cite>
Chambers A. P., Sorrell J. E., Haller A., et al., “The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice,” Cell Metabolism
25 (2017): 927–934.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2017.02.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5385998/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28325479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metabolism&amp;title=The%20Role%20of%20Pancreatic%20Preproglucagon%20in%20Glucose%20Homeostasis%20in%20Mice&amp;author=A.%20P.%20Chambers&amp;author=J.%20E.%20Sorrell&amp;author=A.%20Haller&amp;volume=25&amp;publication_year=2017&amp;pages=927-934&amp;pmid=28325479&amp;doi=10.1016/j.cmet.2017.02.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0129">
<span class="label">129.</span><cite>
Ellingsgaard H., Hauselmann I., Schuler B., et al., “Interleukin‐6 Enhances Insulin Secretion by Increasing Glucagon‐Like Peptide‐1 Secretion From L Cells and Alpha Cells,” Nature Medicine
17 (2011): 1481–1489.</cite> [<a href="https://doi.org/10.1038/nm.2513" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4286294/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22037645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Medicine&amp;title=Interleukin%E2%80%906%20Enhances%20Insulin%20Secretion%20by%20Increasing%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%20Secretion%20From%20L%20Cells%20and%20Alpha%20Cells&amp;author=H.%20Ellingsgaard&amp;author=I.%20Hauselmann&amp;author=B.%20Schuler&amp;volume=17&amp;publication_year=2011&amp;pages=1481-1489&amp;pmid=22037645&amp;doi=10.1038/nm.2513&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0130">
<span class="label">130.</span><cite>
Müller T. D., Finan B., Bloom S. R., et al., “Glucagon‐Like Peptide 1 (GLP‐1),” Molecular Metabolism
30 (2019): 72–130.
</cite> [<a href="https://doi.org/10.1016/j.molmet.2019.09.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6812410/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31767182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Metabolism&amp;title=Glucagon%E2%80%90Like%20Peptide%201%20(GLP%E2%80%901)&amp;author=T.%20D.%20M%C3%BCller&amp;author=B.%20Finan&amp;author=S.%20R.%20Bloom&amp;volume=30&amp;publication_year=2019&amp;pages=72-130&amp;pmid=31767182&amp;doi=10.1016/j.molmet.2019.09.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0131">
<span class="label">131.</span><cite>
Li Y., Cao X., Li L. X., Brubaker P. L., Edlund H., and Drucker D. J., “Beta‐Cell Pdx1 Expression Is Essential for the Glucoregulatory, Proliferative, and Cytoprotective Actions of Glucagon‐Like Peptide‐1,” Diabetes
54 (2005): 482–491.
</cite> [<a href="https://doi.org/10.2337/diabetes.54.2.482" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15677506/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Beta%E2%80%90Cell%20Pdx1%20Expression%20Is%20Essential%20for%20the%20Glucoregulatory,%20Proliferative,%20and%20Cytoprotective%20Actions%20of%20Glucagon%E2%80%90Like%20Peptide%E2%80%901&amp;author=Y.%20Li&amp;author=X.%20Cao&amp;author=L.%20X.%20Li&amp;author=P.%20L.%20Brubaker&amp;author=H.%20Edlund&amp;volume=54&amp;publication_year=2005&amp;pages=482-491&amp;pmid=15677506&amp;doi=10.2337/diabetes.54.2.482&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0132">
<span class="label">132.</span><cite>
Drucker D. J., Philippe J., Mojsov S., Chick W. L., and Habener J. F., “Glucagon‐Like Peptide I Stimulates Insulin Gene Expression and Increases Cyclic AMP Levels in a Rat Islet Cell Line,” Proceedings of the National Academy of Sciences of the United States of America
84 (1987): 3434–3438.
</cite> [<a href="https://doi.org/10.1073/pnas.84.10.3434" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC304885/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3033647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America&amp;title=Glucagon%E2%80%90Like%20Peptide%20I%20Stimulates%20Insulin%20Gene%20Expression%20and%20Increases%20Cyclic%20AMP%20Levels%20in%20a%20Rat%20Islet%20Cell%20Line&amp;author=D.%20J.%20Drucker&amp;author=J.%20Philippe&amp;author=S.%20Mojsov&amp;author=W.%20L.%20Chick&amp;author=J.%20F.%20Habener&amp;volume=84&amp;publication_year=1987&amp;pages=3434-3438&amp;pmid=3033647&amp;doi=10.1073/pnas.84.10.3434&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0133">
<span class="label">133.</span><cite>
Imeryüz N., Yeğen B. C., Bozkurt A., Coşkun T., Villanueva‐Peñacarrillo M. L., and Ulusoy N. B., “Glucagon‐Like Peptide‐1 Inhibits Gastric Emptying via Vagal Afferent‐Mediated Central Mechanisms,” American Journal of Physiology
273 (1997): G920–G927.
</cite> [<a href="https://doi.org/10.1152/ajpgi.1997.273.4.G920" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9357836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology&amp;title=Glucagon%E2%80%90Like%20Peptide%E2%80%901%20Inhibits%20Gastric%20Emptying%20via%20Vagal%20Afferent%E2%80%90Mediated%20Central%20Mechanisms&amp;author=N.%20Imery%C3%BCz&amp;author=B.%20C.%20Ye%C4%9Fen&amp;author=A.%20Bozkurt&amp;author=T.%20Co%C5%9Fkun&amp;author=M.%20L.%20Villanueva%E2%80%90Pe%C3%B1acarrillo&amp;volume=273&amp;publication_year=1997&amp;pages=G920-G927&amp;pmid=9357836&amp;doi=10.1152/ajpgi.1997.273.4.G920&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0134">
<span class="label">134.</span><cite>
Boland M. L., Laker R. C., Mather K., et al., “Resolution of NASH and Hepatic Fibrosis by the GLP‐1R/GcgR Dual‐Agonist Cotadutide via Modulating Mitochondrial Function and Lipogenesis,” Nature Metabolism
2 (2020): 413–431.</cite> [<a href="https://doi.org/10.1038/s42255-020-0209-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7258337/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32478287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Metabolism&amp;title=Resolution%20of%20NASH%20and%20Hepatic%20Fibrosis%20by%20the%20GLP%E2%80%901R/GcgR%20Dual%E2%80%90Agonist%20Cotadutide%20via%20Modulating%20Mitochondrial%20Function%20and%20Lipogenesis&amp;author=M.%20L.%20Boland&amp;author=R.%20C.%20Laker&amp;author=K.%20Mather&amp;volume=2&amp;publication_year=2020&amp;pages=413-431&amp;pmid=32478287&amp;doi=10.1038/s42255-020-0209-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0135">
<span class="label">135.</span><cite>
Hu Y.‐W., Yang J. Y., Ma X., et al., “A lincRNA‐DYNLRB2‐2/GPR119/GLP‐1R/ABCA1‐Dependent Signal Transduction Pathway Is Essential for the Regulation of Cholesterol Homeostasis,” Journal of Lipid Research
55 (2014): 681–697.
</cite> [<a href="https://doi.org/10.1194/jlr.M044669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3966702/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24493833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Lipid%20Research&amp;title=A%20lincRNA%E2%80%90DYNLRB2%E2%80%902/GPR119/GLP%E2%80%901R/ABCA1%E2%80%90Dependent%20Signal%20Transduction%20Pathway%20Is%20Essential%20for%20the%20Regulation%20of%20Cholesterol%20Homeostasis&amp;author=Y.%E2%80%90W.%20Hu&amp;author=J.%20Y.%20Yang&amp;author=X.%20Ma&amp;volume=55&amp;publication_year=2014&amp;pages=681-697&amp;pmid=24493833&amp;doi=10.1194/jlr.M044669&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0136">
<span class="label">136.</span><cite>
Lockie S. H., Heppner K. M., Chaudhary N., et al., “Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon‐Like Peptide‐1 Receptor Signaling,” Diabetes
61 (2012): 2753–2762.
</cite> [<a href="https://doi.org/10.2337/db11-1556" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3478556/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22933116/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Direct%20Control%20of%20Brown%20Adipose%20Tissue%20Thermogenesis%20by%20Central%20Nervous%20System%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%20Receptor%20Signaling&amp;author=S.%20H.%20Lockie&amp;author=K.%20M.%20Heppner&amp;author=N.%20Chaudhary&amp;volume=61&amp;publication_year=2012&amp;pages=2753-2762&amp;pmid=22933116&amp;doi=10.2337/db11-1556&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0137">
<span class="label">137.</span><cite>
Chia C. W., Carlson O. D., Kim W., et al., “Exogenous Glucose‐Dependent Insulinotropic Polypeptide Worsens Post Prandial Hyperglycemia in Type 2 Diabetes,” Diabetes
58 (2009): 1342–1349.
</cite> [<a href="https://doi.org/10.2337/db08-0958" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2682676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19276444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Exogenous%20Glucose%E2%80%90Dependent%20Insulinotropic%20Polypeptide%20Worsens%20Post%20Prandial%20Hyperglycemia%20in%20Type%202%20Diabetes&amp;author=C.%20W.%20Chia&amp;author=O.%20D.%20Carlson&amp;author=W.%20Kim&amp;volume=58&amp;publication_year=2009&amp;pages=1342-1349&amp;pmid=19276444&amp;doi=10.2337/db08-0958&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0138">
<span class="label">138.</span><cite>
Lamont B. J. and Drucker D. J., “Differential Antidiabetic Efficacy of Incretin Agonists Versus DPP‐4 Inhibition in High Fat Fed Mice,” Diabetes
57 (2008): 190–198.
</cite> [<a href="https://doi.org/10.2337/db07-1202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17928394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Differential%20Antidiabetic%20Efficacy%20of%20Incretin%20Agonists%20Versus%20DPP%E2%80%904%20Inhibition%20in%20High%20Fat%20Fed%20Mice&amp;author=B.%20J.%20Lamont&amp;author=D.%20J.%20Drucker&amp;volume=57&amp;publication_year=2008&amp;pages=190-198&amp;pmid=17928394&amp;doi=10.2337/db07-1202&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0139">
<span class="label">139.</span><cite>
Møller C. L., Vistisen D., Færch K., et al., “Glucose‐Dependent Insulinotropic Polypeptide Is Associated With Lower Low‐Density Lipoprotein but Unhealthy Fat Distribution, Independent of Insulin: The ADDITION‐PRO Study,” Journal of Clinical Endocrinology and Metabolism
101 (2016): 485–493.
</cite> [<a href="https://doi.org/10.1210/jc.2015-3133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26505824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Endocrinology%20and%20Metabolism&amp;title=Glucose%E2%80%90Dependent%20Insulinotropic%20Polypeptide%20Is%20Associated%20With%20Lower%20Low%E2%80%90Density%20Lipoprotein%20but%20Unhealthy%20Fat%20Distribution,%20Independent%20of%20Insulin:%20The%20ADDITION%E2%80%90PRO%20Study&amp;author=C.%20L.%20M%C3%B8ller&amp;author=D.%20Vistisen&amp;author=K.%20F%C3%A6rch&amp;volume=101&amp;publication_year=2016&amp;pages=485-493&amp;pmid=26505824&amp;doi=10.1210/jc.2015-3133&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0140">
<span class="label">140.</span><cite>
Mentlein R., Gallwitz B., and Schmidt W. E., “Dipeptidyl‐Peptidase IV Hydrolyses Gastric Inhibitory Polypeptide, Glucagon‐Like Peptide‐1(7‐36)amide, Peptide Histidine Methionine and Is Responsible for Their Degradation in Human Serum,” European Journal of Biochemistry
214 (1993): 829–835.
</cite> [<a href="https://doi.org/10.1111/j.1432-1033.1993.tb17986.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8100523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Biochemistry&amp;title=Dipeptidyl%E2%80%90Peptidase%20IV%20Hydrolyses%20Gastric%20Inhibitory%20Polypeptide,%20Glucagon%E2%80%90Like%20Peptide%E2%80%901(7%E2%80%9036)amide,%20Peptide%20Histidine%20Methionine%20and%20Is%20Responsible%20for%20Their%20Degradation%20in%20Human%20Serum&amp;author=R.%20Mentlein&amp;author=B.%20Gallwitz&amp;author=W.%20E.%20Schmidt&amp;volume=214&amp;publication_year=1993&amp;pages=829-835&amp;pmid=8100523&amp;doi=10.1111/j.1432-1033.1993.tb17986.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0141">
<span class="label">141.</span><cite>
Gutniak M., Orskov C., Holst J. J., Ahrén B., and Efendic S., “Antidiabetogenic Effect of Glucagon‐Like Peptide‐1 (7‐36)amide in Normal Subjects and Patients With Diabetes Mellitus,” New England Journal of Medicine
326 (1992): 1316–1322.
</cite> [<a href="https://doi.org/10.1056/NEJM199205143262003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1348845/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Antidiabetogenic%20Effect%20of%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%20(7%E2%80%9036)amide%20in%20Normal%20Subjects%20and%20Patients%20With%20Diabetes%20Mellitus&amp;author=M.%20Gutniak&amp;author=C.%20Orskov&amp;author=J.%20J.%20Holst&amp;author=B.%20Ahr%C3%A9n&amp;author=S.%20Efendic&amp;volume=326&amp;publication_year=1992&amp;pages=1316-1322&amp;pmid=1348845&amp;doi=10.1056/NEJM199205143262003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0142">
<span class="label">142.</span><cite>
Flint A., Raben A., Astrup A., and Holst J. J., “Glucagon‐Like Peptide 1 Promotes Satiety and Suppresses Energy Intake in Humans,” Journal of Clinical Investigation
101 (1998): 515–520.
</cite> [<a href="https://doi.org/10.1172/JCI990" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC508592/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9449682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Glucagon%E2%80%90Like%20Peptide%201%20Promotes%20Satiety%20and%20Suppresses%20Energy%20Intake%20in%20Humans&amp;author=A.%20Flint&amp;author=A.%20Raben&amp;author=A.%20Astrup&amp;author=J.%20J.%20Holst&amp;volume=101&amp;publication_year=1998&amp;pages=515-520&amp;pmid=9449682&amp;doi=10.1172/JCI990&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0143">
<span class="label">143.</span><cite>
De Silva A., Salem V., Long C. J., et al., “The Gut Hormones PYY 3‐36 and GLP‐1 7‐36 Amide Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans,” Cell Metabolism
14 (2011): 700–706.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2011.09.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3267038/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22000927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metabolism&amp;title=The%20Gut%20Hormones%20PYY%203%E2%80%9036%20and%20GLP%E2%80%901%207%E2%80%9036%20Amide%20Reduce%20Food%20Intake%20and%20Modulate%20Brain%20Activity%20in%20Appetite%20Centers%20in%20Humans&amp;author=A.%20De%20Silva&amp;author=V.%20Salem&amp;author=C.%20J.%20Long&amp;volume=14&amp;publication_year=2011&amp;pages=700-706&amp;pmid=22000927&amp;doi=10.1016/j.cmet.2011.09.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0144">
<span class="label">144.</span><cite>
Kadowaki T., Isendahl J., Khalid U., et al., “Semaglutide Once a Week in Adults With Overweight or Obesity, With or Without Type 2 Diabetes in an East Asian Population (STEP 6): A Randomised, Double‐Blind, Double‐Dummy, Placebo‐Controlled, Phase 3a Trial,” Lancet Diabetes and Endocrinology
10 (2022): 193–206.
</cite> [<a href="https://doi.org/10.1016/S2213-8587(22)00008-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35131037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Diabetes%20and%20Endocrinology&amp;title=Semaglutide%20Once%20a%20Week%20in%20Adults%20With%20Overweight%20or%20Obesity,%20With%20or%20Without%20Type%202%20Diabetes%20in%20an%20East%20Asian%20Population%20(STEP%206):%20A%20Randomised,%20Double%E2%80%90Blind,%20Double%E2%80%90Dummy,%20Placebo%E2%80%90Controlled,%20Phase%203a%20Trial&amp;author=T.%20Kadowaki&amp;author=J.%20Isendahl&amp;author=U.%20Khalid&amp;volume=10&amp;publication_year=2022&amp;pages=193-206&amp;pmid=35131037&amp;doi=10.1016/S2213-8587(22)00008-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0145">
<span class="label">145.</span><cite>
Koska J., Sands M., Burciu C., et al., “Exenatide Protects Against Glucose‐ and Lipid‐Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP‐1 Receptor Agonists in Humans,” Diabetes
64 (2015): 2624–2635.
</cite> [<a href="https://doi.org/10.2337/db14-0976" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4477348/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25720388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Exenatide%20Protects%20Against%20Glucose%E2%80%90%20and%20Lipid%E2%80%90Induced%20Endothelial%20Dysfunction:%20Evidence%20for%20Direct%20Vasodilation%20Effect%20of%20GLP%E2%80%901%20Receptor%20Agonists%20in%20Humans&amp;author=J.%20Koska&amp;author=M.%20Sands&amp;author=C.%20Burciu&amp;volume=64&amp;publication_year=2015&amp;pages=2624-2635&amp;pmid=25720388&amp;doi=10.2337/db14-0976&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0146">
<span class="label">146.</span><cite>
Nørregaard P. K., Deryabina M. A., Tofteng Shelton P., et al., “A Novel GIP Analogue, ZP4165, Enhances Glucagon‐Like Peptide‐1‐Induced Body Weight Loss and Improves Glycaemic Control in Rodents,” Diabetes, Obesity and Metabolism
20 (2018): 60–68.</cite> [<a href="https://doi.org/10.1111/dom.13034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28598027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes,%20Obesity%20and%20Metabolism&amp;title=A%20Novel%20GIP%20Analogue,%20ZP4165,%20Enhances%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%E2%80%90Induced%20Body%20Weight%20Loss%20and%20Improves%20Glycaemic%20Control%20in%20Rodents&amp;author=P.%20K.%20N%C3%B8rregaard&amp;author=M.%20A.%20Deryabina&amp;author=P.%20Tofteng%20Shelton&amp;volume=20&amp;publication_year=2018&amp;pages=60-68&amp;pmid=28598027&amp;doi=10.1111/dom.13034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0147">
<span class="label">147.</span><cite>
Santulli G., “Tirzepatide Versus Semaglutide Once Weekly in Type 2 Diabetes,” New England Journal of Medicine
386 (2022): e17.</cite> [<a href="https://doi.org/10.1056/NEJMc2114590" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8941980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35172066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Tirzepatide%20Versus%20Semaglutide%20Once%20Weekly%20in%20Type%202%20Diabetes&amp;author=G.%20Santulli&amp;volume=386&amp;publication_year=2022&amp;pages=e17&amp;pmid=35172066&amp;doi=10.1056/NEJMc2114590&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0148">
<span class="label">148.</span><cite>
Aronne L. J., Sattar N., Horn D. B., et al., “Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT‐4 Randomized Clinical Trial,” JAMA
331 (2024): 38–48.
</cite> [<a href="https://doi.org/10.1001/jama.2023.24945" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10714284/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38078870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Continued%20Treatment%20With%20Tirzepatide%20for%20Maintenance%20of%20Weight%20Reduction%20in%20Adults%20With%20Obesity:%20The%20SURMOUNT%E2%80%904%20Randomized%20Clinical%20Trial&amp;author=L.%20J.%20Aronne&amp;author=N.%20Sattar&amp;author=D.%20B.%20Horn&amp;volume=331&amp;publication_year=2024&amp;pages=38-48&amp;pmid=38078870&amp;doi=10.1001/jama.2023.24945&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0149">
<span class="label">149.</span><cite>
Heise T., Mari A., DeVries J. H., et al., “Effects of Subcutaneous Tirzepatide Versus Placebo or Semaglutide on Pancreatic Islet Function and Insulin Sensitivity in Adults With Type 2 Diabetes: A Multicentre, Randomised, Double‐Blind, Parallel‐Arm, Phase 1 Clinical Trial,” Lancet Diabetes and Endocrinology
10 (2022): 418–429.
</cite> [<a href="https://doi.org/10.1016/S2213-8587(22)00085-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35468322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Diabetes%20and%20Endocrinology&amp;title=Effects%20of%20Subcutaneous%20Tirzepatide%20Versus%20Placebo%20or%20Semaglutide%20on%20Pancreatic%20Islet%20Function%20and%20Insulin%20Sensitivity%20in%20Adults%20With%20Type%202%20Diabetes:%20A%20Multicentre,%20Randomised,%20Double%E2%80%90Blind,%20Parallel%E2%80%90Arm,%20Phase%201%20Clinical%20Trial&amp;author=T.%20Heise&amp;author=A.%20Mari&amp;author=J.%20H.%20DeVries&amp;volume=10&amp;publication_year=2022&amp;pages=418-429&amp;pmid=35468322&amp;doi=10.1016/S2213-8587(22)00085-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0150">
<span class="label">150.</span><cite>
Willard F. S., Douros J. D., Gabe M. B., et al., “Tirzepatide Is an Imbalanced and Biased Dual GIP and GLP‐1 Receptor Agonist,” JCI Insight
5 (2020): e140532.
</cite> [<a href="https://doi.org/10.1172/jci.insight.140532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7526454/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32730231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JCI%20Insight&amp;title=Tirzepatide%20Is%20an%20Imbalanced%20and%20Biased%20Dual%20GIP%20and%20GLP%E2%80%901%20Receptor%20Agonist&amp;author=F.%20S.%20Willard&amp;author=J.%20D.%20Douros&amp;author=M.%20B.%20Gabe&amp;volume=5&amp;publication_year=2020&amp;pages=e140532&amp;pmid=32730231&amp;doi=10.1172/jci.insight.140532&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0151">
<span class="label">151.</span><cite>
Killion E. A., Lu S.‐C., Fort M., Yamada Y., Véniant M. M., and Lloyd D. J., “Glucose‐Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists?,” Endocrine Reviews
41 (2020): bnz002.
</cite> [<a href="https://doi.org/10.1210/endrev/bnz002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31511854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrine%20Reviews&amp;title=Glucose%E2%80%90Dependent%20Insulinotropic%20Polypeptide%20Receptor%20Therapies%20for%20the%20Treatment%20of%20Obesity,%20Do%20Agonists%20=%20Antagonists?&amp;author=E.%20A.%20Killion&amp;author=S.%E2%80%90C.%20Lu&amp;author=M.%20Fort&amp;author=Y.%20Yamada&amp;author=M.%20M.%20V%C3%A9niant&amp;volume=41&amp;publication_year=2020&amp;pages=bnz002&amp;pmid=31511854&amp;doi=10.1210/endrev/bnz002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0152">
<span class="label">152.</span><cite>
Killion E. A., Chen M., Falsey J. R., et al., “Chronic Glucose‐Dependent Insulinotropic Polypeptide Receptor (GIPR) Agonism Desensitizes Adipocyte GIPR Activity Mimicking Functional GIPR Antagonism,” Nature Communications
11 (2020): 4981.</cite> [<a href="https://doi.org/10.1038/s41467-020-18751-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7536395/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33020469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Chronic%20Glucose%E2%80%90Dependent%20Insulinotropic%20Polypeptide%20Receptor%20(GIPR)%20Agonism%20Desensitizes%20Adipocyte%20GIPR%20Activity%20Mimicking%20Functional%20GIPR%20Antagonism&amp;author=E.%20A.%20Killion&amp;author=M.%20Chen&amp;author=J.%20R.%20Falsey&amp;volume=11&amp;publication_year=2020&amp;pages=4981&amp;pmid=33020469&amp;doi=10.1038/s41467-020-18751-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0153">
<span class="label">153.</span><cite>
Lim D.‐M., Park K.‐Y., Hwang W.‐M., Kim J.‐Y., and Kim B.‐J., “Difference in Protective Effects of GIP and GLP‐1 on Endothelial Cells According to Cyclic Adenosine Monophosphate Response,” Experimental and Therapeutic Medicine
13 (2017): 2558–2564.
</cite> [<a href="https://doi.org/10.3892/etm.2017.4279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5443274/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28565879/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20and%20Therapeutic%20Medicine&amp;title=Difference%20in%20Protective%20Effects%20of%20GIP%20and%20GLP%E2%80%901%20on%20Endothelial%20Cells%20According%20to%20Cyclic%20Adenosine%20Monophosphate%20Response&amp;author=D.%E2%80%90M.%20Lim&amp;author=K.%E2%80%90Y.%20Park&amp;author=W.%E2%80%90M.%20Hwang&amp;author=J.%E2%80%90Y.%20Kim&amp;author=B.%E2%80%90J.%20Kim&amp;volume=13&amp;publication_year=2017&amp;pages=2558-2564&amp;pmid=28565879&amp;doi=10.3892/etm.2017.4279&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0154">
<span class="label">154.</span><cite>
Helmstädter J., Frenis K., Filippou K., et al., “Endothelial GLP‐1 (Glucagon‐Like Peptide‐1) Receptor Mediates Cardiovascular Protection by Liraglutide in Mice With Experimental Arterial Hypertension,” Arteriosclerosis, Thrombosis, and Vascular Biology
40 (2020): 145–158.
</cite> [<a href="https://doi.org/10.1161/atv.0000615456.97862.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6946108/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31747801/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arteriosclerosis,%20Thrombosis,%20and%20Vascular%20Biology&amp;title=Endothelial%20GLP%E2%80%901%20(Glucagon%E2%80%90Like%20Peptide%E2%80%901)%20Receptor%20Mediates%20Cardiovascular%20Protection%20by%20Liraglutide%20in%20Mice%20With%20Experimental%20Arterial%20Hypertension&amp;author=J.%20Helmst%C3%A4dter&amp;author=K.%20Frenis&amp;author=K.%20Filippou&amp;volume=40&amp;publication_year=2020&amp;pages=145-158&amp;pmid=31747801&amp;doi=10.1161/atv.0000615456.97862.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0155">
<span class="label">155.</span><cite>
Erdogdu O., Nathanson D., Sjöholm A., Nyström T., and Zhang Q., “Exendin‐4 Stimulates Proliferation of Human Coronary Artery Endothelial Cells Through eNOS‐, PKA‐ and PI3K/Akt‐Dependent Pathways and Requires GLP‐1 Receptor,” Molecular and Cellular Endocrinology
325 (2010): 26–35.
</cite> [<a href="https://doi.org/10.1016/j.mce.2010.04.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20452396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Endocrinology&amp;title=Exendin%E2%80%904%20Stimulates%20Proliferation%20of%20Human%20Coronary%20Artery%20Endothelial%20Cells%20Through%20eNOS%E2%80%90,%20PKA%E2%80%90%20and%20PI3K/Akt%E2%80%90Dependent%20Pathways%20and%20Requires%20GLP%E2%80%901%20Receptor&amp;author=O.%20Erdogdu&amp;author=D.%20Nathanson&amp;author=A.%20Sj%C3%B6holm&amp;author=T.%20Nystr%C3%B6m&amp;author=Q.%20Zhang&amp;volume=325&amp;publication_year=2010&amp;pages=26-35&amp;pmid=20452396&amp;doi=10.1016/j.mce.2010.04.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0156">
<span class="label">156.</span><cite>
Le Y., Wei R., Yang K., et al., “Liraglutide Ameliorates Palmitate‐Induced Oxidative Injury in Islet Microvascular Endothelial Cells Through GLP‐1 Receptor/PKA and GTPCH1/eNOS Signaling Pathways,” Peptides
124 (2020): 170212.
</cite> [<a href="https://doi.org/10.1016/j.peptides.2019.170212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31770577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Peptides&amp;title=Liraglutide%20Ameliorates%20Palmitate%E2%80%90Induced%20Oxidative%20Injury%20in%20Islet%20Microvascular%20Endothelial%20Cells%20Through%20GLP%E2%80%901%20Receptor/PKA%20and%20GTPCH1/eNOS%20Signaling%20Pathways&amp;author=Y.%20Le&amp;author=R.%20Wei&amp;author=K.%20Yang&amp;volume=124&amp;publication_year=2020&amp;pages=170212&amp;pmid=31770577&amp;doi=10.1016/j.peptides.2019.170212&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0157">
<span class="label">157.</span><cite>
Ishibashi Y., Matsui T., Takeuchi M., and Yamagishi S.‐I., “Glucagon‐Like Peptide‐1 (GLP‐1) Inhibits Advanced Glycation End Product (AGE)‐Induced Up‐Regulation of VCAM‐1 mRNA Levels in Endothelial Cells by Suppressing AGE Receptor (RAGE) Expression,” Biochemical and Biophysical Research Communications
391 (2010): 1405–1408.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2009.12.075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20026306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=Glucagon%E2%80%90Like%20Peptide%E2%80%901%20(GLP%E2%80%901)%20Inhibits%20Advanced%20Glycation%20End%20Product%20(AGE)%E2%80%90Induced%20Up%E2%80%90Regulation%20of%20VCAM%E2%80%901%20mRNA%20Levels%20in%20Endothelial%20Cells%20by%20Suppressing%20AGE%20Receptor%20(RAGE)%20Expression&amp;author=Y.%20Ishibashi&amp;author=T.%20Matsui&amp;author=M.%20Takeuchi&amp;author=S.%E2%80%90I.%20Yamagishi&amp;volume=391&amp;publication_year=2010&amp;pages=1405-1408&amp;pmid=20026306&amp;doi=10.1016/j.bbrc.2009.12.075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0158">
<span class="label">158.</span><cite>
Aronis K. N., Chamberland J. P., and Mantzoros C. S., “GLP‐1 Promotes Angiogenesis in Human Endothelial Cells in a Dose‐Dependent Manner, Through the Akt, Src and PKC Pathways,” Metabolism
62 (2013): 1279–1286.
</cite> [<a href="https://doi.org/10.1016/j.metabol.2013.04.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3755020/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23684008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metabolism&amp;title=GLP%E2%80%901%20Promotes%20Angiogenesis%20in%20Human%20Endothelial%20Cells%20in%20a%20Dose%E2%80%90Dependent%20Manner,%20Through%20the%20Akt,%20Src%20and%20PKC%20Pathways&amp;author=K.%20N.%20Aronis&amp;author=J.%20P.%20Chamberland&amp;author=C.%20S.%20Mantzoros&amp;volume=62&amp;publication_year=2013&amp;pages=1279-1286&amp;pmid=23684008&amp;doi=10.1016/j.metabol.2013.04.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0159">
<span class="label">159.</span><cite>
Zhu Y.‐X., Li Y., Ma Y., et al., “Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model,” Journal of the American Heart Association
12 (2023): e026586.
</cite> [<a href="https://doi.org/10.1161/JAHA.122.026586" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10111486/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36789853/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Heart%20Association&amp;title=Liraglutide%20Accelerates%20Ischemia%E2%80%90Induced%20Angiogenesis%20in%20a%20Murine%20Diabetic%20Model&amp;author=Y.%E2%80%90X.%20Zhu&amp;author=Y.%20Li&amp;author=Y.%20Ma&amp;volume=12&amp;publication_year=2023&amp;pages=e026586&amp;pmid=36789853&amp;doi=10.1161/JAHA.122.026586&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0160">
<span class="label">160.</span><cite>
Osto E., Doytcheva P., Corteville C., et al., “Rapid and Body Weight‐Independent Improvement of Endothelial and High‐Density Lipoprotein Function After Roux‐En‐Y Gastric Bypass: Role of Glucagon‐Like Peptide‐1,” Circulation
131 (2015): 871–881.
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.114.011791" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25673670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Rapid%20and%20Body%20Weight%E2%80%90Independent%20Improvement%20of%20Endothelial%20and%20High%E2%80%90Density%20Lipoprotein%20Function%20After%20Roux%E2%80%90En%E2%80%90Y%20Gastric%20Bypass:%20Role%20of%20Glucagon%E2%80%90Like%20Peptide%E2%80%901&amp;author=E.%20Osto&amp;author=P.%20Doytcheva&amp;author=C.%20Corteville&amp;volume=131&amp;publication_year=2015&amp;pages=871-881&amp;pmid=25673670&amp;doi=10.1161/CIRCULATIONAHA.114.011791&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0161">
<span class="label">161.</span><cite>
Clarke S. J., Giblett J. P., Yang L. L., et al., “GLP‐1 Is a Coronary Artery Vasodilator in Humans,” Journal of the American Heart Association
7 (2018): e010321.
</cite> [<a href="https://doi.org/10.1161/JAHA.118.010321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6404441/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30571482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Heart%20Association&amp;title=GLP%E2%80%901%20Is%20a%20Coronary%20Artery%20Vasodilator%20in%20Humans&amp;author=S.%20J.%20Clarke&amp;author=J.%20P.%20Giblett&amp;author=L.%20L.%20Yang&amp;volume=7&amp;publication_year=2018&amp;pages=e010321&amp;pmid=30571482&amp;doi=10.1161/JAHA.118.010321&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0162">
<span class="label">162.</span><cite>
Ding K.‐H., Zhong Q., Xu J., and Isales C. M., “Glucose‐Dependent Insulinotropic Peptide: Differential Effects on Hepatic Artery vs. Portal Vein Endothelial Cells,” American Journal of Physiology. Endocrinology and Metabolism
286 (2004): E773–E779.
</cite> [<a href="https://doi.org/10.1152/ajpendo.00507.2003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14709420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology.%20Endocrinology%20and%20Metabolism&amp;title=Glucose%E2%80%90Dependent%20Insulinotropic%20Peptide:%20Differential%20Effects%20on%20Hepatic%20Artery%20vs.%20Portal%20Vein%20Endothelial%20Cells&amp;author=K.%E2%80%90H.%20Ding&amp;author=Q.%20Zhong&amp;author=J.%20Xu&amp;author=C.%20M.%20Isales&amp;volume=286&amp;publication_year=2004&amp;pages=E773-E779&amp;pmid=14709420&amp;doi=10.1152/ajpendo.00507.2003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0163">
<span class="label">163.</span><cite>
Ding K.‐H., Zhong Q., and Isales C. M., “Glucose‐Dependent Insulinotropic Peptide Stimulates Thymidine Incorporation in Endothelial Cells: Role of Endothelin‐1,” American Journal of Physiology. Endocrinology and Metabolism
285 (2003): E390–E396.
</cite> [<a href="https://doi.org/10.1152/ajpendo.00509.2002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12721154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology.%20Endocrinology%20and%20Metabolism&amp;title=Glucose%E2%80%90Dependent%20Insulinotropic%20Peptide%20Stimulates%20Thymidine%20Incorporation%20in%20Endothelial%20Cells:%20Role%20of%20Endothelin%E2%80%901&amp;author=K.%E2%80%90H.%20Ding&amp;author=Q.%20Zhong&amp;author=C.%20M.%20Isales&amp;volume=285&amp;publication_year=2003&amp;pages=E390-E396&amp;pmid=12721154&amp;doi=10.1152/ajpendo.00509.2002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0164">
<span class="label">164.</span><cite>
Berglund L. M., Lyssenko V., Ladenvall C., et al., “Glucose‐Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin‐1 and CREB,” Diabetes
65 (2016): 239–254.
</cite> [<a href="https://doi.org/10.2337/db15-0122" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26395740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Glucose%E2%80%90Dependent%20Insulinotropic%20Polypeptide%20Stimulates%20Osteopontin%20Expression%20in%20the%20Vasculature%20via%20Endothelin%E2%80%901%20and%20CREB&amp;author=L.%20M.%20Berglund&amp;author=V.%20Lyssenko&amp;author=C.%20Ladenvall&amp;volume=65&amp;publication_year=2016&amp;pages=239-254&amp;pmid=26395740&amp;doi=10.2337/db15-0122&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0165">
<span class="label">165.</span><cite>
Ben Nasr M., Usuelli V., Dellepiane S., et al., “Glucagon‐Like Peptide 1 Receptor Is a T Cell‐Negative Costimulatory Molecule,” Cell Metabolism
36 (2024): 1302–1319.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2024.05.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38838642/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metabolism&amp;title=Glucagon%E2%80%90Like%20Peptide%201%20Receptor%20Is%20a%20T%20Cell%E2%80%90Negative%20Costimulatory%20Molecule&amp;author=M.%20Ben%20Nasr&amp;author=V.%20Usuelli&amp;author=S.%20Dellepiane&amp;volume=36&amp;publication_year=2024&amp;pages=1302-1319&amp;pmid=38838642&amp;doi=10.1016/j.cmet.2024.05.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0166">
<span class="label">166.</span><cite>
Pujadas G., Varin E. M., Baggio L. L., et al., “The Gut Hormone Receptor GIPR Links Energy Availability to the Control of Hematopoiesis,” Molecular Metabolism
39 (2020): 101008.
</cite> [<a href="https://doi.org/10.1016/j.molmet.2020.101008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7283165/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32389828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Metabolism&amp;title=The%20Gut%20Hormone%20Receptor%20GIPR%20Links%20Energy%20Availability%20to%20the%20Control%20of%20Hematopoiesis&amp;author=G.%20Pujadas&amp;author=E.%20M.%20Varin&amp;author=L.%20L.%20Baggio&amp;volume=39&amp;publication_year=2020&amp;pages=101008&amp;pmid=32389828&amp;doi=10.1016/j.molmet.2020.101008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0167">
<span class="label">167.</span><cite>
Yang L., Chen L., Li D., et al., “Effect of GLP‐1/GLP‐1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis,” Mediators of Inflammation
2021 (2021): 5568159.
</cite> [<a href="https://doi.org/10.1155/2021/5568159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8019627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33854404/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mediators%20of%20Inflammation&amp;title=Effect%20of%20GLP%E2%80%901/GLP%E2%80%901R%20on%20the%20Polarization%20of%20Macrophages%20in%20the%20Occurrence%20and%20Development%20of%20Atherosclerosis&amp;author=L.%20Yang&amp;author=L.%20Chen&amp;author=D.%20Li&amp;volume=2021&amp;publication_year=2021&amp;pages=5568159&amp;pmid=33854404&amp;doi=10.1155/2021/5568159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0168">
<span class="label">168.</span><cite>
Hadjiyanni I., Siminovitch K. A., Danska J. S., and Drucker D. J., “Glucagon‐Like Peptide‐1 Receptor Signalling Selectively Regulates Murine Lymphocyte Proliferation and Maintenance of Peripheral Regulatory T Cells,” Diabetologia
53 (2010): 730–740.
</cite> [<a href="https://doi.org/10.1007/s00125-009-1643-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20225396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Glucagon%E2%80%90Like%20Peptide%E2%80%901%20Receptor%20Signalling%20Selectively%20Regulates%20Murine%20Lymphocyte%20Proliferation%20and%20Maintenance%20of%20Peripheral%20Regulatory%20T%20Cells&amp;author=I.%20Hadjiyanni&amp;author=K.%20A.%20Siminovitch&amp;author=J.%20S.%20Danska&amp;author=D.%20J.%20Drucker&amp;volume=53&amp;publication_year=2010&amp;pages=730-740&amp;pmid=20225396&amp;doi=10.1007/s00125-009-1643-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0169">
<span class="label">169.</span><cite>
Xu Q., Zhang X., Li T., and Shao S., “Exenatide Regulates Th17/Treg Balance via PI3K/Akt/FoxO1 Pathway in Db/Db Mice,” Molecular Medicine
28 (2022): 144.
</cite> [<a href="https://doi.org/10.1186/s10020-022-00574-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9719171/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36463128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Medicine&amp;title=Exenatide%20Regulates%20Th17/Treg%20Balance%20via%20PI3K/Akt/FoxO1%20Pathway%20in%20Db/Db%20Mice&amp;author=Q.%20Xu&amp;author=X.%20Zhang&amp;author=T.%20Li&amp;author=S.%20Shao&amp;volume=28&amp;publication_year=2022&amp;pages=144&amp;pmid=36463128&amp;doi=10.1186/s10020-022-00574-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0170">
<span class="label">170.</span><cite>
da Silva E. M., Yariwake V. Y., Alves R. W., de Araujo D. R., and Andrade‐Oliveira V., “Crosstalk Between Incretin Hormones, Th17 and Treg Cells in Inflammatory Diseases,” Peptides
155 (2022): 170834.
</cite> [<a href="https://doi.org/10.1016/j.peptides.2022.170834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35753504/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Peptides&amp;title=Crosstalk%20Between%20Incretin%20Hormones,%20Th17%20and%20Treg%20Cells%20in%20Inflammatory%20Diseases&amp;author=E.%20M.%20da%20Silva&amp;author=V.%20Y.%20Yariwake&amp;author=R.%20W.%20Alves&amp;author=D.%20R.%20de%20Araujo&amp;author=V.%20Andrade%E2%80%90Oliveira&amp;volume=155&amp;publication_year=2022&amp;pages=170834&amp;pmid=35753504&amp;doi=10.1016/j.peptides.2022.170834&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0171">
<span class="label">171.</span><cite>
Efimova I., Steinberg I., Zvibel I., et al., “GIPR Signaling in Immune Cells Maintains Metabolically Beneficial Type 2 Immune Responses in the White Fat From Obese Mice,” Frontiers in Immunology
12 (2021): 643144.
</cite> [<a href="https://doi.org/10.3389/fimmu.2021.643144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7947693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33717200/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Immunology&amp;title=GIPR%20Signaling%20in%20Immune%20Cells%20Maintains%20Metabolically%20Beneficial%20Type%202%20Immune%20Responses%20in%20the%20White%20Fat%20From%20Obese%20Mice&amp;author=I.%20Efimova&amp;author=I.%20Steinberg&amp;author=I.%20Zvibel&amp;volume=12&amp;publication_year=2021&amp;pages=643144&amp;pmid=33717200&amp;doi=10.3389/fimmu.2021.643144&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0172">
<span class="label">172.</span><cite>
Moschovaki Filippidou F., Kirsch A. H., Thelen M., et al., “Glucagon‐Like Peptide‐1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T‐Cell Proliferation,” American Journal of Pathology
190 (2020): 400–411.
</cite> [<a href="https://doi.org/10.1016/j.ajpath.2019.10.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31759969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Pathology&amp;title=Glucagon%E2%80%90Like%20Peptide%E2%80%901%20Receptor%20Agonism%20Improves%20Nephrotoxic%20Serum%20Nephritis%20by%20Inhibiting%20T%E2%80%90Cell%20Proliferation&amp;author=F.%20Moschovaki%20Filippidou&amp;author=A.%20H.%20Kirsch&amp;author=M.%20Thelen&amp;volume=190&amp;publication_year=2020&amp;pages=400-411&amp;pmid=31759969&amp;doi=10.1016/j.ajpath.2019.10.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0173">
<span class="label">173.</span><cite>
Radbakhsh S., Atkin S. L., Simental‐Mendia L. E., and Sahebkar A., “The Role of Incretins and Incretin‐Based Drugs in Autoimmune Diseases,” International Immunopharmacology
98 (2021): 107845.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2021.107845" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34126341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Immunopharmacology&amp;title=The%20Role%20of%20Incretins%20and%20Incretin%E2%80%90Based%20Drugs%20in%20Autoimmune%20Diseases&amp;author=S.%20Radbakhsh&amp;author=S.%20L.%20Atkin&amp;author=L.%20E.%20Simental%E2%80%90Mendia&amp;author=A.%20Sahebkar&amp;volume=98&amp;publication_year=2021&amp;pages=107845&amp;pmid=34126341&amp;doi=10.1016/j.intimp.2021.107845&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0174">
<span class="label">174.</span><cite>
Drucker D. J. and Holst J. J., “The Expanding Incretin Universe: From Basic Biology to Clinical Translation,” Diabetologia
66 (2023): 1765–1779.
</cite> [<a href="https://doi.org/10.1007/s00125-023-05906-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36976349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=The%20Expanding%20Incretin%20Universe:%20From%20Basic%20Biology%20to%20Clinical%20Translation&amp;author=D.%20J.%20Drucker&amp;author=J.%20J.%20Holst&amp;volume=66&amp;publication_year=2023&amp;pages=1765-1779&amp;pmid=36976349&amp;doi=10.1007/s00125-023-05906-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0175">
<span class="label">175.</span><cite>
Wan S. and Sun H., “Glucagon‐Like Peptide‐1 Modulates RAW264.7 Macrophage Polarization by Interfering With the JNK/STAT3 Signaling Pathway,” Experimental and Therapeutic Medicine
17 (2019): 3573–3579.
</cite> [<a href="https://doi.org/10.3892/etm.2019.7347" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6447820/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30988739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20and%20Therapeutic%20Medicine&amp;title=Glucagon%E2%80%90Like%20Peptide%E2%80%901%20Modulates%20RAW264.7%20Macrophage%20Polarization%20by%20Interfering%20With%20the%20JNK/STAT3%20Signaling%20Pathway&amp;author=S.%20Wan&amp;author=H.%20Sun&amp;volume=17&amp;publication_year=2019&amp;pages=3573-3579&amp;pmid=30988739&amp;doi=10.3892/etm.2019.7347&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0176">
<span class="label">176.</span><cite>
Chaudhuri A., Ghanim H., Vora M., et al., “Exenatide Exerts a Potent Antiinflammatory Effect,” Journal of Clinical Endocrinology and Metabolism
97 (2012): 198–207.
</cite> [<a href="https://doi.org/10.1210/jc.2011-1508" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3251936/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22013105/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Endocrinology%20and%20Metabolism&amp;title=Exenatide%20Exerts%20a%20Potent%20Antiinflammatory%20Effect&amp;author=A.%20Chaudhuri&amp;author=H.%20Ghanim&amp;author=M.%20Vora&amp;volume=97&amp;publication_year=2012&amp;pages=198-207&amp;pmid=22013105&amp;doi=10.1210/jc.2011-1508&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0177">
<span class="label">177.</span><cite>
Arakawa M., Mita T., Azuma K., et al., “Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon‐Like Peptide‐1 Receptor Agonist, Exendin‐4,” Diabetes
59 (2010): 1030–1037.
</cite> [<a href="https://doi.org/10.2337/db09-1694" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2844811/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20068138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Inhibition%20of%20Monocyte%20Adhesion%20to%20Endothelial%20Cells%20and%20Attenuation%20of%20Atherosclerotic%20Lesion%20by%20a%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%20Receptor%20Agonist,%20Exendin%E2%80%904&amp;author=M.%20Arakawa&amp;author=T.%20Mita&amp;author=K.%20Azuma&amp;volume=59&amp;publication_year=2010&amp;pages=1030-1037&amp;pmid=20068138&amp;doi=10.2337/db09-1694&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0178">
<span class="label">178.</span><cite>
Sha S., Liu X., Zhao R., et al., “Effects of Glucagon‐Like Peptide‐1 Analog Liraglutide on the Systemic Inflammation in High‐Fat‐Diet‐Induced Mice,” Endocrine
66 (2019): 494–502.
</cite> [<a href="https://doi.org/10.1007/s12020-019-02081-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31542859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrine&amp;title=Effects%20of%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%20Analog%20Liraglutide%20on%20the%20Systemic%20Inflammation%20in%20High%E2%80%90Fat%E2%80%90Diet%E2%80%90Induced%20Mice&amp;author=S.%20Sha&amp;author=X.%20Liu&amp;author=R.%20Zhao&amp;volume=66&amp;publication_year=2019&amp;pages=494-502&amp;pmid=31542859&amp;doi=10.1007/s12020-019-02081-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0179">
<span class="label">179.</span><cite>
Finan B., Müller T. D., Clemmensen C., Perez‐Tilve D., DiMarchi R. D., and Tschöp M. H., “Reappraisal of GIP Pharmacology for Metabolic Diseases,” Trends in Molecular Medicine
22 (2016): 359–376.
</cite> [<a href="https://doi.org/10.1016/j.molmed.2016.03.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27038883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Molecular%20Medicine&amp;title=Reappraisal%20of%20GIP%20Pharmacology%20for%20Metabolic%20Diseases&amp;author=B.%20Finan&amp;author=T.%20D.%20M%C3%BCller&amp;author=C.%20Clemmensen&amp;author=D.%20Perez%E2%80%90Tilve&amp;author=R.%20D.%20DiMarchi&amp;volume=22&amp;publication_year=2016&amp;pages=359-376&amp;pmid=27038883&amp;doi=10.1016/j.molmed.2016.03.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0180">
<span class="label">180.</span><cite>
Yang Y., Wang Y., Zhou Y., Deng J., and Wu L., “Tirzepatide Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via IL‐17 Signaling Pathway,” Molecular and Cellular Biochemistry
480 (2024): 1241–1254, 10.1007/s11010-024-05066-1.
</cite> [<a href="https://doi.org/10.1007/s11010-024-05066-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38965127/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Biochemistry&amp;title=Tirzepatide%20Alleviates%20Oxidative%20Stress%20and%20Inflammation%20in%20Diabetic%20Nephropathy%20via%20IL%E2%80%9017%20Signaling%20Pathway&amp;author=Y.%20Yang&amp;author=Y.%20Wang&amp;author=Y.%20Zhou&amp;author=J.%20Deng&amp;author=L.%20Wu&amp;volume=480&amp;publication_year=2024&amp;pages=1241-1254&amp;pmid=38965127&amp;doi=10.1007/s11010-024-05066-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0181">
<span class="label">181.</span><cite>
Rivera F. B., Ybañez M. J. C., Magalong J. V., et al., “Enrollment of Females in Randomized Trials for Glucagon‐Like Peptide 1 Receptor Agonists: A Systematic Review,” JACC: Advances
3 (2024): 101386.
</cite> [<a href="https://doi.org/10.1016/j.jacadv.2024.101386" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11585747/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39583870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC:%20Advances&amp;title=Enrollment%20of%20Females%20in%20Randomized%20Trials%20for%20Glucagon%E2%80%90Like%20Peptide%201%20Receptor%20Agonists:%20A%20Systematic%20Review&amp;author=F.%20B.%20Rivera&amp;author=M.%20J.%20C.%20Yba%C3%B1ez&amp;author=J.%20V.%20Magalong&amp;volume=3&amp;publication_year=2024&amp;pages=101386&amp;pmid=39583870&amp;doi=10.1016/j.jacadv.2024.101386&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0182">
<span class="label">182.</span><cite>
Lincoff A. M., Brown‐Frandsen K., Colhoun H. M., et al., “Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes,” New England Journal of Medicine
389 (2023): 2221–2232.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2307563" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37952131/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Semaglutide%20and%20Cardiovascular%20Outcomes%20in%20Obesity%20Without%20Diabetes&amp;author=A.%20M.%20Lincoff&amp;author=K.%20Brown%E2%80%90Frandsen&amp;author=H.%20M.%20Colhoun&amp;volume=389&amp;publication_year=2023&amp;pages=2221-2232&amp;pmid=37952131&amp;doi=10.1056/NEJMoa2307563&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0183">
<span class="label">183.</span><cite>
Raparelli V., Elharram M., Moura C. S., et al., “Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus,” Journal of the American Heart Association
9 (2020): e012940.
</cite> [<a href="https://doi.org/10.1161/JAHA.119.012940" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6988160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31902326/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Heart%20Association&amp;title=Sex%20Differences%20in%20Cardiovascular%20Effectiveness%20of%20Newer%20Glucose%E2%80%90Lowering%20Drugs%20Added%20to%20Metformin%20in%20Type%202%20Diabetes%20Mellitus&amp;author=V.%20Raparelli&amp;author=M.%20Elharram&amp;author=C.%20S.%20Moura&amp;volume=9&amp;publication_year=2020&amp;pages=e012940&amp;pmid=31902326&amp;doi=10.1161/JAHA.119.012940&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0184">
<span class="label">184.</span><cite>
Onishi Y., Oura T., Matsui A., Matsuura J., and Iwamoto N., “Analysis of Efficacy and Safety of Dulaglutide 0.75 Mg Stratified by Sex in Patients With Type 2 Diabetes in 2 Randomized, Controlled Phase 3 Studies in Japan,” Endocrine Journal
64 (2017): 553–560.
</cite> [<a href="https://doi.org/10.1507/endocrj.EJ16-0552" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28367916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrine%20Journal&amp;title=Analysis%20of%20Efficacy%20and%20Safety%20of%20Dulaglutide%200.75%20Mg%20Stratified%20by%20Sex%20in%20Patients%20With%20Type%202%20Diabetes%20in%202%20Randomized,%20Controlled%20Phase%203%20Studies%20in%20Japan&amp;author=Y.%20Onishi&amp;author=T.%20Oura&amp;author=A.%20Matsui&amp;author=J.%20Matsuura&amp;author=N.%20Iwamoto&amp;volume=64&amp;publication_year=2017&amp;pages=553-560&amp;pmid=28367916&amp;doi=10.1507/endocrj.EJ16-0552&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0185">
<span class="label">185.</span><cite>
Xie C., Huang W., Sun Y., et al., “Disparities in the Glycemic and Incretin Responses to Intraduodenal Glucose Infusion Between Healthy Young Men and Women,” Journal of Clinical Endocrinology and Metabolism
108 (2023): e712–e719.
</cite> [<a href="https://doi.org/10.1210/clinem/dgad176" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10438868/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36987568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Endocrinology%20and%20Metabolism&amp;title=Disparities%20in%20the%20Glycemic%20and%20Incretin%20Responses%20to%20Intraduodenal%20Glucose%20Infusion%20Between%20Healthy%20Young%20Men%20and%20Women&amp;author=C.%20Xie&amp;author=W.%20Huang&amp;author=Y.%20Sun&amp;volume=108&amp;publication_year=2023&amp;pages=e712-e719&amp;pmid=36987568&amp;doi=10.1210/clinem/dgad176&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0186">
<span class="label">186.</span><cite>
Brennan I. M., Feltrin K. L., Nair N. S., et al., “Effects of the Phases of the Menstrual Cycle on Gastric Emptying, Glycemia, Plasma GLP‐1 and Insulin, and Energy Intake in Healthy Lean Women,” American Journal of Physiology. Gastrointestinal and Liver Physiology
297 (2009): G602–G610.
</cite> [<a href="https://doi.org/10.1152/ajpgi.00051.2009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19556358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology.%20Gastrointestinal%20and%20Liver%20Physiology&amp;title=Effects%20of%20the%20Phases%20of%20the%20Menstrual%20Cycle%20on%20Gastric%20Emptying,%20Glycemia,%20Plasma%20GLP%E2%80%901%20and%20Insulin,%20and%20Energy%20Intake%20in%20Healthy%20Lean%20Women&amp;author=I.%20M.%20Brennan&amp;author=K.%20L.%20Feltrin&amp;author=N.%20S.%20Nair&amp;volume=297&amp;publication_year=2009&amp;pages=G602-G610&amp;pmid=19556358&amp;doi=10.1152/ajpgi.00051.2009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0187">
<span class="label">187.</span><cite>
Handgraaf S., Dusaulcy R., Visentin F., Philippe J., and Gosmain Y., “17‐β Estradiol Regulates Proglucagon‐Derived Peptide Secretion in Mouse and Human α‐ and L Cells,” JCI Insight
3 (2018): e98569.
</cite> [<a href="https://doi.org/10.1172/jci.insight.98569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5928861/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29618657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JCI%20Insight&amp;title=17%E2%80%90%CE%B2%20Estradiol%20Regulates%20Proglucagon%E2%80%90Derived%20Peptide%20Secretion%20in%20Mouse%20and%20Human%20%CE%B1%E2%80%90%20and%20L%20Cells&amp;author=S.%20Handgraaf&amp;author=R.%20Dusaulcy&amp;author=F.%20Visentin&amp;author=J.%20Philippe&amp;author=Y.%20Gosmain&amp;volume=3&amp;publication_year=2018&amp;pages=e98569&amp;pmid=29618657&amp;doi=10.1172/jci.insight.98569&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0188">
<span class="label">188.</span><cite>
Finan B., Yang B., Ottaway N., et al., “Targeted Estrogen Delivery Reverses the Metabolic Syndrome,” Nature Medicine
18 (2012): 1847–1856.</cite> [<a href="https://doi.org/10.1038/nm.3009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3757949/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23142820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Medicine&amp;title=Targeted%20Estrogen%20Delivery%20Reverses%20the%20Metabolic%20Syndrome&amp;author=B.%20Finan&amp;author=B.%20Yang&amp;author=N.%20Ottaway&amp;volume=18&amp;publication_year=2012&amp;pages=1847-1856&amp;pmid=23142820&amp;doi=10.1038/nm.3009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0189">
<span class="label">189.</span><cite>
Richard J. E., Anderberg R. H., López‐Ferreras L., Olandersson K., and Skibicka K. P., “Sex and Estrogens Alter the Action of Glucagon‐Like Peptide‐1 on Reward,” Biology of Sex Differences
7 (2016): 6.
</cite> [<a href="https://doi.org/10.1186/s13293-016-0059-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4715328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26779332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biology%20of%20Sex%20Differences&amp;title=Sex%20and%20Estrogens%20Alter%20the%20Action%20of%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%20on%20Reward&amp;author=J.%20E.%20Richard&amp;author=R.%20H.%20Anderberg&amp;author=L.%20L%C3%B3pez%E2%80%90Ferreras&amp;author=K.%20Olandersson&amp;author=K.%20P.%20Skibicka&amp;volume=7&amp;publication_year=2016&amp;pages=6&amp;pmid=26779332&amp;doi=10.1186/s13293-016-0059-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0190">
<span class="label">190.</span><cite>
Vogel H., Wolf S., Rabasa C., et al., “GLP‐1 and Estrogen Conjugate Acts in the Supramammillary Nucleus to Reduce Food‐Reward and Body Weight,” Neuropharmacology
110 (2016): 396–406.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2016.07.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27496691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=GLP%E2%80%901%20and%20Estrogen%20Conjugate%20Acts%20in%20the%20Supramammillary%20Nucleus%20to%20Reduce%20Food%E2%80%90Reward%20and%20Body%20Weight&amp;author=H.%20Vogel&amp;author=S.%20Wolf&amp;author=C.%20Rabasa&amp;volume=110&amp;publication_year=2016&amp;pages=396-406&amp;pmid=27496691&amp;doi=10.1016/j.neuropharm.2016.07.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0191">
<span class="label">191.</span><cite>
Coupland C., Sun N., Khalil A., et al., “Estrogenic Activity of E2‐Conjugated GLP‐1 Is Mediated by Intracellular Endolysosomal Acidification and Estrone Metabolism,” Molecular Metabolism
96 (2025): 102136, 10.1016/j.molmet.2025.102136.
</cite> [<a href="https://doi.org/10.1016/j.molmet.2025.102136" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12032945/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40204014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Metabolism&amp;title=Estrogenic%20Activity%20of%20E2%E2%80%90Conjugated%20GLP%E2%80%901%20Is%20Mediated%20by%20Intracellular%20Endolysosomal%20Acidification%20and%20Estrone%20Metabolism&amp;author=C.%20Coupland&amp;author=N.%20Sun&amp;author=A.%20Khalil&amp;volume=96&amp;publication_year=2025&amp;pages=102136&amp;pmid=40204014&amp;doi=10.1016/j.molmet.2025.102136&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0192">
<span class="label">192.</span><cite>
Gallwitz B., Dagogo‐Jack S., Thieu V., et al., “Effect of Once‐Weekly Dulaglutide on Glycated Haemoglobin (HbA1c) and Fasting Blood Glucose in Patient Subpopulations by Gender, Duration of Diabetes and Baseline HbA1c,” Diabetes, Obesity &amp; Metabolism
20 (2018): 409–418.</cite> [<a href="https://doi.org/10.1111/dom.13086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6084353/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28817231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes,%20Obesity%20&amp;%20Metabolism&amp;title=Effect%20of%20Once%E2%80%90Weekly%20Dulaglutide%20on%20Glycated%20Haemoglobin%20(HbA1c)%20and%20Fasting%20Blood%20Glucose%20in%20Patient%20Subpopulations%20by%20Gender,%20Duration%20of%20Diabetes%20and%20Baseline%20HbA1c&amp;author=B.%20Gallwitz&amp;author=S.%20Dagogo%E2%80%90Jack&amp;author=V.%20Thieu&amp;volume=20&amp;publication_year=2018&amp;pages=409-418&amp;pmid=28817231&amp;doi=10.1111/dom.13086&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0193">
<span class="label">193.</span><cite>
Wilding J. P. H., Overgaard R. V., Jacobsen L. V., Jensen C. B., and le Roux C. W., “Exposure‐Response Analyses of Liraglutide 3.0 Mg for Weight Management,” Diabetes, Obesity and Metabolism
18 (2016): 491–499.</cite> [<a href="https://doi.org/10.1111/dom.12639" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5069568/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26833744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes,%20Obesity%20and%20Metabolism&amp;title=Exposure%E2%80%90Response%20Analyses%20of%20Liraglutide%203.0%E2%80%89Mg%20for%20Weight%20Management&amp;author=J.%20P.%20H.%20Wilding&amp;author=R.%20V.%20Overgaard&amp;author=L.%20V.%20Jacobsen&amp;author=C.%20B.%20Jensen&amp;author=C.%20W.%20le%20Roux&amp;volume=18&amp;publication_year=2016&amp;pages=491-499&amp;pmid=26833744&amp;doi=10.1111/dom.12639&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0194">
<span class="label">194.</span><cite>
Shadid S., Abosi‐Appeadu K., de Maertelaere A. S., et al., “Effects of Gender‐Affirming Hormone Therapy on Insulin Sensitivity and Incretin Responses in Transgender People,” Diabetes Care
43 (2020): 411–417.
</cite> [<a href="https://doi.org/10.2337/dc19-1061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31740479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Effects%20of%20Gender%E2%80%90Affirming%20Hormone%20Therapy%20on%20Insulin%20Sensitivity%20and%20Incretin%20Responses%20in%20Transgender%20People&amp;author=S.%20Shadid&amp;author=K.%20Abosi%E2%80%90Appeadu&amp;author=A.%20S.%20de%20Maertelaere&amp;volume=43&amp;publication_year=2020&amp;pages=411-417&amp;pmid=31740479&amp;doi=10.2337/dc19-1061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0195">
<span class="label">195.</span><cite>
Xu W., Qadir M. M. F., Nasteska D., et al., “Architecture of Androgen Receptor Pathways Amplifying Glucagon‐Like Peptide‐1 Insulinotropic Action in Male Pancreatic β Cells,” Cell Reports
42 (2023): 112529.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2023.112529" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10312392/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37200193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Reports&amp;title=Architecture%20of%20Androgen%20Receptor%20Pathways%20Amplifying%20Glucagon%E2%80%90Like%20Peptide%E2%80%901%20Insulinotropic%20Action%20in%20Male%20Pancreatic%20%CE%B2%20Cells&amp;author=W.%20Xu&amp;author=M.%20M.%20F.%20Qadir&amp;author=D.%20Nasteska&amp;volume=42&amp;publication_year=2023&amp;pages=112529&amp;pmid=37200193&amp;doi=10.1016/j.celrep.2023.112529&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0196">
<span class="label">196.</span><cite>
Graybill S., Hatfield J., Kravchenko M., et al., “Neutral Effect of Exenatide on Serum Testosterone in Men With Type 2 Diabetes Mellitus: A Prospective Cohort,” Andrology
9 (2021): 792–800.
</cite> [<a href="https://doi.org/10.1111/andr.12966" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33400403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Andrology&amp;title=Neutral%20Effect%20of%20Exenatide%20on%20Serum%20Testosterone%20in%20Men%20With%20Type%202%20Diabetes%20Mellitus:%20A%20Prospective%20Cohort&amp;author=S.%20Graybill&amp;author=J.%20Hatfield&amp;author=M.%20Kravchenko&amp;volume=9&amp;publication_year=2021&amp;pages=792-800&amp;pmid=33400403&amp;doi=10.1111/andr.12966&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0197">
<span class="label">197.</span><cite>
Xing C., Zhao H., Zhang J., and He B., “Effect of Metformin Versus Metformin Plus Liraglutide on Gonadal and Metabolic Profiles in Overweight Patients With Polycystic Ovary Syndrome,” Frontiers in Endocrinology
13 (2022): 945609.
</cite> [<a href="https://doi.org/10.3389/fendo.2022.945609" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9428699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36060969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Endocrinology&amp;title=Effect%20of%20Metformin%20Versus%20Metformin%20Plus%20Liraglutide%20on%20Gonadal%20and%20Metabolic%20Profiles%20in%20Overweight%20Patients%20With%20Polycystic%20Ovary%20Syndrome&amp;author=C.%20Xing&amp;author=H.%20Zhao&amp;author=J.%20Zhang&amp;author=B.%20He&amp;volume=13&amp;publication_year=2022&amp;pages=945609&amp;pmid=36060969&amp;doi=10.3389/fendo.2022.945609&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0198">
<span class="label">198.</span><cite>
Bierhansl L., Conradi L.‐C., Treps L., Dewerchin M., and Carmeliet P., “Central Role of Metabolism in Endothelial Cell Function and Vascular Disease,” Physiology
32 (2017): 126–140.
</cite> [<a href="https://doi.org/10.1152/physiol.00031.2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5337830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28202623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiology&amp;title=Central%20Role%20of%20Metabolism%20in%20Endothelial%20Cell%20Function%20and%20Vascular%20Disease&amp;author=L.%20Bierhansl&amp;author=L.%E2%80%90C.%20Conradi&amp;author=L.%20Treps&amp;author=M.%20Dewerchin&amp;author=P.%20Carmeliet&amp;volume=32&amp;publication_year=2017&amp;pages=126-140&amp;pmid=28202623&amp;doi=10.1152/physiol.00031.2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0199">
<span class="label">199.</span><cite>
Galle J., Quaschning T., Seibold S., and Wanner C., “Endothelial Dysfunction and Inflammation: What Is the Link?,” Kidney International
63 (2003): S45–S49, 10.1046/j.1523-1755.63.s84.12.x.</cite> [<a href="https://doi.org/10.1046/j.1523-1755.63.s84.12.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12694307/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20International&amp;title=Endothelial%20Dysfunction%20and%20Inflammation:%20What%20Is%20the%20Link?&amp;author=J.%20Galle&amp;author=T.%20Quaschning&amp;author=S.%20Seibold&amp;author=C.%20Wanner&amp;volume=63&amp;publication_year=2003&amp;pages=S45-S49&amp;pmid=12694307&amp;doi=10.1046/j.1523-1755.63.s84.12.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0200">
<span class="label">200.</span><cite>
Geltink R. I. K., Kyle R. L., and Pearce E. L., “Unraveling the Complex Interplay Between T Cell Metabolism and Function,” Annual Review of Immunology
36 (2018): 461–488.</cite> [<a href="https://doi.org/10.1146/annurev-immunol-042617-053019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6323527/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29677474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annual%20Review%20of%20Immunology&amp;title=Unraveling%20the%20Complex%20Interplay%20Between%20T%20Cell%20Metabolism%20and%20Function&amp;author=R.%20I.%20K.%20Geltink&amp;author=R.%20L.%20Kyle&amp;author=E.%20L.%20Pearce&amp;volume=36&amp;publication_year=2018&amp;pages=461-488&amp;pmid=29677474&amp;doi=10.1146/annurev-immunol-042617-053019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0201">
<span class="label">201.</span><cite>
Gerriets V. A., Kishton R. J., Nichols A. G., et al., “Metabolic Programming and PDHK1 Control CD4+ T Cell Subsets and Inflammation,” Journal of Clinical Investigation
125 (2015): 194–207.
</cite> [<a href="https://doi.org/10.1172/JCI76012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4382238/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25437876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Metabolic%20Programming%20and%20PDHK1%20Control%20CD4+%20T%20Cell%20Subsets%20and%20Inflammation&amp;author=V.%20A.%20Gerriets&amp;author=R.%20J.%20Kishton&amp;author=A.%20G.%20Nichols&amp;volume=125&amp;publication_year=2015&amp;pages=194-207&amp;pmid=25437876&amp;doi=10.1172/JCI76012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0202">
<span class="label">202.</span><cite>
Angelin A., Gil‐de‐Gómez L., Dahiya S., et al., “Foxp3 Reprograms T Cell Metabolism to Function in Low‐Glucose, High‐Lactate Environments,” Cell Metabolism
25 (2017): 1282–1293.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2016.12.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5462872/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28416194/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metabolism&amp;title=Foxp3%20Reprograms%20T%20Cell%20Metabolism%20to%20Function%20in%20Low%E2%80%90Glucose,%20High%E2%80%90Lactate%20Environments&amp;author=A.%20Angelin&amp;author=L.%20Gil%E2%80%90de%E2%80%90G%C3%B3mez&amp;author=S.%20Dahiya&amp;volume=25&amp;publication_year=2017&amp;pages=1282-1293&amp;pmid=28416194&amp;doi=10.1016/j.cmet.2016.12.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0203">
<span class="label">203.</span><cite>
Weyrich M., Cremer S., Gerster M., et al., “Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease,” Circulation
150 (2024): 746–757.
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.124.069139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11361358/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39005209/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Loss%20of%20Y%20Chromosome%20and%20Cardiovascular%20Events%20in%20Chronic%20Kidney%20Disease&amp;author=M.%20Weyrich&amp;author=S.%20Cremer&amp;author=M.%20Gerster&amp;volume=150&amp;publication_year=2024&amp;pages=746-757&amp;pmid=39005209&amp;doi=10.1161/CIRCULATIONAHA.124.069139&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0204">
<span class="label">204.</span><cite>
Kelly D. M. and Jones T. H., “Testosterone: A Vascular Hormone in Health and Disease,” Journal of Endocrinology
217 (2013): R47–R71.
</cite> [<a href="https://doi.org/10.1530/JOE-12-0582" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23549841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Endocrinology&amp;title=Testosterone:%20A%20Vascular%20Hormone%20in%20Health%20and%20Disease&amp;author=D.%20M.%20Kelly&amp;author=T.%20H.%20Jones&amp;volume=217&amp;publication_year=2013&amp;pages=R47-R71&amp;pmid=23549841&amp;doi=10.1530/JOE-12-0582&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0205">
<span class="label">205.</span><cite>
Certo M., Elkafrawy H., Pucino V., Cucchi D., Cheung K. C. P., and Mauro C., “Endothelial Cell and T‐Cell Crosstalk: Targeting Metabolism as a Therapeutic Approach in Chronic Inflammation,” British Journal of Pharmacology
178 (2021): 2041–2059.
</cite> [<a href="https://doi.org/10.1111/bph.15002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8246814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31999357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Endothelial%20Cell%20and%20T%E2%80%90Cell%20Crosstalk:%20Targeting%20Metabolism%20as%20a%20Therapeutic%20Approach%20in%20Chronic%20Inflammation&amp;author=M.%20Certo&amp;author=H.%20Elkafrawy&amp;author=V.%20Pucino&amp;author=D.%20Cucchi&amp;author=K.%20C.%20P.%20Cheung&amp;volume=178&amp;publication_year=2021&amp;pages=2041-2059&amp;pmid=31999357&amp;doi=10.1111/bph.15002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="apha70091-bib-0206">
<span class="label">206.</span><cite>
Arnold A. P., “Conceptual Frameworks and Mouse Models for Studying Sex Differences in Physiology and Disease: Why Compensation Changes the Game,” Experimental Neurology
259 (2014): 2–9.
</cite> [<a href="https://doi.org/10.1016/j.expneurol.2014.01.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4125548/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24509348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20Neurology&amp;title=Conceptual%20Frameworks%20and%20Mouse%20Models%20for%20Studying%20Sex%20Differences%20in%20Physiology%20and%20Disease:%20Why%20Compensation%20Changes%20the%20Game&amp;author=A.%20P.%20Arnold&amp;volume=259&amp;publication_year=2014&amp;pages=2-9&amp;pmid=24509348&amp;doi=10.1016/j.expneurol.2014.01.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data sharing not applicable to this article as no datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Acta Physiologica (Oxford, England) are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/apha.70091"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/APHA-241-e70091.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12368768/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12368768/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368768%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368768/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12368768/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12368768/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40838278/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12368768/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40838278/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12368768/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12368768/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="duDCnMd3GZO5xLlTm24VbMwcgwb1XopRgp7aaeVjDBEww0DVXGoyGnaXM8hWMNNt">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
